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ABSTRACT
ELUCIDATING THE DETERMINANTS OF ALVEOLAR EPITHELIAL CELL FATE FROM
LUNG DEVELOPMENT TO REGENERATION
Derek C. Liberti
Edward E. Morrisey
The alveolus is the functional unit of gas exchange in the lung and home to two major
epithelial cell lineages: alveolar epithelial type 1 (AT1) and type 2 (AT2) cells. Large,
squamous AT1 cells cover the vast majority of the adult lung surface area, creating the
gas diffusible interface between the external environment and the vasculature. Cuboidal
AT2 cells secrete pulmonary surfactant to reduce surface tension at this air-liquid
interface to prevent alveolar collapse. These cells are essential for lung function, and
many are lost upon lung injury. Thus, understanding the signals required to generate
and regenerate these cells is vital to develop interventions to support long term
pulmonary health. In this dissertation, I use a combination of epigenetic and
transcriptomic profiling, in vivo mouse genetic and injury models, ex vivo organoid
assays, and human patient tissue to define essential mediators of the developmental
emergence, lineage commitment, and plasticity of AT1 and AT2 cells. I demonstrate that
Dnmt1 ensures the proper specification and compartmentalization of proximal and distal
epithelial cell lineages during development. Developing a method to segment
heterogeneously injured adult lung tissue into distinct zones by severity, I define specific
injury niches and characterize the spatially restricted cellular responses to damage
intensity in mice and humans. I determine that Fgfr2 maintains early AT2 cell identity
and balances AT2 cell proliferation and differentiation during lung regeneration.
Additionally, I demonstrate the extent of AT1 cell plasticity during neonatal and adult
regeneration to generate AT2 cells. Finally, I show that Klf5 regulates AT1 cell lineage
v

commitment during both lung development and regeneration. This work defines
essential factors that determine alveolar epithelial cell fate and reveals how these
choices impact both lung development and regeneration.
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CHAPTER 1: INTRODUCTION

This chapter includes sections adapted from work published in Trends in Molecular
Medicine (Liberti and Morrisey, 2021).

1.1 Summary
The lung is an architecturally complex organ that bridges the external environment with
the internal environment of an organism to enable respiration. This chapter will
summarize the major lung epithelial cell types, review the major pre- and postnatal
stages of lung development, describe the incredible regenerative capacity of the lung
after acute injury, and highlight open questions in the field of lung biology to
contextualize the work in this dissertation. Future chapters will investigate two
fundamental questions in lung cell biology: how are cell fate choices made and how do
these choices impact tissue development and regeneration?

1.2 The lung: form and function
In biological systems, structure begets function, and the lung is no exception. Beginning
as the trachea transitions into the main stem bronchi, the lung consists of a sophisticated
branched network of airways, lined with various luminal epithelial cell lineages that
maintain airway hydration and capture and remove undesirable pathogens and debris.
These airway lineages are maintained in large part by basal cells, which can self-renew
and differentiate into most if not all luminal airway epithelia, including goblet cells, club
cells, multi-ciliated cells, neuroendocrine cells, tuft cells, and ionocytes (Figure 1.1A)
(Davis and Wypych, 2021, Montoro et al., 2018, Plasschaert et al., 2018, Hong et al.,
2004b, Rock et al., 2009, Hajj et al., 2007, Hong et al., 2004a). In mice, the airways
1

extend, and their luminal diameters are reduced, until they terminate in the alveolar
compartment. However, in humans and most other large mammals, as the airways
systematically and gradually diminish in size, they generate distinct compartments, such
as the respiratory bronchioles, before interdigitating with the alveolar parenchyma (Hsia
et al., 2013). The alveoli are the sites where long, squamous alveolar epithelial type 1
(AT1) cells intertwine with the capillary plexus to provide the gas diffusible interface
between the external environment and the vascular system. To prevent alveolar collapse
at this air-liquid interface, alveolar epithelial type 2 (AT2) cells produce and secrete
pulmonary surfactant, a mixture of lipids and proteins that reduce alveolar surface
tension. The adult lung is largely quiescent. During long term homeostasis, AT2 cells
maintain the alveolar epithelium through occasional proliferation and differentiation into
AT1 cells, and this facultative progenitor function extends to adult injury on a more
robust scale (Figure 1.1B) (Barkauskas et al., 2013). However, it remains unclear how
AT1 cells respond after lung injury and what mechanisms regulate alveolar epithelial cell
fate choices during lung regeneration.

1.3 Lung specification, branching morphogenesis, and alveologenesis
Lung epithelial cell fate decisions play important roles in alveolar repair and
regeneration. Much of our knowledge of the critical pathways controlling these decisions
draws from investigation of the highly stereotyped developmental processes guiding the
formation of the structurally complex adult lung. In mice, the master transcription factor
Nkx2.1 drives lung specification from the ventral anterior foregut endoderm around
embryonic day 9.0 (E9.0) (Minoo et al., 1999, Yuan et al., 2000). Patterning and
specification of the early lung lineages, as well as the intricate prenatal branching
process of the lung itself, are directed by a combination of factors including
2

biomechanical forces, autocrine signaling within the endoderm, and paracrine signaling
between the endoderm and the surrounding mesoderm through a variety of pathways
including Fgf, Bmp, Wnt, RA, Shh, Notch, and Tgf-β (Conrad et al., 2021, Li et al., 2018,
Sekine et al., 1999, Chang et al., 2013, Lebeche et al., 1999, Weaver et al., 2000, Frank
et al., 2019, Volckaert et al., 2013, Arman et al., 1999, Abler et al., 2009, De Langhe et
al., 2008, Goss et al., 2009, Li et al., 2013, Ikonomou et al., 2020, Harris-Johnson et al.,
2009, Kadzik et al., 2014, Li et al., 2005, Li et al., 2002, Mucenski et al., 2003, Rajagopal
et al., 2008, Shu et al., 2005, Shu et al., 2002, Wang et al., 2016b, Menshykau et al.,
2014, Rankin et al., 2012, White et al., 2006, Miller et al., 2001, Tsao et al., 2016, Mori et
al., 2015, Tsao et al., 2009, Chen et al., 2007, Lü et al., 2007). Work describing these
pathways has shown that the early lung becomes quickly compartmentalized into
proximal airway and the distal alveolar compartments from which the epithelial lineages
of the airway and alveolus arise (Kadzik and Morrisey, 2012, Morrisey and Hogan, 2010,
Domyan and Sun, 2011, McCulley et al., 2015, Sivakumar and Frank, 2019, Swarr and
Morrisey, 2015, Morrisey et al., 2013, Herriges and Morrisey, 2014, Fernandes-Silva et
al., 2020, Kugler et al., 2015, Xu et al., 2012, Kiyokawa and Morimoto, 2020, Aros et al.,
2021, Fernandes-Silva et al., 2017). Moreover, a recent study has illustrated that
specification of the distal alveolar epithelial lineages occurs much earlier than previously
appreciated and that alveolar epithelial cells are largely specified by E15.5 (Frank et al.,
2019). However, the role of epigenetics in the lung remains underappreciated (Pierre
and Marconett, 2021). The investigation of the developing lung epigenome may provide
insight into how the proximal-distal boundary is both established and maintained
throughout both development and adult life.

3

After birth, the transition to air breathing initiates the final phase of lung development
called alveologenesis, which is complete in mice by 4-6 weeks of age (Pozarska et al.,
2017). This phase involves the formation of secondary septa where crosstalk between
the alveolar epithelium and a transient population of secondary crest myofibroblasts
leads to a dramatic increase in alveolar surface area and the formation of the adult
alveolar niche (He et al., 2021, Li et al., 2019a, Li et al., 2020a, Zepp et al., 2021, Lignelli
et al., 2019, Branchfield et al., 2016). Alveolar epithelial cells proliferate minimally during
this time with the exception of a small window of AT2 cell proliferation during early
alveologenesis (Frank et al., 2016, Yang et al., 2016). The mechanical and biochemical
signaling driving progenitor cell action and guiding cell fate specification and proliferation
during development are of particular interest in modeling the regenerative processes in
the adult lung after injury. For example, AT1 cell spreading beginning around E17.5 is
thought to be a major driver of the increase in alveolar complexity during lung
development (Wang et al., 2016b). This spreading may be recapitulated after adult injury
as AT2 cells differentiate into comparatively large AT1 cells, driving morphological
remodeling to generate new alveoli. Additionally, AT1 cells have recently been shown to
act as signaling hubs, directing lung development (Zepp et al., 2021). It remains to be
seen whether and how this activity extends to adult regeneration.

1.4 Lung injury and regeneration
While largely quiescent at homeostasis, many of the resident alveolar cells can respond
robustly to tissue damage, resulting from various perturbations from daily inhaled
irritants to acute infection, to repair and regenerate the lung. Functional lung
regeneration after injury requires restoration of lost respiratory capacity due to
destruction of alveoli and distal airway structures. This regeneration involves two
4

fundamental requirements: 1) replacement of lost cells and 2) reformation of disrupted
tissue architecture. However, these activities are balanced by the need for emergency
repair of the barrier between the external environment and internal tissues to prevent
severe acute illness and death. The advent of murine in vivo lineage tracing systems
coupled with models of acute respiratory distress syndrome (ARDS) have greatly
increased our knowledge of the cell types involved in repair and regeneration of the lung
(Zepp and Morrisey, 2019, Fernanda de Mello Costa et al., 2020, Basil et al., 2020,
Leach and Morrisey, 2018, Alysandratos et al., 2021b, Whitsett et al., 2019). However,
our understanding of the molecular mechanisms driving these cellular behaviors is
limited by the tools available to dissect out the complex intercellular coordination of
these cell types in a spatial and temporal manner. Moreover, lung injury is
heterogeneous and may generate distinct regenerative niches depending on severity of
injury in a particular area, complicating analysis. Nevertheless, the development of in
vivo murine lineage tracing tools and injury models has greatly improved our
understanding of lung regeneration.

The major driver of alveolar regeneration is the AT2 cell. AT2 cells are best
characterized as facultative progenitors in that they are largely quiescent at homeostasis
but can respond rapidly and robustly to acute lung injury. After lung injury, AT2 cells
expand clonally and differentiate into AT1 cells (Barkauskas et al., 2013, Evans et al.,
1973). These behaviors are regulated by a variety of signaling pathways including Wnt,
Fgf, Tgf-β, Bmp, and Hippo, as well as inflammation (Choi et al., 2020, LaCanna et al.,
2019, Katsura et al., 2019, Nabhan et al., 2018, Zacharias et al., 2018, Zepp et al., 2017,
Riemondy et al., 2019, Wu et al., 2020, Dorry et al., 2020, MacKenzie et al., 2015,
Quantius et al., 2016, Yuan et al., 2019, Chung et al., 2018). However, it is unclear how
5

AT2 cells balance the decision to proliferate versus differentiate after acute lung injury.
In contrast to that of AT2 cells, the role of AT1 cells in lung regeneration remains largely
unknown. It has been suggested that AT1 cells possess a limited ability to reprogram
into AT2 cells in a compensatory regrowth model (Jain et al., 2015). Yet, no studies to
date have evaluated AT1 cell plasticity in a regenerative context except to show that
they do not contribute to dysplastic lung repair (Ray et al., 2016). Additionally, while
many studies report that AT2 cells generate AT1 cells during lung regeneration, this
concept has not been tested in the context of neonatal injury when the alveolar niche is
quite different from that of adults.

The most distal region of the mouse airway contains the bronchioalveolar junction
(BADJ), where the airways abruptly open into the alveolar compartment. A rare
population of bronchoalveolar stem cells (BASCs) exists at this juncture and is
characterized by co-expression of both airway secretory cell markers (e.g. Scgb1a1) and
alveolar AT2 cell markers (e.g. Sftpc) (Kim et al., 2005). The lack of restricted markers
specific to these cells has hampered the detailed investigation of BASCs and their
contribution to lung regeneration. Moreover, while careful lineage tracing studies have
recently corroborated BASC contribution to distal lung regeneration across multiple
injuries, these reports provide conflicting assessments of the necessity of BASCs for
functional lung regeneration (Salwig et al., 2019, Liu et al., 2019). Nevertheless, the
existence of BASCs suggests that the thin boundary between the airway and alveolar
compartments in mice leads to some niche overlap, allowing for plasticity between
airway versus alveolar cell fates. However, in humans, this BADJ region is replaced by
the respiratory airway region, containing respiratory bronchioles, where airway and
alveolar epithelial cells exist intermingled in close proximity (Basil and Morrisey, 2021,
6

Basil et al., 2022, Kadur Lakshminarasimha Murthy et al., 2022). Recent work identified
a secretory cell type within this region that can give rise to AT2 cells (Basil et al., 2022).
Whether this cell type represents the human equivalent of a BASC remains an open
question.

Some severe injuries can elicit a response from basal cell-like progenitor cells, which
infiltrate into the alveolar space. These p63+ progenitor cells form Krt5+ pod structures,
which can be readily identified morphologically as they appear similar to airway
bronchiolar epithelium (Vaughan et al., 2015, Kumar et al., 2011, Loosli et al., 1975).
These progenitors do not appear to readily or substantially contribute to AT1 or AT2 cell
regeneration, but the epithelial tissue generated by these cells appears to persist long
after injury resolution (Fernanda de Mello Costa et al., 2020). These structures may act
as an emergency barrier repair mechanism in the setting of acute lung damage. Future
work elucidating how these cells are stimulated to infiltrate into the alveolar space and
how they are able to largely maintain their airway epithelial cell identity in the alveolar
compartment will be of great interest.

1.5 Modeling lung epithelial cell behavior ex vivo
The advent of 3D culture systems has revolutionized our capability to model epithelial
cell behavior. These cultures are often referred to as organoids, and they have enabled
investigation of the mechanistic underpinnings of cell organization and fate decisions ex
vivo (Clevers, 2016, Kobayashi et al., 2020). While immortalized cell lines can provide a
simple, inexpensive model for examining molecular pathways, they often fail to
recapitulate behaviors of their in vivo counterparts (Lou and Leung, 2018, Carius et al.,
2021). Some of the first reported organoid assays in the lung were generated from basal
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cells, often referred to as tracheospheres or bronchospheres (Rock et al., 2009). As
outlined above, basal cells line the trachea and main stem bronchus of the mouse lung
and are distinguished by their expression of restricted markers including Keratin 5,
Keratin 14, the transcription factor Trp63, and the cell surface protein NGFR. This
restricted marker expression enables multiple methods of isolation of these cells for
organoid assays, including via genetic reporter lines and antibodies. In contrast to mice,
human lung basal cells are found throughout the airway tree, extending not only to the
terminal bronchioles but even to a small number in the most distal respiratory
bronchioles (Fernanda de Mello Costa et al., 2020, Evans et al., 2001, Rock et al.,
2010). This difference in distribution in the human lung suggests that basal cells are
more involved both in homeostasic maintainance and in the injury response in the distal
human lung.

Primary human basal cells can be grown, passaged, and expanded extensively, albeit
not indefinitely (Gao et al., 2015, Mou et al., 2016, Peters-Hall et al., 2018, Lee et al.,
2020, Hynds et al., 2019, Berical et al., 2019, Butler et al., 2016). While recent work
reports generation of neuroendocrine, goblet, and tuft cells from airway organoids,
human and mouse basal cell organoids differentiate primarily into multi-ciliated and club
cells (Figure 1.2) (Rock et al., 2009, Miller et al., 2020, Greaney et al., 2020, Hild and
Jaffe, 2016, Katsura and Hogan, 2021, Nikolić et al., 2017). These cell fate decisions
have been shown to be regulated by a variety of pathways including Notch, Fgf, Bmp, IL6/Stat3, and Tgf-β-Id2 signaling (Rock et al., 2011, Miller et al., 2020, Tadokoro et al.,
2016, Yuan et al., 2019, Tadokoro et al., 2014, Kiyokawa et al., 2021, Balasooriya et al.,
2017, Lin et al., 2021). The expansion and differentiation potential of basal cell
organoids has led to the development of basal cell biobanks from both normal and
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diseased human lungs, which could serve as possible reservoirs for both basic research
and future cell therapies for airway diseases (Sachs et al., 2019).

The Hogan Laboratory pioneered the use of AT2 cells in organoids, showing that mouse
AT2 cells grown in Matrigel proliferate and differentiate into AT1 cells (Barkauskas et al.,
2013). In this system, AT2 cells can be expanded through co-culture with lung fibroblasts
(Table 1.1) (Zepp et al., 2017, Zacharias et al., 2018, Frank et al., 2016, Barkauskas et
al., 2013, Chung et al., 2018). AT2 cell organoids, often called alveolar organoids or
alveolospheres, have since been used for a variety of purposes, including defining
pathways that promote AT2 cell proliferation, AT2-AT1 cell differentiation, and modeling
lung disease (Katsura et al., 2019, Frank et al., 2016, Chung et al., 2018, Sun et al.,
2019). Alveolar organoids have also been used to characterize mesenchymal-epithelial
signaling to better define the paracrine signals that regulate lung regeneration (Zepp et
al., 2017, Chung et al., 2018, Lee et al., 2017). These studies have helped to define
distinct mesenchymal cell lineages in the lung that are either pro-regenerative or profibrotic after acute lung injury (Zepp et al., 2017).

While organoids provide insight into AT2 cell pro-regenerative behaviors, they do not
always fully recapitulate in vivo biology. For instance, Bmpr1a promotes AT2-AT1 cell
differentiation both in mouse organoid assays and after pneumonectomy in vivo (Chung
et al., 2018). However, while Bmp signaling through addition of BMP4 or constitutive
activation Bmpr1a in AT2 cells negatively impacts proliferation and colony forming
efficiency of alveolar organoids, there is little impact on AT2 cell proliferation upon loss
of Bmpr1a in vivo after pneumonectomy (Chung et al., 2018). One potential explanation
for this discrepancy is the existence of many compensatory inputs to proliferation that
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are present in the alveolar niche in vivo and absent ex vivo. Indeed, it may be that there
are multiple parallel drivers of AT2 cell proliferation. Organoids provide a useful platform
to test such hypotheses by simplifying a complex disease landscape into a tunable
system to model cellular behavior in response to precise perturbations. The dissolution
of tissue to a single cell suspension likely resembles severe injury, given the harsh
digestion and isolation methods needed to obtain AT2 cells and the forced clonal
outgrowth to form organoids. Such conditions recapitulate the driving principles behind
regeneration: survival, proliferation, and differentiation (Figures 1.3A-B). Organoid
assays enable the untangling of overlapping molecular pathways that can be masked in
vivo through activation of compensatory mechanisms. Thus, the combination of
organoids with in vivo modeling permits a deeper understanding of how different signals
drive cellular behavior.

1.6 Pluripotent stem cell models of lung epithelial cell behavior
One of the major recent innovations in modeling epithelial behavior lies in the
implementation of pluripotent stem cell (PSC) technology in organoid assay
development. From the generation of human PSC-derived AT2 cells and basal cells, we
have learned that many of the same processes directing murine development are
analogous to those that drive human lung development (Hawkins et al., 2021, Jacob et
al., 2017). Similarly, these models hold promise for correlating findings in mouse models
with human disease, for modeling genetic diseases, for enabling drug screening, and for
the development of cell therapies (Kong et al., 2021, Evans and Lee, 2020, Li et al.,
2020b, Barkauskas et al., 2017, Katsura and Hogan, 2021).
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The advancement of pluripotent stem cell (PSC) technology greatly ameliorates the
limitations of the availability of source material and tools in primary human lung epithelial
cell assays. In recent years, several groups have developed directed differentiation
protocols, recapitulating highly stereotyped developmental signaling patterns in vitro, to
mimic the in vivo specification processes along both proximal and distal epithelial
lineage differentiation. This directed differentiation system allows for the generation of
virtually limitless human experimental material. Moreover, a huge advantage of this
system lies in the ability to generate PSCs from patient samples to model diseases, and
with the advent of CRISPR/Cas9 gene editing technology, it is possible to induce or
correct various mutations in PSC lines with greater ease. However, PSC models rely on
complex directed differentiation protocols to derive a particular cell type of interest for
investigation, and some genetic manipulations can disrupt this differentiation process,
potentially limiting this model to the study of cell type specific disease paradigms.
Moreover, the efficiency of these procedures is variable, leading to the ultimate
generation of heterogenous cell populations in addition to the cell type of interest. This
heterogeneity can be circumvented through the use of cellular enrichment techniques,
including fluorescence-activated cell sorting with cell surface antibodies and genetically
introduced fluorescent reporters. However, culture conditions that enforce maintenance
of an undifferentiated state in a stem cell, like a basal cell, are not straightforward and
may ultimately impact stem cell function. Despite some limitations, PSCs provide a
versatile tool that facilitates the identification of human cell lineage relationships,
provides a model for human lung diseases, and allows for high throughput screening to
identify factors and pathways that can promote lung regeneration.
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PSC-derived proximal lineages hold great promise in particular for modeling genetic
diseases like cystic fibrosis. The generation of PSC-derived basal, secretory, and multiciliated cells has allowed for the development of ex vivo human models of airway
epithelial lineage relationships and disease modeling (Figure 1.4) (Hawkins et al., 2021,
Sachs et al., 2019, McCauley et al., 2018, Konishi et al., 2016, Suzuki et al., 2021,
Huang et al., 2014). The importance of these studies to the advancement of our
understanding of human lung biology is clear, and ongoing investigations are critical to
explore how similar these PSC-derived lineages are to their in vivo counterparts. It
remains to be seen if such cells can be reproducibly used for in vivo engraftment and
future cell therapies. As previous work has shown, culture conditions required for
expansion of particular lineages may predispose cells to unwanted trans-differentiation
upon transplantation (Weiner et al., 2019). Yet, the building of large biobanks of primary
and PSC-derived basal cells from human airways could significantly accelerate the
screening of potential therapies for diseases including cystic fibrosis (Sachs et al., 2019,
Gentzsch et al., 2017, Hawkins et al., 2021).

The creation of induced AT2-like cells derived from PSCs, or iAT2 cells, reflects the
impressive extent of our current knowledge of lung developmental biology (Jacob et al.,
2017, Gotoh et al., 2014, Huang et al., 2014, Dye et al., 2015, Chen et al., 2017, Jacob
et al., 2019). These cells can be efficiently generated and propagated as organoids and
they have recently been used to study SARS-CoV-2 infection (Hekman et al., 2021,
Huang et al., 2020, Li et al., 2021, Lu et al., 2021, Ebisudani et al., 2021). Additionally,
while iAT2 cells provide a useful model to study growth dynamics, iAT2 cells are limited
in their ability to model human lung cell biology. In vivo, AT2 cells act as facultative
progenitors capable of self-renewal and differentiation into AT1 cells. However, few
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groups have convincingly demonstrated AT1 cell generation from iAT2 cells and even
these groups rely on in vivo maturation of cultures, mesenchymal feeder cells, or plating
in 2D culture conditions with serum to achieve this rare result (Kanagaki et al., 2021,
Yamamoto et al., 2017, Huang et al., 2014, Jacob et al., 2017). These data suggest that
there is still much we do not understand about the signals necessary to generate and
maintain AT1 cells (Table 1.1, Figure 1.5A-B).

1.7 Conclusion
This chapter reviews our current knowledge of the processes governing lung
development and regeneration, including some of the major in vivo and ex vivo tools
models used in the lung biology field. This dissertation addresses several of the
outstanding questions highlighted above focusing on the overarching theme of alveolar
epithelial cell fate choice. In the chapters that follow, I identify and investigate the
epigenetic maintenance of the proximal-distal boundary during prenatal lung
development. I then describe the development and implementation of an automated
image analysis tool capable of segmenting damaged lung tissue by severity to improve
our understanding of the heterogenous damage resulting from lung injury. Using this
tool, I assess the differential responses of AT2 cells to various signals across this
heterogenous regenerative landscape and determine how AT2 cells balance identity
maintenance versus differentiation after lung injury. Next, I explore AT1 cell plasticity in
different injury contexts in both neonatal and adult mice. Finally, I identify Klf5 as an
essential regulator of AT1 cell lineage commitment in both development and lung
regeneration. Together, these data illustrate some of the essential factors that determine
alveolar epithelial cell fate choice and how these choices drive both lung development
and regeneration.
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Table 1.1: Mouse and human AT2 cell organoid culture methodologies.
Source
Mouse
AT2 cells

Isolation method

Supporting cells

• Fluorescent
• Commercially
lineage reporter
available human
based (Zepp et
fibroblasts (Sun et
al., 2017,
al., 2019)
Barkauskas et
al., 2013, Chung • Cultured primary
et al., 2018,
mouse lung
Liberti et al.,
fibroblasts
2021, Katsura et
(Zacharias et al.,
al., 2019, Sun et
2018, Frank et al.,
al., 2019, Lee et
2016, Liberti et al.,
al., 2017,
2021, Choi et al.,
Lechner et al.,
2020)
2017, Katsura et
al., 2020,
• Freshly isolated
Kobayashi et al.,
primary mouse lung
2020, Choi et al.,
fibroblasts
2020)
(Barkauskas et al.,
2013, Zepp et al.,
• Antibody based
2017, Chung et al.,
(Katsura et al.,
2018, Katsura et al.,
2019, Shiraishi
2019, Lee et al.,
et al., 2019b)
2017, Shiraishi et
al., 2019b,
• Fluorescent
Kobayashi et al.,
lineage reporter
2020)
and antibody
based (Frank et
• Macrophages
al., 2016,
(Lechner et al.,
Zacharias et al.,
2017, Choi et al.,
2018, Weiner et
2020)
al., 2019)
• Feeder-free
(Katsura et al.,
2020, Weiner et al.,
2019, Shiraishi et
al., 2019b)
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AT1 cell
differentiation
(by protein markers)
• PDPN+ (Frank et
al., 2016,
Barkauskas et al.,
2013, Katsura et al.,
2019, Lee et al.,
2017)
• AQP5+ (Zacharias
et al., 2018,
Barkauskas et al.,
2013, Zepp et al.,
2017, Shiraishi et
al., 2019b)
• HOPX+
(Barkauskas et al.,
2013, Chung et al.,
2018, Zepp et al.,
2017, Katsura et al.,
2019, Sun et al.,
2019, Shiraishi et
al., 2019b, Choi et
al., 2020)
• AGER+ (Liberti et
al., 2021, Katsura et
al., 2019, Katsura et
al., 2020, Kobayashi
et al., 2020)
• AGER+ (overlap
with SFTPC+)
(Lechner et al.,
2017)
• CAV1+ (Choi et al.,
2020)

Human
AT2 cells

Human
pluripotent
stem cells

• Antibody based
(Zacharias et al.,
2018, Katsura et
al., 2020, Youk
et al., 2020,
Ebisudani et al.,
2021,
Barkauskas et
al., 2013)

• No selection
(Huang et al.,
2014, Dye et al.,
2015, Chen et
al., 2017)

• Commercially
available human
fibroblasts
(Zacharias et al.,
2018, Barkauskas et
al., 2013)
• Feeder-free
(Katsura et al.,
2020, Ebisudani et
al., 2021, Youk et
al., 2020)
• Commercially
available human
fibroblasts (Gotoh et
al., 2014,
Yamamoto et al.,
2017)

• Fluorescent
lineage reporter
• Feeder-free (Jacob
and antibody
et al., 2017, Jacob
based (Jacob et
et al., 2019)
al., 2017, Jacob
et al., 2019,
Gotoh et al.,
2014,
Yamamoto et al.,
2017)
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• AQP5+ (Zacharias
et al., 2018, Youk et
al., 2020)
• AQP5 (overlap with
SFTPC+ and
SFTPB+) (Ebisudani
et al., 2021)
• AGER+ (Youk et al.,
2020, Katsura et al.,
2020)
• AQP5+ (Gotoh et
al., 2014, Huang et
al., 2014,
Yamamoto et al.,
2017)
• HOPX+ (Huang et
al., 2014, Dye et al.,
2015, Chen et al.,
2017) (not restricted
to human AT1 cells)
(Liebler et al., 2016)
• PDPN+ (Huang et
al., 2014, Dye et al.,
2015, Yamamoto et
al., 2017) (not of
suitable specificity
for mixed
airway/alveolar
organoids)

Figure 1.1: Lung epithelial lineages
(A) Basal cells can give rise to the major luminal epithelial lineages of the airway. (B)
Alveolar epithelial type 2 cells proliferate and differentiate into alveolar epithelial type 1
cells to maintain adult homeostasis and to regenerate the lung after acute injury.
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Figure 1.2: Primary airway organoids
(Top) Basal cells can be isolated from the tracheas of multiple species (e.g. mouse, rat,
and human) or the large airways (e.g. human) and can be expanded and differentiated in
vitro. (Bottom) lung bud tip progenitors of the developing human lung can form robust
airway organoids capable of expansion and differentiation. Club cells: light blue, ciliated
cells: orange, goblet cells: green, tuft cell: dark blue, pulmonary neuroendocrine cell:
brown.
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Figure 1.3: Primary alveolar organoids
(A) Isolation of alveolar epithelial type 2 (AT2) cells (green) from lungs utilizing genetic
reporters (mouse) or antibody-based methods (mouse and/or human) involves digestion
of distal alveoli for subsequent culture in air-liquid interface (shown) or submersion
droplet culture. (B) (top) Mouse-derived AT2 cells expand and differentiate readily into
alveolar epithelial type 1 (AT1) cells (red) over several weeks.
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Figure 1.4: Pluripotent stem cell (PSC) derived airway alveolar organoids
PSC-derived airway organoids can be generated directly from NKX2.1+ progenitors or
from PSC-derived basal cells (PSCs: yellow, club cells: blue, ciliated cells: orange,
goblet cell: green).
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Figure 1.5: Future directions for generating PSC-derived AT1 cells
(A) Current methodologies to generate alveolar epithelial type 1 (AT1) cells from PSCs
(yellow) in vitro rely on generation of alveolar epithelial type 2 (AT2) cells (green) first
and rely on 2D culture conditions and serum containing media or feeder cell co-culture to
induce differentiation. (B) Future work investigating the reinforcement of signaling
pathways associated with maintenance of AT1 cell identity and inhibition of signaling
pathways associated with maintenance of AT2 cell identity just after the specification of
NKX2.1 progenitors (grey) may promote generation of AT1 (red) cells from PSCs.
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CHAPTER 2: DNMT1 IS REQUIRED FOR PROXIMAL-DISTAL PATTERNING
OF THE LUNG ENDODERM AND FOR RESTRAINING ALVEOLAR EPITHELIAL
TYPE 2 CELL FATE

This chapter is largely adapted from work published in Developmental Biology and was
performed in collaboration with Jarod A. Zepp (Liberti et al., 2019). Kyle H. Liberti
provided essential software engineering expertise to process imaging data in this study.
Christina A. Bartoni performed experiments and collected samples used for RNA
sequencing. Su Zhou and Minmin Lu contributed to histological preparation, and Michael
P. Morley aided in bioinformatic analysis.

2.1 Summary
Lung endoderm development occurs through a series of finely coordinated
transcriptional processes that are regulated by epigenetic mechanisms. However, the
role of DNA methylation in regulating lung endoderm development remains poorly
understood. We demonstrate that DNA methyltransferase 1 (Dnmt1) is required for early
branching morphogenesis of the lungs and for restraining epithelial fate specification.
Loss of Dnmt1 leads to an early branching defect, a loss of epithelial polarity and
proximal endodermal cell differentiation, and an expansion of the distal endoderm
compartment. Dnmt1 deficiency also disrupts epithelial-mesenchymal crosstalk and
leads to precocious distal endodermal cell differentiation with premature expression of
alveolar type 2 cell restricted genes. Even after the majority of epithelial cells are
specified at E15.5, Dnmt1 is still required to maintain the boundary between the proximal
and distal epithelial compartments. These data reveal an important requirement for
Dnmt1 in early lung development to promote proper branching morphogenesis, maintain
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proximal endodermal cell fate, and suppress premature activation of distal epithelial cell
fate.

2.2 Introduction
The lung endoderm is initially specified from a small number of Nkx2.1 expressing cells
within the ventral anterior foregut endoderm. These Nkx2.1+ endoderm cells give rise to
the entirety of lung epithelium and are patterned in a proximal-distal fashion in part
through a process called branching morphogenesis. Throughout this temporally
regulated process, early endodermal precursors undergo fate decisions along the highly
patterned proximal-distal axis (Hines and Sun, 2014, Swarr and Morrisey, 2015, Whitsett
et al., 2019). This patterning serves to spatially restrict proximal from distal epithelial
progenitors. Proximal epithelial precursors, marked by expression of Sox2, give rise to
airway lineages, such as ciliated and secretory cells. Distal epithelial precursors, marked
by Sox9, will ultimately give rise to alveolar lineages, alveolar type 1 (AT1) and type 2
(AT2) cells, which form the surface for gas exchange and produce pulmonary surfactant
respectively. Branching morphogenesis and cell fate specification are critical for the
proper formation of the mature lung, and perturbations of either of these processes can
result in the rapid onset of perinatal distress or lethality.

Epigenetic mechanisms of gene regulation have been previously shown to play critical
roles in lung development. For instance, chromatin modifying enzymes Hdac1/2 are
required in the lung epithelium to maintain expression of Sox2 and, subsequently, for
proximal airway development (Wang et al., 2013). Additionally, Hdac3 regulates AT1 cell
spreading, which is required for distal alveolar maturation (Wang et al., 2016a, Wang et
al., 2016b). Further, the Ezh2 component of Prc2 plays an essential role in the
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development of both epithelial and mesenchymal lineages, where it represses basal cell
lineage commitment in the epithelium and constrains smooth muscle cell fate in the
mesoderm (Snitow et al., 2016, Snitow et al., 2015).

DNA methylation has been shown to be a critical regulator of cell differentiation in
multiple organs, including the prostate, intestine, kidney, and brain. Loss of Dnmt1 in
these organs induces both precocious differentiation and a loss of proper
morphogenesis (Joseph et al., 2019, Elliott et al., 2015, Sheaffer et al., 2014, Li et al.,
2019b, Takizawa et al., 2001, Fan et al., 2005). Dnmt1 is primary known as a
maintenance DNA methyltransferase, copying methylation patterns to newly synthesized
DNA during replication, and it is required for embryonic development as Dnmt1 null mice
exhibit developmental arrest by E9.5, resulting in lethality before E11.0 (Li et al., 1992).
Despite its clear importance in organ development, the specific role of Dnmt1 in
regulating lung development is unknown.

In this study, we demonstrate that endodermal Dnmt1 is required for lung
morphogenesis and for epithelial cell fate specification. Branching defects appear in
Dnmt1 deficient lungs as early as E11.5. As morphogenesis progresses, Dnmt1-deficient
lungs fail to branch properly, leading to the formation of cystic sacs and lung hypoplasia.
We show that Dnmt1 is required to maintain proximal-distal patterning and that loss of
Dnmt1 expression in the endoderm results in the expansion of the distal compartment
with a concomitant loss of proximal epithelial cell fate and the disruption of epithelial
polarity and epithelial-mesenchymal crosstalk. Dnmt1 also acts to restrain distal
epithelial cell differentiation to maintain the boundary between the proximal and distal
compartments with loss of Dnmt1 leading to precocious AT2 cell fate acquisition and
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disruption of the proximal-distal axis even after alveolar epithelial cell specification.
These data show that Dnmt1 plays a critical role in defining the proximal-distal patterning
of the lung endoderm and is essential in restricting AT2 cell fate in early lung
development.

2.3 Endodermal loss of Dnmt1 leads to lung hypoplasia
To begin defining the role of DNA methylation during lung endoderm development, we
examined the expression of Dnmt1, a major maintenance DNA methylation factor.
Analysis of mouse lung epithelial RNA-seq data shows that Dnmt1 is highly expressed in
the embryonic day 12.5 (E12.5) lung endoderm compared to the adult lung epithelium
(Figure 2.1A) (Herriges et al., 2014). Immunohistochemistry (IHC) for DNMT1 protein
demonstrates that it is present throughout the mesoderm and endoderm in the
developing lung (Figure 2.1B). To determine the importance of Dnmt1 in lung
development,

we

inactivated

Dnmt1

in

the

lung

endoderm

by

generating

ShhCre;Dnmt1Flox/Flox (Dnmt1EKO) mice (Figure 2.1C). At E14.5, Dnmt1EKO lungs appeared
hypoplastic, and by E18.5 the airways became dilated and cystic in appearance
(Figures 2.1D and E). These data demonstrate that Dnmt1 is expressed at high levels
in both the developing lung endoderm and mesoderm, and its expression in the
endoderm is essential for normal lung development.

2.4 Dnmt1 is required for proximal-distal patterning
To examine the effect of loss of Dnmt1 on the developing lung, cell death, and
proliferation were assessed. Loss of DNMT1 protein was confirmed at E14.5, and this
loss was accompanied by both an increase in apoptotic endodermal cells and a
significant decrease in proliferating cells (Figures 2.2A-C). Epithelial identity is at least
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partially preserved in Dnmt1EKO mutants as they continue to express Nkx2.1 (Figure
2.2D). However, epithelial shape and polarity appeared dysregulated in Dnmt1EKO
mutants as evidenced by aberrant CDH1 staining at E14.5 (Figure 2.2C). We next
assessed whether smooth muscle and endothelial cells were present and properly
localized in Dnmt1EKO mutants. TAGLN, also known as SM22A, immunostaining
revealed that while there was less smooth muscle present in Dnmt1EKO lungs, it
continued to encircle large vessels and proximal airways as in control lungs (Figure
2.2D). Additionally, PECAM1 immunostaining indicated vascularization of Dnmt1EKO
lungs (Figure 2.2D). To determine whether proximal-distal patterning was affected in
Dnmt1EKO lungs, expression of the critical transcriptional regulators Sox2 and Sox9 was
assessed. Reduced Sox2 expression and expanded Sox9 expression indicated that
proximal-distal patterning of the lung endoderm was disrupted (Figure 2.2E). However,
Sox9 expression in cartilage precursors appeared to be normal (Figure 2.2E). Similar
results were obtained with Foxp2, a marker of distal endoderm, and Ssea1, a marker of
proximal endoderm (Figure 2.2D) (Shu et al., 2001). These observations indicate that
loss of Dnmt1 results in increased cell death, decreased proliferation, and impaired
patterning of the proximal-distal endoderm axis in the developing lung.

2.5 Dnmt1 is essential to maintain epithelial-mesenchymal crosstalk and epithelial
polarity
After observing defects in both proximal-distal patterning and epithelial shape, we next
investigated whether Dnmt1 was required for epithelial-mesenchymal crosstalk and
polarity (Figure 2.3A). To determine whether epithelial-mesenchymal crosstalk was
impacted in Dnmt1EKO lungs, we performed RNA fluorescence in situ hybridization
(FISH) for genes known to be essential for guiding branching morphogenesis. Fgf
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signaling is known to play a key role in branching morphogenesis by driving growth of
the budding endodermal tips of the developing lung (Kadzik et al., 2014, Lebeche et al.,
1999, Weaver et al., 2000, Abler et al., 2009). We found that Fgfr2 expression was
decreased in Dnmt1EKO lungs compared to control, suggesting that the Dnmt1 mutant
endoderm was less receptive to branching signals from the mesoderm (Figure 2.3B).
Additionally, Fgf10 expression appeared increased and expanded (Figure 2.3B). Shh
and Bmp4 are also critical signaling factors that regulate branching morphogenesis.
While Shh is expressed throughout the developing endoderm, it is enriched at budding
tips where it is thought to suppress Fgf signaling to promote bifurcation of developing
lung buds along with Bmp4, which is typically restricted to the distal compartment
(Lebeche et al., 1999, Kadzik et al., 2014, Weaver et al., 2000, Miller et al., 2001,
Litingtung et al., 1998, Pepicelli et al., 1998). Analysis of Bmp4 and Shh expression in
Dnmt1EKO lungs revealed they were enriched throughout the endoderm, consistent with
our previous observation of the expansion of the distal compartment (Figure 2.3B).
These data suggest that loss of endodermal Dnmt1 disrupts the epithelial-mesenchymal
signaling required for proper branching morphogenesis.

To assess whether epithelial polarity was disrupted in Dnmt1EKO lungs, we examined the
localization of cell surface and polarity associated proteins. CTNNB1 immunostaining
revealed abnormal epithelial cell shape in Dnmt1 mutant lungs compared to controls
(Figure 2.3C). Immunostaining for ZO-1, which is typically restricted to the apical
membrane, revealed aberrant localization in the Dnmt1 mutant epithelial cells to both the
lateral and basal membranes in addition to the apical membrane (Figure 2.3D).
Dnmt1EKO lungs also exhibit ectopic localization of CDH1 to the apical surface of mutant
epithelial cells and a loss of the columnar shape characteristic of normal distal
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epithelium (Figure 2.3E). DLG1 protein is primarily restricted to the basal membrane of
normal developing lung endodermal cells, but in Dnmt1EKO lungs protein was observed
at the basal membrane, within the cytoplasm, and on the lateral cell membrane (Wan et
al., 2013) (Figure 2.3F). Similarly, while LAMA1 was found properly deposited in the
basement membrane of Dnmt1EKO lungs, it also appeared aberrantly localized
throughout the endoderm of Dnmt1 mutants (Figures 2.3D and F). The presence of
detached clusters of cellular debris in the luminal space of Dnmt1 mutant endodermal
buds was also readily apparent, indicating a sloughing off of cells, consistent with a loss
of polarity and increased apoptosis (Figures 2.2C-E, 2.3D, and 2.3F). These data
suggest that loss of endodermal Dnmt1 perturbs both epithelial-mesenchymal crosstalk
and epithelial polarity leading to improper branching and to the formation of deformed,
cystic lung buds.

2.6 Dnmt1 activity is required for proximal endoderm differentiation in the lung
We next sought to determine whether Dnmt1 was required for lung epithelial cell fate
determination. Dnmt1EKO mutant lung tissue at E18.5 is highly dysplastic with a cystic
appearance (Figure 2.4A). Immunostaining for NKX2.1 indicated that Dnmt1EKO mutants
continue to express Nkx2.1 in the endodermal lining of the dysplastic airways (Figures
2.4A and C). TAGLN and PECAM1 were observed in Dnmt1EKO mutants with the large
cystic lungs surrounded by smooth muscle (Figure 2.4B). There was almost a complete
loss of proximal epithelial cells as noted by the dramatic loss of Foxj1 and Scgb1a1
expressing cells (Figure 2.4C). Intriguingly, the distal lung AT1 and AT2 epithelial cell
fates appeared to be present in Dnmt1EKO animals, as cells expressing either Hopx or
Sftpc were observed (Figure 2.4C). These data suggest that Dnmt1 regulates the
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differentiation of proximal epithelial cells from the Nkx2.1 expressing early endodermal
lung progenitors.

2.7 Dnmt1 is necessary for branching morphogenesis
Our data suggest an expansion of distal Sox9+ epithelial cell fates and a commensurate
loss of Sox2+ proximal cells in Dnmt1EKO mutant lungs. Previous work has shown that
perturbations in the proximal-distal axis due to loss or gain of Sox9 expression in the
lung endoderm result in cystic appearing distal tips (Rockich et al., 2013). To assess the
changes in branching morphogenesis, we examined Dnmt1EKO mutant lungs at E12.5.
DNMT1 protein loss is clear at E12.5, and there is a subtle defect in Dnmt1EKO lungs by
H&E staining (Figures 2.5A-B). The proximal-distal axis appeared largely normal by
E12.5 in Dnmt1EKO lungs (Figure 2.5C).

Consistent with the lack of proximal-distal perturbations at E12.5, we did not observe a
significant defect in proliferation of the epithelium in the Dnmt1EKO lungs (Figure 2.5D).
However, whole mount imaging revealed that at E12.5 there was defective lateral
domain branching in Dnmt1EKO lungs (Figure 2.5E). Due to the subtle branching defect
observed at E12.5, we next tested whether loss of Dnmt1 leads to progressive
impairment in branching morphogenesis, thus impacting proximal-distal patterning. To
determine whether loss of Dnmt1 impacted branching morphogenesis in a lung intrinsic
manner, we performed time-lapse imaging of control and Dnmt1EKO mutant lungs
harvested at E11.5 and cultured as explants as previously described (Kadzik et al.,
2014, Carraro et al., 2010, Del Moral and Warburton, 2010, Schnatwinkel and
Niswander, 2013). Imaging these lung explants for 72 hours revealed a severe
impairment of branching in the Dnmt1EKO lungs compared to the littermate controls
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(Figure 2.5F and Movies S1-S2 (please see online version of manuscript to view
movies (Liberti et al., 2019))). By the end of the time-lapse experiment, the Dnmt1EKO
lungs were dysmorphic in appearance and lacked the highly iterative branching
observed in the controls. To investigate the potential effect of loss of Dmnt1 in other
organs expressing ShhCre, we examined the developing gut at E12.5 and 14.5. IHC for
DNMT1 confirmed loss of DNMT1 protein at these timepoints (Figures 2.6A-B).
However, H&E staining as well as IHC for CDH1 demonstrated no obvious
morphological defects consistent with a previous report (Figure 2.6A-B) (Elliott et al.,
2015). Together, these data indicate that loss of Dnmt1 leads to progressive failure of
lung development due to defects in branching morphogenesis, cell polarity, and
proximal-distal patterning of the lung endoderm.

2.8 Endodermal Dnmt1 activity represses the distal alveolar type 2 cell fate
To determine the transcriptional targets of Dnmt1 mediated repression, we isolated
lungs at E12.5 from Dnmt1EKO and littermate controls and performed RNA sequencing
(RNA-seq). E12.5 was chosen to reduce secondary and tertiary gene expression
changes due to the major phenotypic defects observed in Dnmt1EKO mutant lungs at later
timepoints. Principal component analysis revealed distinct gene expression changes due
to loss of Dnmt1 (Figure 2.7A). Intriguingly, differential gene expression analysis
revealed de-repression of distal lung epithelial cell restricted genes including Id2 and
surfactant genes Sftpa1, Sftpb, and Sftpc (Figures 2.7B-D). Gene ontology of the top
differentially expressed genes included de-repression of genes associated with
Hedgehog signaling and alveolar lamellar body formation (Figure 2.7D). Further
examination indicated that a number of known AT2 cell specific transcripts were
upregulated in the Dnmt1EKO tissue based on the RNA-seq data (Figure 2.7D). We
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confirmed that Dnmt1 expression was reduced and Sftpc was highly enriched in the
Dnmt1EKO mutants by quantitative real-time PCR (qPCR) (Figure 2.7E). Moreover,
immunostaining revealed rare epithelial cells expressing SFTPC and SFTPB in
Dnmt1EKO at E12.5, which became more abundant by E14.5. SFTPC and SFTPB protein
were not detected in Dnmtcontrol lungs at E12.5. SFTPB protein was observed in control
littermate lungs at E14.5, but expression was restricted to the distal endoderm (Figure
2.7F). In contrast, SFTPB protein in Dnmt1EKO lungs was localized throughout the
endoderm, consistent with the precocious expansion of the distal endoderm phenotype
in these mutants (Figure 2.7F). Taken together, these data suggest that loss of Dnmt1
results in precocious differentiation of early Sox9+ epithelial precursors towards a more
terminal distal fate, specifically AT2 cell fate.

2.9 Dnmt1 is required to maintain the boundary between the airway and alveolar
compartments
Our data suggest that Dnmt1 is required to restrict alveolar epithelial cell fate
commitment during early lung development. To determine whether Dnmt1 is similarly
required after specification of the vast majority of the alveolar epithelium and
compartmentalization of the airway versus the alveolar space, we inactivated Dnmt1 at
E15.5

in

the

airway

epithelium

and

lineage

traced

these

cells

using

Sox2CreERT2;Dnmt1fl/fl;R26RtdTomato mice (Figure 2.8A) (Frank et al., 2019). Sox2CreERT2
labeling at E15.5 is largely restricted to the airway epithelium with rare cells labeled in
the alveolar compartment (Figure 2.8B). However, in 2 out of 6 Dnmt1-deficient mice,
we observed a great number of lineage traced alveolar epithelial cells (Figure 2.8B).
While this phenotype was not completely penetrant, it further suggests that Dnmt1
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restricts the alveolar potential of epithelial progenitors to maintain the boundary between
the airway and alveolar epithelial compartments.

2.10 Discussion
The role of epigenetic factors in regulating lung branching morphogenesis and epithelial
cell fate specification remain poorly understood. Our data reveal that Dnmt1 is required
to regulate proximal-distal endoderm patterning, restrict AT2 cell fate, and maintain the
boundary between the proximal and distal epithelial compartments. These results
indicate the necessity of DNA methylation for correct temporal activation of lung
epithelial cell fate specification and for the spatial segregation of proximal and distal
epithelial lineages.

Previous reports of the relationship between branching morphogenesis and proximaldistal patterning of the airways suggest a connection between these two processes
(Alanis et al., 2014, Chang et al., 2013). Our data support this concept as precocious
differentiation in Dnmt1-deficient endoderm correlates with defective branching.
However, the exact mechanistic interaction between these two processes is unclear.
Interestingly, previous studies examining other epigenetic regulatory pathways during
lung development have also revealed a loss of early proximal-distal patterning of the
endoderm. Combined loss of Hdac 1 and 2 in the developing lung endoderm also led to
a decrease in Sox2 expressing proximal endoderm progenitors (Wang et al., 2013).
Additionally, this study showed an increase in certain distal lung endoderm paracrine
signaling factors, such as Bmp4, consistent with our data. A different study revealed that
loss of Sin3a, a component of the NuRD chromatin remodeling complex, also led to
decreased proximal lung endoderm development (Yao et al., 2017). The similarity
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between these two studies and those presented in the current report suggest a particular
sensitivity of proximal lung endoderm development to epigenetic perturbation. Whether
these three pathways converge on a common epigenetic regulatory node to cause such
a phenotype will require further investigation.

The interaction between Fgf, Bmp, and Shh signaling is essential for early lung
development. While few genes are down-regulated at E12.5 in DnmtEKO lungs, Ptch1 is
of particular interest because it a direct target of Shh signaling and has been suggested
to pattern Fgf10 expression during branching morphogenesis (Figure 2.7C) (Ho and
Wainwright, 2017, Abler et al., 2009). Ptch1 expression is thought to be a direct readout
of Shh signaling (Abler et al., 2009). Moreover, it has been shown that early ablation of
mesodermal Ptch1 leads to reduced Fgf10 expression (Ho and Wainwright, 2017).
However, our data show that both Shh and Fgf10 are expanded in E14.5 DnmtEKO lungs
despite down-regulation of Ptch1 at E12.5 (Figures 2.3B and 2.7C). This data suggests
that Ptch1 down-regulation at E12.5 indicates a defect in Dnmt1 mutant mesodermal
receptivity to Shh, limiting Shh signaling from the endoderm to the mesoderm. Loss of
Ptch1 could also be reinforced by down-regulation of endodermal Fgfr2, which is known
to negatively impact Ptch1 expression and branching morphogenesis (Figure 2.3B)
(Abler et al., 2009). Previous examination of Shh null mice revealed that loss of Shh
leads to an expansion of Fgf10 in the lung mesoderm and increased Bmp4 in the
endoderm, consistent with our results (Pepicelli et al., 1998). Moreover, because Fgf10
is known to induce Bmp4 expression, as Fgf10 expression expands unrestricted to
surround the developing endoderm, it could further upregulate Bmp4, inhibiting proximal
endoderm specification consistent with the expansion of the distal endoderm at the cost
of the proximal that we observe in Dnmt1EKO lungs (Weaver et al., 2000, Lebeche et al.,
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1999). Additionally, expansion of Bmp4 and Shh and loss of Fgfr2 in the endoderm
would in turn perturb receptivity of the endoderm to the increased Fgf10 signal from the
mesoderm leading to the improper expansion and branching seen in Dnmt1 mutant
lungs. Further studies aimed at uncovering how epigenetic mechanisms regulating
endoderm development impact epithelial-mesenchymal crosstalk will be invaluable to
our understanding of how early patterning is maintained throughout development.

DNA methylation is required to restrain differentiation in early embryos (Sen et al., 2010,
Hargan-Calvopina et al., 2016). Moreover, loss of Dnmt1 in the early embryo and in
organs, such as the intestine, brain, and skin, leads to precocious differentiation, which
is consistent with our findings in the lung (Elliott et al., 2015, Fan et al., 2005, Takizawa
et al., 2001, Sen et al., 2010, Hargan-Calvopina et al., 2016). Remarkably, loss of Dnmt1
consistently correlates with reactivation of primordial germ cell restricted genes such as
Dazl, Sohlh2, Tex19.1, Pet2, genes of the reproductive homeobox (Rhox) cluster Gm9,
Rhox2a, Rhox2f, Rhox2d, and genes expressed in the germ line of the early embryo
4930550L24Rik, Mov10l1, Tex13, Rpl39l, Rpl10l, Tuba3a, Tuba3b (Hargan-Calvopina et
al., 2016, Li et al., 2019b, Tsui et al., 2000, Chen et al., 2014, Shin et al., 2017, Crichton
et al., 2017, Bergsagel et al., 1992, Branco et al., 2016, Borgel et al., 2010, Auclair et al.,
2014, Hackett et al., 2012, Maatouk et al., 2006, Arand et al., 2012). Our RNA-seq
analysis shows that these genes are among the most differentially expressed in
Dnmt1EKO lungs compared to control lungs. Together, these data suggest that Dnmt1 is
required in multiple organs to suppress aberrant gene expression to allow proper cell
differentiation and morphogenesis to proceed. Further study is necessary to understand
whether and how reactivation of these genes associated with early embryonic
development may direct precocious differentiation toward a particular cell fate.
33

Lung morphogenesis and differentiation in the early embryo are maintained by a precise
temporal and spatially restricted developmental program. Our understanding of how
proximal-distal patterning is achieved and maintained in the developing lung, despite
scores of elegant studies, remains limited. Our results show that loss of Dnmt1 in the
epithelium leads to loss of proximal endoderm development, defects in branching
morphogenesis, epithelial polarity, and epithelial-mesenchymal crosstalk, and premature
activation of the AT2 cell transcriptional program. Together with other work examining
epigenetic regulation of lung development, our study suggests that endodermal
differentiation during lung development requires specific epigenetic cues that promote
the development of the proper ratio of proximal and distal progenitor cells from the
multipotent early lung endoderm.

2.11 Materials and methods
Animals
The information related to the generation and genotyping of the Sox2CreERT2,
Dnmt1flox,Shhcre, and R26RCL-TdTom mouse lines have been previously described (JacksonGrusby et al., 2001, Harfe et al., 2004, Madisen et al., 2010, Arnold et al., 2011). The
mice used for this study were purchased from Jackson Laboratories and were
maintained on a mixed background. Animal procedures were completed under the
guidance of the University of Pennsylvania Institutional Animal Care and Use
Committee. ShhCre;Dnmt1Flox/+ littermates (Dnmtcontrol) were used as controls for all
experiments unless specifically noted in figures as control, indicating littermate wildtype
controls were used. At least three biological replicates were used for all experiments.
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Histology, Immunohistochemistry, and RNA FISH
Whole embryos were fixed in 2% paraformaldehyde overnight, dehydrated with a series
of ethanol washes (30%, 50%, 70%, 95%, and 100%), embedded in paraffin wax, and
sectioned at a thickness of 6-8μm. Standard procedures were employed for Hematoxylin
and eosin (H&E) staining (also see Chapter 3).

Immunohistochemistry was performed with the following antibodies: Dnmt1 (rabbit,
Novus, nb100-264, 1:500), Ttf1 (Nxk2.1) (rabbit, Santa Cruz, sc-13040, 1:50) Foxj1
(mouse, eBioscience, 14-9965-80, 1:250), Scgb1a1 (rabbit, Santa Cruz, sc-9772, 1:20),
Hopx (mouse, Santa Cruz, sc-398703, 1:200), Sftpc (rabbit, Millipore, ab3786, 1:100),
Sftpb (rabbit, Abcam, ab40876, 1:500), cleaved Casp3 (rabbit, Cell Signaling, 9664s,
1:50), Phosphohistone H3 (mouse, Cell Signaling, 9706L, 1:200), Cdh1 (E-cadherin)
(rabbit, Cell Signaling, 3195S, 1:100), Sox2 (goat, Santa Cruz, sc-17320, 1:10) , Sox9
(rabbit, Santa Cruz, sc-20095, 1:50), Foxp2 (rabbit antisera, 1:50), Ssea1 (mouse,
Millipore, mab4301, 1:100), Tagln (Sm22a) (goat, Abcam, ab10135, 1:50), Pecam1 (rat,
HistoBioTec, dia-310, 1:200), Ctnnb1 (mouse, BD Biosciences, 610154, 1:25), Zo-1
(mouse, Thermo Fisher, 33-9100, 1:100), SAP-97 (Dlg1) (mouse, Santa Cruz, sc-9961,
1:50), Lama1 (rabbit, Sigma Aldrich, L9393, 1:200), Lamp3 (DC-Lamp) (rat, Novus,
DDX0191P-100, 1:100), Rfp (tdtomato) (goat, Origene, AB8181-200 1:100)

RNA FISH was performed using RNAscope probes as indicated by the manufacturer
(Advanced Cell Diagnostics). The following RNAscope probes were used: Mm-Fgfr2-noXHs (Advanced Cell Diagnostics, catalog# 443501), Mm-Fgf10-C2 (Advanced Cell
Diagnostics, catalog# 446371-C2), Mm-Bmp4-C1 (Advanced Cell Diagnostics, catalog#
401301), and Mm-Shh-C2 (Advanced Cell Diagnostics, catalog# 314361-C2).
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Representative images from stained slides were acquired using either a Nikon Eclipse Ni
widefield microscope, including processing with NIS-Elements Advanced Research
deconvolution software, or a Zeiss LSM 710 confocal microscope. Images were
processed using Fiji software. Lungs used for the whole mount images were dissected in
phosphate buffered saline (Corning), fixed in 2% paraformaldehyde (Thermo Fisher)
overnight, imaged on a Leica TCS SP8 confocal microscope, and processed using
Imaris software.

Quantitative analysis
The proportion of proliferating epithelial cells was determined by immunostaining for
Cdh1 and Phosphohistone H3. Images were captured using a Zeiss LSM 710 confocal
microscope. At least 500 cells from equivalent structures were counted per mouse using
ImageJ software. Researchers were blinded to the identity of samples during counting.
Branch point analysis was performed using Imaris software.

RNA Sequencing and Analysis
RNA was extracted with Trizol (Life Technologies) from snap-frozen embryonic day 12.5
mutant and littermate lungs. Library prep with PolyA selection and ultra-low input RNAseq library preparation was performed by GeneWiz, LLC. Fastq ﬁles were evaluated for
quality with the FastQC program and subsequently aligned against the mouse reference
genome (mm9) using the STAR aligner (Dobin et al., 2013). Duplicate reads, ﬂagged
with the MarkDuplicates program from Picard tools, were excluded from analysis. Read
counts per gene for Ensembl (v67) gene annotations were computed using the
Rsubread R package. Gene counts represented as counts per million (CPM) were
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nominalized using TMM method in the edgeR R package, and genes with 25% of
samples with a CPM < 1 were deemed low expressed and removed. The data were
transformed with the VOOM function from the limma R package to generate a linear
model to perform differential gene expression analysis (Law et al., 2014). Given the
small sample size of the experiment, we employed the empirical Bayes procedure as
implemented in limma to adjust the linear fit and to calculate P values. P values were
adjusted for multiple comparisons using the Benjamini-Hochberg procedure. Plots as
shown in Figure 2.7 were generated in R, and GO enrichment analysis was performed
using the GAGE R package. The Gene Expression Omnibus number for the RNA-seq
data is GSE129177.

Live imaging
Explants were cultured as previously described with slight modification (Del Moral and
Warburton, 2010, Carraro et al., 2010). Briefly, lungs were dissected from E11.5
embryos in cold PBS and placed on 0.4μm pore transwell inserts in DMEM/F12 (Gibco)
supplemented with Antibiotic-Antimycotic (Gibco). Lungs were imaged using the EVOS
FL Auto 2 Imaging System, cultured on an incubated stage at 37°C and 5% CO2, and
imaged every hour for 3 days.

Statistical analysis
Statistical tests were performed in Prism 7. A student’s t-test was performed to compare
experimental groups. A difference between groups was considered statistically
significant if P < 0.05.
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qPCR
RNA was extracted from whole lungs at E12.5 by Trizol (Life Technologies) isolation.
Synthesis of cDNA was performed using a QuantiTect Whole Transcriptome Kit
(Qiagen). Three biological replicates were used for all experiments and were from the
same samples used for RNA-seq analysis. Data were normalized to GAPDH. Data are
represented by mean ± SEM. Quantitative real-time PCR was performed using SYBR
Green (Applied Biosystems) on a QuantStudio 7 Flex using the primer sets in Table 2.1.
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Table 2.1: qPCR primers.
qPCR Primers
Target

Forward Primer (5’-3’)

Reverse Primer (5’-3’)

Gapdh

AGGTTGTCTCCTGCGACTTCA

CCAGGAAATGAGCTTGACAAAGTT

Nkx2.1

ATGGTACGGCGCCAACCCAGA

CATGCCACTCATATTCATGCCGCT

Sox2

TGCACATGGCCCAGACTA

TTCTCCAGTTCGCAGTCCAG

Sox9

CGGCTCCAGCAAGAACAAG

GCGCCCACACCATGAAG

Dnmt1

ATCCTGTGAAAGAGAACCCTGT

CCGATGCGATAGGGCTCTG

Sftpc

AGCAAAGAGGTCCTGATGGAG

CACAACCACGATGAGAAGGCGTTT

Gene

AGT
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Figure 2.1: Endodermal Dnmt1 is required for lung development.
(A) RNA-seq analysis of Dnmt1 expression in E12.5 and adult lungs (units reflected in
fragments

per

kilobase

of

transcript

per

million

mapped

reads).

(B)

Immunohistochemistry (IHC) for DNMT1 at E11.5 and E17.5 in both the endodermal and
mesenchymal compartments (dashed lines demarcate endoderm) (scale bar: 50μm). (C)
Experimental schematic of developmental time points assessed in endodermal Dnmt1
knockout model. (D) Comparison of Dnmt1EKO and Dnmt1control lungs at E14.5 (white
arrows indicate cystic buds). (E) Hematoxylin and eosin (H&E) staining of Dnmt1EKO
lungs demonstrate defective developmental progression by E14.5 and failure by E18.5
(black arrows point to cystic buds) (scale bar: 500μm).
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Figure 2.2: Endodermal loss of Dnmt1 disrupts proximal-distal patterning.
(A) IHC for DNMT1 at E14.5 in Dnmt1control and Dnmt1EKO lungs (dashed lines demarcate
endoderm) (scale bar: 50μm). (B) IHC for cleaved CASP3 in Dnmt1control and Dnmt1EKO
lungs at E14.5 (dashed lines demarcate endoderm) (scale bar: 50μm). (C) Quantification
of epithelial cell proliferation by assessment of CDH1 and Phosphohistone H3 double
positive cells in Dnmt1control and Dnmt1EKO lungs at E14.5. CDH1 stain reveals perturbed
epithelial cell shape and aberrant twisting of epithelial buds in Dnmt1EKO lungs (scale
bar: 50μm, student’s two-tailed t-test, P<0.001). (D) IHC for epithelial cell marker
NKX2.1, smooth muscle marker TAGLN (smooth muscle surrounding vessels is marked
by white arrows, smooth muscle surrounding airways is marked by yellow arrows), and
endothelial cell marker PECAM1 in both Dnmt1EKO and Dnmt1control lungs. IHC for
proximal endoderm marker SSEA1 and distal endoderm marker FOXP2 reveals
perturbed proximal/distal patterning in Dnmt1EKO lungs (proximal endoderm is marked by
a yellow arrow, distal endoderm is marked by a white arrow) (scale bar: 100μm). (E) IHC
for SOX2 and SOX9 in serial sections shows expansion of the distal endoderm
compartment (proximal endoderm is marked by yellow arrows, distal endoderm is
marked by white arrows, cartilage progenitors are marked by black arrows) (scale bar:
100μm).
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Figure 2.3: Dnmt1 is essential to maintain epithelial-mesenchymal crosstalk and
epithelial polarity.
(A) A model of Dnmt1control (top) vs. Dnmt1EKO (bottom) lungs demonstrating the
expansion of the distal compartment, perturbed epithelial cell shape, and abnormal
twisting of epithelial buds in Dnmt1EKO lungs. (B) RNA FISH reveals decreased Fgfr2
expression in Dnmt1EKO endoderm and an expansion of Fgf10 expression in the
mesoderm. Bmp4 and Shh expression are expanded in Dnmt1EKO lungs consistent with
expansion of the distal endodermal compartment (white dashed line demarcates
endoderm, white arrows indicate distal buds of the endoderm) (scale bar: 50μm). (C)
IHC for CTNNB1 reveals loss of characteristic columnar shape in Dnmt1 mutant
epithelial cells (scale bars: 25μm). (D) IHC for ZO-1 (white arrows) and LAMA1 (yellow
arrows) reveals ectopic ZO-1 localization to the lateral and basal membrane and
abnormal localization of LAMA1 in Dnmt1EKO lungs (scale bars from left to right: 50μm,
50 μm, 5 μm). (E) IHC for CDH1 reveals perturbed epithelial cell shape and aberrant
localization of CDH1 protein to the apical membrane in mutants (scale bars: 25μm). (F)
IHC for DLG1 (white arrows) and LAMA1 (yellow arrows) shows the proper localization
of DLG1 to the basal membrane and deposition of LAMA1 in the basement membrane in
controls compared to cytosolic and abnormal lateral membrane staining of DLG1 in
mutants. LAMA1 is present in the basement membrane but is again abnormally localized
in Dnmt1EKO endodermal cells (scale bars from left to right: 50μm, 50 μm, 5 μm).
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Figure 2.4: Loss of Dnmt1 impacts endodermal differentiation.
(A) H&E and IHC for NKX2.1 and DAPI reveal cystic sacs in place of a normal branched
network with a paucity of NKX2.1+ cells in Dnmt1EKO lungs (scale bars: 500μm). (B) IHC
for TAGLN and PECAM1 demonstrates E18.5 lungs are vascularized and that large
vessels are surrounded with smooth muscle (vessels are marked by white arrows).
Smooth muscle also lines the large cysts in Dnmt1EKO lungs (yellow arrow (top image)
marks smooth muscle surrounding an airway, yellow arrow (bottom image) marks
smooth muscle lining cystic lung buds) (scale bars: 25μm). (C) A magnified image of IHC
for NKX2.1 shows epithelial cells are present at E18.5 (first image marked by white
arrows). Airway epithelial cell types marked by SCGB1A1 and FOXJ1 (second image,
white and yellow arrows respectively) are rare in Dnmt1EKO lungs, while alveolar
epithelial type 1 cells marked by HOPX (third image, white arrows) and alveolar
epithelial type 2 cells marked by SFTPC (fourth image, white arrows) are more common
(scale bar: 25μm).
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Figure 2.5: Dnmt1 is required for proper branching morphogenesis.
(A) DNMT1 is lost in the lung endoderm in Dnmt1EKO lungs at E12.5 (dashed lines
demarcate endoderm) (scale bar: 50μm). (B) Dnmt1EKO lungs display a subtle branching
defect by H&E staining at E12.5 (black lines demarcate endoderm) (scale bar: 100μm).
(C) IHC for SOX2 and SOX9 reveals no major disturbance of the proximal-distal axis at
E12.5 (scale bar: 100μm). (D) Quantification of epithelial cell proliferation by assessment
of CDH1 and Phosphohistone H3 double positive cells in Dnmt1EKO and Dnmt1control
lungs at E12.5 (scale bar: 50μm, student’s two-tailed t-test, P>0.05). (E) Branch point
analysis of E12.5 lungs (scale bars: 150μm, student’s one-tailed t-test, P<0.05). (F) Still
images from ex vivo live imaging of E11.5 lungs at 0, 24, and 72 hours of culture reveal
that the perturbed branching patterns and formation of cystic sacs in Dnmt1EKO lungs are
lung intrinsic defects. White arrow indicates loss of a domain branch in Dnmt1EKO lungs
(scale bar: 500μm).
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Figure 2.6: Dnmt1 is not required for prenatal gut development.
(A) H&E staining of Dnmt1control and Dnmt1EKO intestines at E12.5 reveals no gross defect
in epithelial gut tube morphology in mutants (black arrows point to midgut where
magnified images shown were acquired). IHC for DNMT1 in the gut at E12.5 (dashed
lines demarcate gut tube). IHC for CDH1 demonstrates no obvious defect in epithelial
cell shape (scale bars (left to right): 250μm, 50μm, 50 μm). (B) H&E staining of
Dnmt1control and Dnmt1EKO intestines at E14.5 reveals no gross defect in epithelial gut
tube morphology (black arrows point to midgut where magnified images shown were
acquired). IHC for DNMT1 reveals loss of DNMT1 protein at E14.5 with some cells
escaping deletion indicating some mosaicism (dashed lines demarcate gut tube). IHC for
CDH1 demonstrates no obvious defect in epithelial cell shape (scale bars (left to right):
250μm, 50μm, 50 μm).
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Figure 2.7: Dnmt1 knockout lungs exhibit precocious AT2 cell differentiation
signature.
(A) PCA plot of RNA sequencing data from E12.5 DNMT1control and Dnmt1EKO lungs. (BC) Visualization of differentially expressed transcripts in Dnmt1EKO versus control lungs
by volcano plot and heat map show distal endoderm markers and surfactant genes
enriched in Dnmt1EKO lungs. (D) GO category analysis reveals alveolar lamellar body
related genes to be among the most upregulated in Dnmt1EKO lungs. Heatmap shows the
top differentially expressed genes in the alveolar lamellar body GO category (scale is z
score). (E) qPCR verification of Nkx2.1, Sox2, and Sox9 expression confirms no
significant difference in expression between Dnmt1EKO and control lungs, while
expression of Dnmt1 is significantly decreased and Sftpc is significantly enriched in
Dnmt1EKO lungs. (F) Endodermal cells stain positive for SFTPB and SFTPC protein in
Dnmt1EKO lungs at E12.5. At E14.5 SFTPB staining is expanded throughout the
endoderm of Dnmt1EKO lungs and SFTPC staining is more abundant in Dnmt1EKO
compared to Dnmt1control lungs (scale bars: 50μm).
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Figure 2.8: Dnmt1 is required to maintain the boundary between the airway and
alveolar epithelial compartments
(A) Experimental schematic showing that tamoxifen (TAM) was administered to
Sox2CreERT2;Dnmt1fl/+;R26RtdTomato (n = 7) and Sox2CreERT2;Dnmt1fl/fl;R26RtdTomato (n = 6)
mice at E15.5 and harvested at E18.5. (B) IHC for lineage marker tdTomato, HOPX, and
LAMP3 at E18.5 (scale bar: 100μm). White arrows mark AT2 cells in the alveolar
compartment and yellow arrows mark AT1 cells in the alveolar compartment.
Sox2CreERT2;Dnmt1fl/fl;R26RtdTomato images are representative of 2 out of 6 mice where the
phenotype was observed.
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CHAPTER 3: MAPPING THE HETEROGENOUS REGENERATIVE LANDSCAPE
The work presented in this chapter was performed in collaboration with William A.
Liberti. Su Zhou assisted with histological preparation.

3.1 Summary
Scientists and physicians often qualitatively assess the degree of tissue damage in
response to respiratory illness. However, these assessments can vary, making it
challenging to quantitatively compare across patient samples scored by different
individuals. Therefore, there is a need to standardize methods to objectively and
reproducibly quantify damaged lung tissue. Using a novel data driven approach, we
present a simple, statistically based, unsupervised method to quantitatively identify and
segregate regions of injury based on severity, using color and contrast of tissue stained
with well characterized, commonly used histological markers. This approach can be
generalized to any whole-slide imaging of lung tissue, allowing a quantitative comparison
of injury responses across samples, animals, and diseases. We demonstrate the
effectiveness of this method using a murine influenza injury model, as well as human
influenza, idiopathic pulmonary fibrosis, and coronavirus disease 2019 (COVID-19)
patient tissue. We provide a user-friendly Matlab codebase with relevant examples to
enable rapid dissemination, adoption, and expansion of this approach.

3.2 Introduction
While the lung is a largely quiescent organ at homeostasis, it can mount rapid and
robust emergency repair and regenerative responses after acute injury. These
responses are driven by complex processes at the cellular level, and steady progress is
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being made in our understanding of the cell types and signals involved (Sivakumar and
Frank, 2019, Zepp and Morrisey, 2019, Basil et al., 2020, Fernanda de Mello Costa et
al., 2020). However, the lack of standardized methods to assess lung damage makes it
challenging to quantitatively compare results both between laboratories and across
diseases, limiting our understanding of lung regeneration. This need has been felt
acutely during the recent and rapid emergence of the COVID-19 pandemic. Moreover,
this global pandemic has underscored our limited understanding of lung regeneration,
the long-term impacts of severe acute injury, and the cellular and architectural
remodeling

characteristic

of

chronic

lung

diseases.

The

development

and

implementation of standardized tools to study lung injury would greatly improve our
understanding of how the tissue responds to acute infections, like SARS-CoV-2, how
these infections are similar to or different from other infectious diseases like H1N1
influenza, and how the lasting effects of these diseases compare to, lead to, or
exacerbate chronic lung disease. Ultimately, standardized tools would allow us to better
leverage general principles learned from decades of infectious disease research to
understand tissue responses to emerging pathogens.

Injury in the lung is heterogeneous, and the cellular regenerative responses vary greatly
across the disparately damaged regions of the injured lung (Zacharias et al., 2018,
Katsura et al., 2019, Xi et al., 2017). Our understanding of these responses relies
heavily on careful lineage tracing and reverse genetics studies in mice. However, while
the majority of studies must by design analyze the heterogeneity of regenerative
responses using region of interest-based approaches, the selection criteria for these
regions of interest is not impartial. In addition to being subject to bias, careful binning
requires professional expertise and is extremely laborious. The lack of a standardized
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approach for region of interest selection can easily result in variability in analysis across
the tissue and across samples, providing a strong rationale for the development of
computer vision and computational imaging approaches to remove bias from and
automate tissue analysis.

Segmentation software is an active area of development, and numerous algorithms have
been developed to assess damaged lungs from CT scans or tissue sections images
(Testa et al., 2021, Gilhodes et al., 2017, Wei et al., 2019, El-Bana et al., 2020, Gerard
et al., 2021). However, currently, no widely available methods exist to unbiasedly map
the heterogeneous landscape of multiple lung injuries. Here, we propose an unbiased
computational imaging tool to segment the heterogeneous landscape of tissue damage.
We demonstrate the ability of this tool to reproducibly demarcate the boundaries
between different regions by severity of injury in a mouse influenza model. Further, we
identify distinct epithelial, endothelial, and mesenchymal behaviors in a regionally
restricted manner. Finally, the application of this methodology to human influenza,
fibrosis, and COVID-19 affected lung tissue highlights the wide variety of applications for
this approach.

3.3 Reproducible identification of injury regions across tissue and between
animals
While all lung injuries result in heterogenous tissue damage, influenza results in
stereotypically spatially restricted cellular behaviors, including the emergence of
bronchus-associated lymphoid tissue (BALT) and the formation of airway derived
bronchiolized epithelium, or Krt5+ pods (Randall, 2010, Vaughan et al., 2015, Kumar et
al., 2011, Fernanda de Mello Costa et al., 2020). These disease hallmarks, along with
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other morphological perturbations associated with diffuse alveolar damage, can be
reproducibly identified by experienced pathologists and scientists by their distinct
appearance in simple hematoxylin and eosin (H&E) stained tissue sections. We
examined the degree to which simple image features, such as pixel density, could be
used to provide automated, reproducible segmentation of tissue damage severity. Using
this approach, we segmented influenza infected murine tissue 14 days post injury (dpi)
into three distinct categories: 1. severely injured, 2. moderately damaged, and 3. largely
normal tissue (Figure 3.1A). The injury maps resulting from this analysis not only allow
the comparison of damaged tissue across the heterogenous regenerative landscape of a
single mouse but they also enable reproducible comparison of spatially restricted cellular
behaviors between multiple mice (Figures 3.1B-D). This analysis is unbiased, and it can
be used to extract information about the extent of the tissue encompassed by different
injury levels to more deeply inform animal phenotyping (Figure 3.1E). Measuring the
mean squared error across 5 serial tissue sections at 14 dpi, we observed that mean
squared error increases as a function of distance from the reference slide (Figures 3.1FG). This result suggests the main source of error between sections is driven by
anatomical differences between tissue sections not the staining or classification
approach.

Thus,

we

determined

that

adjacent

sections

are

preferred

for

immunohistochemistry (IHC) staining analysis of identified injury categories. Together,
these data show that our automated imaging approach can be used to reliably identify
distinct injury categories after acute injury to enable reproducible comparisons of
spatially restricted cellular behaviors between and across animals.
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3.4 Epithelial, endothelial, and mesenchymal distribution after influenza
To enable the demarcation of injury categories, we implemented an automated function
to demarcate the boundary between severe, damaged, and normal clusters to define
distinct injury zones after influenza at 14 dpi (Figures 3.2A-G). Severe zones contain
the most dramatic tissue perturbations, including hallmarks of severe tissue inflammation
and emergency barrier maintenance, such as BALT and Krt5+ pods (Figures 3.2E, H-I’).
These areas are not well vascularized consistent with previous reports of these regions
being hypoxic (Figures 3.2J-K’) (Xi et al., 2017). These areas have varied
mesenchymal responses, ranging from dense mesenchymal cell accumulation to
sparser regions, which are more dominated by Krt5+ pods (Figures 3.2L-M’). Damaged
zones are defined by the presence of densely compacted tissue with more diffuse
inflammation (Figures 3.2F-F’). These zones are devoid of Krt5+ pods, and instead
contain concentrated areas of alveolar epithelial cells re-interfacing with the regenerating
endothelium (Figures 3.2H-I, I’’, J-K, and K’’). The dense concentration of
mesenchymal cells in this zone likely reflects alveolar remodeling (Figures 3.2L-M and
M’’). Normal zones represent largely homeostatic tissue architecture with typical
distributions of epithelial, endothelial, and mesenchymal lineages characteristic of the
uninjured lung (Figures 3.2G-G’, H-I, I’’’, J-K, K’’’, L-M, and M’’’). These data
demonstrate that our automated imaging approach can segment three distinct zones,
each consisting of spatially restricted cellular behaviors.

3.5 Zonal analysis of human lung damage from influenza, fibrosis, and COVID-19
Human diseased tissue can be difficult to quantitatively assess between patients,
particularly at the cellular level, due to many uncontrollable experimental and technical
complications, including variable timing of disease progression at time of tissue
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acquisition and lack of blood clearance and tissue inflation. To determine whether our
methodology could be applied to reproducibly assess human diseased tissue, we
compared influenza, idiopathic pulmonary fibrosis (IPF), and COVID-19 patient tissue.
Influenza infection in humans results in distinct morphological perturbations similar to
what we observe in mice (Figure 3.3A). While the morphological perturbations are quite
different in appearance in fibrotic tissue, we continue to observe distinctions in severity
of injury across the tissue (Figure 3.3B). In contrast, COVID-19 tissue appeared more
similar to influenza infected rather than fibrotic tissue (Figure 3.3C). Zonal analysis of
influenza patient tissue revealed similar results to what we observed in mice (Figure
3.3D). Despite the lack of tissue inflation, highly inflamed regions and areas containing
Krt5+ cells were marked as severely injured (Figures 3.3D-F). Large airways and blood
vessels are also marked as severe zones, consistent with what we see in mice and
normal human tissue (Figures 3.1B and D, 3.3D-F and 3.4A-F). These severe zones
contained few or no alveolar epithelial type 1 (AT1) or type 2 (AT2) cells (Figures 3.3DF). In contrast, compacted tissue densely populated with AT1 and AT2 cells were
marked as damaged (Figures 3.3D-F). The IPF patient tissue was much more
dramatically injured, and while our imaging approach performs optimally with more
heterogeneity, it successfully segregated anatomically discrete regions, binning Krt5+
cells, large airways and blood vessels, and fibrotic tissue within severe zones (Figures
3.3G-I). AT1 and AT2 cells were again found within damaged zones (Figures 3.3G-I).
However, note that not all damaged zones contained AT1 and AT2 cells (Figures 3.3GI). The COVID-19 patient tissue was also amenable to our imaging approach (Figure
3.3J). Krt5+ cells, large airways and blood vessels, and severely inflamed areas all fell
within severe zones (Figures 3.3J-L). Severe zones contained few AT1 or AT2 cells,
which were more restricted to damaged zones (Figures 3.3J-L). We did not observe
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evidence of fibrosis in this tissue (Figures 3.3C and L). Some tissue areas along the
periphery of the sections were also marked as damaged zones, suggesting that our
imaging approach is not robust to pervasive tissue artifacts (Figures 3.3J). Together,
these data show that our approach is capable of segmenting injured tissue from several
human diseases.

3.6 Discussion
Now more than ever, there is a need to quantify the effects of lung damage in response
to respiratory diseases to improve our understanding of short- and long-term pulmonary
health. However, lung injury is heterogeneous, making it difficult to quantitatively assess.
To date, standard laboratory practice has involved individual judgment of what injured
areas to assess, which is challenging, labor intensive, biased, and leads to widespread
variability across studies. We now provide an open access statistically based tool for the
unbiased, reproducible assessment of the heterogeneous lung injury landscape in
mouse and human disease contexts.

Our system is simple to incorporate into image analysis pipelines. While we observe the
most consistent outcomes in tissue sections containing diverse injury hallmarks, we
have included additional functionality to assess multiple tissue sections at once to add
heterogeneity and enhance reproducibility. As new technology emerges to assess
cellular responses after injury, including new spatial transcriptomic methodologies, we
foresee our imaging approach as a complimentary tool to enhance the identification and
characterization of distinct injury niches (Rao et al., 2021, Moses and Pachter, 2022).
Ultimately, our method enables the assessment of the spatially restricted responses of
lung cells to injury and the molecular regulators of these behaviors. These data will
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provide new insights into the regulation of lung regeneration and putative targets for
clinical interventions for chronic and acute lung diseases.

3.7 Materials and methods
Design and Implementation
Our approach consists of three stages: 1. tissue acquisition and histological staining, 2.
image capture, and 3. quantitative analysis of acquired images.

Tissue acquisition and staining
Experiments were all performed with a minimum of n = 3 animals/individuals per
condition unless otherwise indicated in the figure legends. Mice were maintained on a
mixed C57BL/6 and CD1 background. PR8 H1N1 influenza was a kind gift from Dr. John
Wherry at the University of Pennsylvania. To perform influenza infection, 50uL of virus
diluted in cold PBS was intranasally administered to anesthetized mice at a dose of
approximately 1LD50. All procedures for animal experiments were executed according
to guidance from the University of Pennsylvania Institutional Animal Care and Use
Committee. Murine tissue was prepared as previously described (see Chapters 4-6)
(Liberti et al., 2021, Penkala et al., 2021). Briefly, lungs were inflated with 2%
paraformaldehyde at a pressure of 25cm H2O and fixed overnight with gentle rotation at
4°C. Tissue was washed with PBS 4-6 times then dehydrated with a graded ethanol
series (30%, 50%, 70%, 100%) and stored in 100% ethanol at -20°C until embedding.
Tissue was embedded in paraffin wax and sectioned at a 6μm thickness. De-identified
human lung samples were acquired from unused, donated organs for transplantation via
an established protocol approved by University of Pennsylvania Institutional Review
Board with informed consent according to institutional procedures. Human tissue was
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fixed in formalin or 2% paraformaldehyde fixed overnight with gentle rotation at 4°C and
washed, embedded, and sectioned the same as the murine tissue.

Hematoxylin and eosin (H&E) staining was performed to visualize tissue. Samples were
deparaffinized by treatment with xylene twice for 10-20 minutes and rehydrated by
treatment with 100% ethanol for 1-2 minutes and 95% ethanol for 1-2 minutes. Samples
were then rinsed in tap water followed by distilled water. Samples were stained with
hematoxylin for 3-5 minutes and then washed in tap water. Samples were then dipped in
a solution of 1% HCl in 70% ethanol 1-2 times and washed in running tap water for 15
minutes. Next, samples were dipped in 95% ethanol and stained with eosin for 1-4
minutes. After staining, samples were dipped in 95% ethanol 5-6 times. This step was
repeated with fresh 95% ethanol. Next, samples were dipped in 100% ethanol 5-6 times.
This step was repeated with fresh 100% ethanol. Samples were cleared in xylene twice
and mounted with Permount mounting media (Fisher scientific, cat#: SP15-100).

Immunohistochemistry (IHC) was performed with the following antibodies: Acta2
(mouse, Sigma Aldrich, cat#: A5228, 1:200), Ager (rabbit, Cell Signaling, cat#: 6996S,
1:100), Cdh1 (rabbit, cat#: 3195, Cell Signaling, 1:100), Emcn (goat, R&D Systems,
cat#: AF4666, 1:500), Krt5 (rabbit, Abcam, cat#: ab52635, 1:500), Lamp3 (rat, Novus,
cat#: DDX0191P-100, 1:100), Nkx2.1 (rabbit, Abcam cat#: ab76013, 1:50), Vim (rabbit,
Santa Cruz, cat#: sc-7557-R, 1:100).

Microscopy
Consistent image acquisition parameters ensure the rigor and reproducibility of the
automated analysis. Images were acquired using the widefield EVOS FL Auto 2 imaging
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system or a Nikon Eclipse 80i to scan individual tissue sections on a slide. While
comparing tissue sections across slides is possible with identical image acquisition
settings on the same microscope, comparing sections within a single slide will control for
potential differences in staining between slides, leading to the most consistent results.
Additionally, images should be labelled with simple nomenclature and dimensions
should be kept consistent. Tiles were stitched using Fiji or NIS-Elements software.

Quantitative analysis with algorithmic approach
When analyzing multiple images together (recommended) images are first concatenated
in order to classify all to a reference image. Next, images are preprocessed by
smoothing with a gaussian kernel. Next, color based segmentation is implemented
based on a simple Matlab (mathworks) routine (see an example here: Color-Based
Segmentation Using K-Means Clustering). K-means clustering with k=4 effectively
segments images into injury regions. Boundaries are drawn around the overlapping
regions to define zones.

Data Availability
All code used in this manuscript are freely available:
Codebase: https://github.com/WALIII/LungDamage
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Figure 3.1: Morphological segmentation of lung damage severity
(A) Model showing that lung damage is heterogenous and can be segmented into
distinct zones based on morphology (severe: severely perturbed tissue morphology,
damaged: moderately altered tissue morphology, and normal: largely homeostatic tissue
morphology). (B) Tiled and stitched images of hematoxylin and eosin (H&E) stained
tissue sections of influenza infected tissue at 14 days post injury (dpi), demonstrating
heterogeneity of tissue damage after infection (scale bars: 1000μm; n = 4). (C) Model
showing an H&E stained tissue section can be compared to adjacent slides stained with
a variety of markers. (D) Clustered images of the H&E stains in (C). (E) Quantification of
the percentage of tissue consisting of severe, damaged, and normal zones from images
in (D). (F) Model showing the comparison of H&E stained serial sections. (G) Mean
squared error in the comparison of section 1 to each subsequent section in a series of 5
serial sections (error bars represent SEM, n = 3).
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Figure 3.2: Epithelial, endothelial, and mesenchymal distribution after influenza
(A) Tiled and stitched image of an H&E stain of influenza infected tissue at 14 dpi (red
square: severe zone, green square: damaged zones, blue square: normal zone, scale
bar: 1000μm). (B) Clustered image of the H&E stain in (A). (C) Clustered image of the
H&E stain in (A). White lines mark the boundary between severe and damaged clusters
demarcating the severe zones. (D) Clustered image of the H&E stain in (A). White lines
mark the boundary between damaged and normal clusters demarcating the damaged
zones. (E-E’) Zoomed in severe zone area marked by red square in (A). Clustered
image shown in (E) and H&E stain shown in (E’). White lines mark the boundary
between severe and damaged zones. (F-F’) Zoomed in damaged zone area marked by
green square in (A). Clustered image shown in (F) and H&E stain show in (F’). White
lines mark the boundary between severe and damaged zones. (G-G’) Zoomed in normal
zone area marked by blue square in (A). Clustered image shown in (G) and H&E stain
shown in (G’) (scale bar: 100μm). (H) Tiled and stitched image of immunohistochemistry
(IHC) for epithelial cell markers CDH1 and NKX2.1. Dashed white box shows zoomed in
region in (I) (scale bar: 1000μm). (I) Zoomed in region from (H) (red square: severe
zone, green square: damaged zone, blue square: normal zone, scale bar: 1000μm). (I’)
Zoomed in region marked by red box in (I). (I’’) Zoomed in region marked by green box
in (I). (I’’’) Zoomed in region marked by blue box in (I) (scale bar: 100μm). (J) Tiled and
stitched image of IHC for endothelial cell marker EMCN. Dashed white box shows
zoomed in region in (K) (scale bar: 1000μm). (K) Zoomed in region from (J) (red square:
severe zone, green square: damaged zone, blue square: normal zone, scale bar:
1000μm). (K’) Zoomed in region marked by red box in (K). (K’’) zoomed in region marked
by green box in (K). (K’’’) Zoomed in region marked by blue box in (K) (scale bar:
100μm). (L) Tiled and stitched image of IHC for mesodermal marker VIM. Dashed white
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box shows zoomed in region in (M) (scale bar: 1000μm). (M) Zoomed in region from (L)
(red square: severe zone, green square: damaged zone, blue square: normal zone,
scale bar: 1000μm). (M’) Zoomed in region marked by red box in (M). (M’’) Zoomed in
region marked by green box in (M). (M’’’) Zoomed in region marked by blue box in (M)
(scale bar: 100μm).
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Figure 3.3: Zonal analysis of human lung damage from influenza, fibrosis, and
SARS-CoV-2
(A) Tiled and stitched image of an H&E stain of human lung tissue after influenza
infection. Right images are zoomed in regions marked by the colored squares (red
square: severe zone, green square: damaged zone, blue square: normal zone, scale
bar: 1500μm, n = 1). (B) Tiled and stitched image of an H&E stain of human lung tissue
from a patient with idiopathic pulmonary fibrosis. Right images are zoomed in regions
marked by the colored squares (red square: severe zone, green square: damaged zone,
blue square: normal zone, scale bar: 1500μm, n = 3). (C) Tiled and stitched image of an
H&E stain of human lung tissue from a patient diagnosed with coronavirus disease 2019
(COVID-19) resulting from SARS-CoV-2 infection. Right images are zoomed in regions
marked by the colored squares (red square: severe zone, green square: damaged zone,
blue square: normal zone, scale bar: 1500μm, n = 1). (D) Clustered image of the H&E
stain in (A). (E) Tiled and stitched image of IHC for KRT5 (basal cell marker) and LAMP3
(AT2 cell marker) on a slide adjacent to the H&E stained slide shown in (A). Dashed
white box shows the zoomed in region shown in the breakout channel images on the
right. (F) Tiled and stitched image of IHC for AGER (AT1 cell marker) and ACTA2
(airway smooth muscle or myofibroblast marker) on a slide adjacent to the H&E stained
slide shown in (A). Dashed white box shows the zoomed in region shown in the breakout
channel images on the right. (G) Clustered image of the H&E stain in (B). (H) Tiled and
stitched image of IHC for KRT5 and LAMP3 on a slide adjacent to the H&E stained slide
shown in (B). Dashed white box shows the zoomed in region shown in the breakout
channel images on the right. (I) Tiled and stitched image of IHC for AGER and ACTA2
on a slide adjacent to the H&E stained slide shown in (B). Dashed white box shows the
zoomed in region shown in the breakout channel images on the right. (J) Clustered
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image of the H&E stain in (C). (K) Tiled and stitched image of IHC for KRT5 and LAMP3
on a slide adjacent to the H&E stained slide shown in (C). Dashed white box shows the
zoomed in region shown in the breakout channel images on the right. (L) Tiled and
stitched image of IHC for AGER and ACTA2 on a slide adjacent to the H&E stained slide
shown in (C). Dashed white box shows the zoomed in region shown in the breakout
channel images on the right.
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Figure 3.4: Zonal analysis of normal human lung damage
(A) Tiled and stitched image of an H&E stain of normal human lung tissue. Dashed black
box marks zoomed in area of images in (C) (scale bar: 1500μm). (B) Clustered image of
the H&E stain in (A). (C) zoom in of the H&E stain in (A) (scale bar: 200μm). (D)
clustered image of the H&E stain in (C). (E) IHC for KRT5 and LAMP3 of the equivalent
area to that shown in (C) from an adjacent slide (scale bar: 200μm). (F) IHC for AGER
and ACTA2 of the equivalent area to that shown in (C) from an adjacent slide (scale bar:
200μm).
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CHAPTER 4: ALVEOLAR EPITHELIAL CELL FATE IS MAINTAINED IN A
SPATIALLY RESTRICTED MANNER TO PROMOTE LUNG REGENERATION AFTER
ACUTE INJURY

This chapter is adapted from work published in (and featured on the cover of) Cell
Reports (Liberti et al., 2021). Madison M. Kremp assisted in the acquisition and
quantification of histological data. William A. Liberti created the software related to the
mapping of the heterogenous lung injury landscape. Ian J. Penkala performed flow
cytometry, and he and Shanru Li provided mice and technical support. Su Zhou assisted
with histological preparation.

4.1 Summary
Alveolar epithelial type 2 (AT2) cells integrate signals from multiple molecular pathways
to proliferate and differentiate to drive regeneration of the lung alveolus. Utilizing in vivo
genetic and ex vivo organoid models, we investigated the role of Fgfr2 signaling in AT2
cells across the lifespan and during adult regeneration after influenza infection. We show
that, while dispensable for adult homeostasis, Fgfr2 restricts AT2 cell fate during
postnatal lung development. Using an unbiased computational imaging approach, we
demonstrate that Fgfr2 promotes AT2 cell proliferation and restrains differentiation in
actively regenerating areas after injury. Organoid assays reveal that Fgfr2-deficient AT2
cells remain competent to respond to multiple parallel proliferative inputs. Moreover,
genetic blockade of AT2 cell cytokinesis demonstrates that cell division and
differentiation are uncoupled during alveolar regeneration. These data reveal that Fgfr2
maintains AT2 cell fate, balancing proliferation and differentiation during lung alveolar
regeneration.
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4.2 Introduction
The distal compartment of the lung contains the alveoli, where the majority of gas
exchange with the external environment occurs in mammals. The predominant epithelial
cell lineages within this niche are the alveolar type 1 (AT1) and type 2 (AT2) cells (Zepp
and Morrisey, 2019). AT1 cells form a thin, gas diffusible interface with the pulmonary
capillary plexus, which is essential for respiration. AT2 cells generate and secrete
pulmonary surfactant, which reduces surface tension to prevent alveolar collapse.
During normal adult homeostasis, the lungs are quiescent, exhibiting a very low rate of
cellular turnover. However, acute injury damages alveoli by destroying resident AT1 and
AT2 cells, depleting the lung of respiratory capacity.

Injury to the lungs is often heterogeneous and can elicit a varied regenerative response
depending on the type of damage and its severity (Basil et al., 2020, Sivakumar and
Frank, 2019, Whitsett et al., 2019, Xi et al., 2017, Zepp and Morrisey, 2019,
Alysandratos et al., 2021b). These varying responses are highlighted by distinct
alterations in tissue architecture (also see Chapter 3) (Zacharias et al., 2018).
Appropriate alveolar architecture must be reconstructed to restore gas exchange, which
requires the activation of the lung’s resident facultative progenitors: AT2 cells. In
response to lung damage, AT2 cells both rapidly proliferate and differentiate into AT1
cells to regenerate alveoli (Barkauskas et al., 2013). Yet, the cellular and molecular
processes that regulate these AT2 cell behaviors are poorly understood. This lack of
understanding is due in part to the heterogeneous nature of injury and tissue repair,
which makes the investigation of these processes complicated to address empirically.
However, elucidating the molecular mechanisms involved in activating AT2 cell
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proliferation and driving differentiation into AT1 cells is critical to develop methods to
promote alveolar regeneration after lung damage.

Fibroblast growth factor (Fgf) signaling is a potent mitogenic pathway that drives lung
development and injury regeneration. Fgfr2 signaling is required for lung branching
morphogenesis and for maintenance of prenatal AT2 cell fate (Abler et al., 2009, Chang
et al., 2013, Lebeche et al., 1999, Li et al., 2018, Weaver et al., 2000, Sekine et al.,
1999, De Moerlooze et al., 2000, Mori et al., 2019). Moreover, loss of Fgf signaling
during the postnatal period of lung development, alveologenesis, increases the
vulnerability of the lung to injury (Hokuto et al., 2004). In adults, Fgf signaling has been
implicated as essential for AT2 cell homeostasis (Dorry et al., 2020, Yuan et al., 2019). A
recent study suggests that the combined loss of Fgfr1, Fgfr2, and Fgfr3 in AT2 cells
results in decreased survival and proliferation of AT2 cells during adult homeostasis and
after bleomycin injury (Dorry et al., 2020). Fgf ligands, Fgf7 and Fgf10, stimulate AT2
cell proliferation through Fgfr2 after injury, and exogenous stimulation with or overexpression of these ligands may aid in lung regeneration (MacKenzie et al., 2015, Gupte
et al., 2009, Quantius et al., 2016, Yuan et al., 2019, Zacharias et al., 2018, Zepp et al.,
2017). However, this stimulation may also cause AT2 cells to be more susceptible to
viral infection (Nikolaidis et al., 2017). Together, these findings suggest that Fgfr2 has
other functions beyond regulating cell proliferation during injury repair and regeneration
in the lung.

We assessed the role of Fgfr2 in AT2 cells across the lifespan to determine how it may
balance proliferation versus differentiation both at homeostasis and after acute injury to
the lung. Loss of Fgfr2 during alveologenesis reveals that this signaling pathway acts to
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restrict AT2 cell fate. In the adult lung, AT2 cell-specific inactivation of Fgfr2 did not
disrupt AT2 cell homeostasis for up to one year. Given the heterogenous nature of lung
injury and regeneration, we leveraged our unbiased machine learning approach
described in Chapter 3 to further classify regenerating regions into distinct zones for
analysis. Using this technique, we show that Fgfr2-deficient AT2 cells exhibit both a
decreased level of proliferation and a greater ability to differentiate into AT1 cells
exclusively in regions of active alveolar remodeling, indicating the necessity of Fgf
signaling in a spatially specific manner in tissue regeneration. Organoid assays reveal
that while inactivation of Fgfr2 eliminates the ability of AT2 cells to respond to Fgfr2
ligand stimulation, Fgfr2 is not necessary for overall AT2 cell proliferation. This result is
due, in part, to Fgfr2-deficient AT2 cells maintaining their competence to respond to
parallel mitogenic signals, including immune cytokines. Moreover, blockade of AT2 cell
division through inactivation of Ect2 uncouples division from differentiation in these cells,
demonstrating that AT2 cell fate decisions are made independent of proliferative
competency. Thus, our studies reveal that Fgf mediated alveolar regeneration occurs in
a spatially specific manner and highlights the critical parallel inputs that control AT2 cell
proliferation in an inflammatory injury and regeneration model. Importantly, our studies
reveal that AT2 cell identity is actively maintained during regeneration and suggest that
Fgfr2 acts not only to promote proliferation but also to restrain AT2 cell fate.

4.3 Fgfr2 restricts AT2 cell identity during postnatal lung development
To assess the role of Fgfr2 in AT2 cell development during alveologenesis, we
generated SftpcCreERT2;Fgfr2fl/fl;R26EYFP mice to both functionally inactivate Fgfr2 and to
trace the fate of the AT2 cell lineage starting at postnatal day zero (P0). We found that
AT2 cell-specific loss of Fgfr2 resulted in an increase in the percentage of lineage traced
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cells expressing the AT1 cell marker Hopx (Figure 4.1A). While the majority of these
Hopx+ lineage traced cells also expressed the canonical AT2 cell marker Sftpc at P5, as
alveologenesis progressed to P15 and P28, these cells lost expression of Sftpc, while
retaining Hopx expression. This progressive loss of Sftpc and gain of Hopx expression in
lineage traced cells suggests that loss of Fgfr2 in AT2 cells leads to a transition from an
AT2 to an AT1 cell fate (Figures 3.1A-C). We confirmed that Fgfr2 was functionally
inactivated in Fgfr2 mutant AT2 cells using a custom RNA fluorescence in situ
hybridization (FISH) probe to detect the deleted Fgfr2 exons 8-10 (Figure 4.1D).

AT2 cells are known to proliferate to a limited degree over the course of alveologenesis
(Frank et al., 2016, Yang et al., 2016). Therefore, we compared AT2 cell proliferative
potential between control and Fgfr2 mutant lungs by EdU incorporation around the
earliest peak in AT2 cell proliferation at P5 (Frank et al., 2016). These data reveal more
EdU incorporation in Fgfr2-deficient AT2 cells compared to controls, suggesting there is
a compensatory increase in AT2 cell proliferation upon loss of Fgfr2 at this time (Figures
4.1E-F). EdU+ Fgfr2-deficient AT2 cell-derived AT1 cells were rare, consistent with the
minimal proliferation of the normal AT1 cell population during postnatal development
(Frank et al., 2016, Yang et al., 2016). Additionally, there was no apparent change in
markers of cell death, suggesting that the increased in the percentage of lineage traced
AT1 cells was not due to loss of AT2 cells (Figure 4.1G). To determine whether the loss
of AT2 cell fate in Fgfr2 mutant lungs impacts adult lung architecture, we performed
mean linear intercept (MLI) analysis on P28 lungs and found no significant morphometric
difference between control and mutant lungs (Figures 4.1H-I). Further, while the
expansion of Fgfr2-deficient AT2 cells we observed at P5 did not lead to a statistically
significant increase in total lineage traced cells at P28, it seemed to increase the AT2
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cell population enough that the percentage of total AT1 cells of the total alveolar
epithelium at P28 appeared unchanged (Figures 4.1J-L). These results show that Fgfr2
acts to restrict AT2 cell fate during postnatal alveologenesis.

4.4 Fgfr2 is dispensable for AT2 cell homeostasis
To determine whether Fgfr2 is required for AT2 cell homeostasis in the adult lung, we
inactivated Fgfr2 in AT2 cells and lineage traced these cells in adult mice and assessed
lung morphometry and AT2 cell fate at three timepoints: one month, six months, and one
year. We observed no obvious change in lung architecture in Fgfr2 mutant lungs
compared to controls (Figure 4.2A). Moreover, MLI analysis revealed no difference
between mutant and control lungs at any time point (Figure 4.2B). While the lung is
largely a quiescent organ at homeostasis, AT2 cells are known to self-renew and
differentiate into AT1 cells slowly over time during normal homeostasis (Barkauskas et
al., 2013). To determine whether loss of Fgfr2 would impact long term AT2 cell survival
or AT2 to AT1 transition at homeostasis, we compared the number of lineage labeled
cells and the percentage of lineage labeled AT2 cell-derived AT1 cells in Fgfr2-deficient
versus control lungs. We found no change in the number of lineage labeled cells
between Fgfr2 mutant and control lungs at any time point, suggesting there was no
change in AT2 cell survival over time (Figures 4.2C-D). Even after one year, we did not
observe a difference in the percentage of lineage labelled AT2 cell-derived AT1 cells
between mutant and control lungs, suggesting mutant AT2 cells exhibited normal
homeostatic turnover into AT1 cells over time (Figures 4.2C and E). Together, our
results demonstrate that Fgfr2 is not required in AT2 cells to maintain lung alveolar
homeostasis.
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4.5 Zonal analysis reveals a spatially specific role for Fgfr2 in regulating AT2 cell
proliferation
To examine whether Fgfr2 is required for AT2 cell-mediated lung regeneration, we
investigated the behavior of adult Fgfr2-deficient AT2 cells after acute influenza
infection. In control lungs 14 days post influenza infection (dpi), we found enriched
expression of Fgfr2 ligands Fgf7 and Fgf10 in morphologically perturbed areas of tissue
(Figures 4.3A and 4.4A). This enrichment is consistent with previous reports that both
the intracellular signaling and the accompanying injury response differ across the
heterogeneously damaged tissue (Zacharias et al., 2018, Katsura et al., 2019).
Moreover, our lab previously described the heterogenous damage caused by influenza
and identified distinct zones of injury (Zacharias et al., 2018). However, the distinction
between these zones can often be difficult to discern, making analysis challenging. To
ensure rigorous, reproducible analysis, we employed our lung damage assessment
program described in Chapter 3, which leverages the heterogenous nature of lung injury
and computer vision to unbiasedly bin injured regions into distinct zones. Using this
computational image analysis approach, we segmented damaged tissue into three
zones of injury: severe, damaged, and normal (Figure 4.3B). Severe zones are
characterized by maximal alveolar damage. A hallmark of severe influenza infection is
the emergence of Keratin 5 (Krt5) expressing airway epithelial cells, which migrate into
the alveolar space in an attempt to provide a rapid but dysplastic response to injury (Ray
et al., 2016, Zuo et al., 2015, Vaughan et al., 2015, Fernanda de Mello Costa et al.,
2020). We found Krt5+ cells exclusively in Severe zones, while markers of AT1 cells are
largely absent from this zone (Figures 4.3C and E-F). While these zones are typically
thought to be alveolar deserts, we find a small number of AT2 cells in some of these
zones (Figures 4.3C and G). The AT2 cells in severe zones are highly proliferative and
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very rarely differentiate into AT1 cells in this injury context as noted by the vast majority
of SftpcCreERT2 traced cells in these zones expressing Sftpc (Figure 4.3C). In contrast,
damaged zones are defined by active morphological remodeling, are devoid of Krt5+
cells, and harbor dense collections of AT1 and AT2 cells (Figures 4.3D and E’-G’).
These zones contain both proliferating and differentiating AT2 cells (Figure 4.3D).
Normal zones similarly lack Krt5+ cells and consist of largely homeostatic tissue
architecture with both AT1 cells lining the alveolar walls and AT2 cells distributed
throughout the alveoli. (Figures 4.3E’’-G’’). To determine whether Fgfr2 regulates AT2
cell-mediated lung regeneration, we compared the percentage of Ki67+ cells in control
or Fgfr2-deficient AT2 cells in both damaged and severe zones on 14 dpi. While we saw
a decrease in proliferative AT2 cells in damaged zones consistent with previous reports,
we did not see a statistically significant change in proliferation in AT2 cells in Severe
zones (Figures 4.3J-K). The lack of a significant, detectable difference in Severe zones
could not be explained by an inability of Fgfr2-deficient AT2 cells to survive injury as we
confirmed the presence of Fgfr2-deficient AT2 cells in both severe and damaged zones
at 14 dpi (Figure 4.4B). Moreover, while there is some AT2 cell proliferation in normal
zones, it is quite variable, consistent with the heterogeneity of the injury itself, and no
difference was observed between Fgfr2-deficient or replete AT2 cells at 14 dpi (Figures
4.4C-D). Together, our data suggest that Fgfr2 is preferentially important to promote AT2
cell proliferation in damaged zones, which are sites of active tissue regeneration (Figure
4.3L).

4.6 Multiple and redundant inputs promote AT2 cell proliferation
To investigate more directly whether Fgfr2 is required for AT2 cell proliferation, we
employed an ex vivo organoid model to compare the growth of isolated, lineage traced
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Fgfr2-deficient versus control AT2 cells from uninjured mice (Figure 4.5A) (Barkauskas
et al., 2013). Consistent with our previous findings in Severe zones in the influenza injury
and regeneration model, we observed no obvious difference in size between control and
mutant organoids after 21 days of culture (Figure 4.6A). To verify that this lack of a
difference was not due to competitive loss of Fgfr2-deficient AT2 cells from impeded
survival or growth of Fgfr2 replete cells resulting from incomplete inactivation of Fgfr2,
we confirmed the loss of Fgfr2 in these mutant organoid cultures (Figure 4.6A).
Moreover, we verified expression of Sftpc and Ager, an AT1 cell marker, in these mutant
organoids, suggesting that Fgfr2-deficient AT2 cells were able to expand and
differentiate comparably to controls (Figure 4.6A). Comparing control and mutant
organoid growth over the course of 21 days in culture, we found no statistically
significant difference in organoid size or growth rate over time (Figures 4.6B-C).
Additionally, we found no difference in colony forming efficiency, suggesting that Fgfr2deficient AT2 cells survive and grow comparably to controls (Figure 4.6D). Because our
findings suggest that Fgfr2 is not required for AT2 cell proliferation, we sought to
determine whether loss of Fgfr2 would impact AT2 cell responsiveness to other
mitogenic signals (Figure 4.6E). Fgfr2 is the primary receptor for Fgf7, which we have
previously shown stimulates mature AT2 cell proliferation (Zacharias et al., 2018, Zepp
et al., 2017). To investigate the responsiveness of control versus Fgfr2-deficient AT2
cells to Fgf signaling, we provided exogenous Fgf7 to the organoid cultures. Control AT2
cell-derived organoids exhibited robust growth upon Fgf7 stimulation due to augmented
AT2 cell proliferation and differentiation into AT1 cells consistent with our previous
studies (Figure 4.6F) (Zacharias et al., 2018, Zepp et al., 2017). Conversely, organoids
generated from Fgfr2-deficient AT2 cells did not respond to Fgf7 treatment (Figure
4.6F). Visualizing growth over time, we found that control organoids responded rapidly to
82

exogenous Fgf7 (Figure 4.6G). Fgf7 treated control organoids demonstrated a
statistically significant increase in growth compared to untreated control and Fgf7 treated
Fgfr2-deficient organoids after seven days of stimulation (14 days of culture) (Figures
4.6G-I). However, this growth plateaued after nine days of stimulation (16 days of
culture) (Figure 4.6G). Thus, Fgfr2 deficient AT2 cells do not respond to exogenous
Fgf7, even though the level added in these assays is likely higher than what occurs in
vivo during alveolar regeneration.

Recent reports have suggested that inflammatory signaling is important for stimulating
AT2 cell-mediated lung regeneration (Choi et al., 2020, Katsura et al., 2019). To
examine whether loss of Fgfr2 impacts the AT2 cell response to immune cytokine
stimulation, we treated Fgfr2-deficient and control AT2 cell organoids with IL-1α, IL-1β,
and TNFα. At 21 days of culture, both IL-1α and IL-1β stimulated robust organoid
growth, while TNFα led to a slight but not statistically significant increase in organoid
size, regardless of presence or absence of Fgfr2 (Figures 4.6J-K). Additionally, we
found no difference between the organoid growth of Fgfr2-deficient and control
organoids stimulated with any of the three cytokines (Figures 4.7A-C). Together, our
results show that immune cytokines promote robust AT2 cell growth independent of
Fgfr2 signaling, suggesting that Fgfr2 is not the sole regulator of AT2 cell proliferation
and that alveolar regeneration integrates multiple proliferative inputs.

4.7 Loss of Fgfr2 promotes AT2 to AT1 cell differentiation
To assess whether loss of Fgfr2 would alter the fate of AT2 cells during lung
regeneration similar to our findings during alveologenesis, we lineage traced Fgfr2deficient and control AT2 cells and evaluated AT2 to AT1 cell differentiation through
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expression of Sftpc and Hopx in damaged zones at 14 and 28 dpi. Fgfr2-deficient AT2
cells differentiated more readily into AT1 cells in damaged zones leading to an increase
in lineage traced AT1 cells in mutant lungs at 14 dpi (Figures 4.8A-B and 4.9A-B). This
difference persisted to 28 dpi (Figures 4.8C-D). Moreover, the increase in lineage traced
AT1 cells in mutant lungs led to an overall increase in total AT1 cells as a percentage of
total alveolar epithelium in damaged zones (Figures 4.8E-F). AT1 cells are known to
spread dramatically during normal development, contributing to the complex architecture
of the adult lung alveolus (Wang et al., 2016b, Yang et al., 2016). We surmised that the
differentiation of AT2 cells into large squamous AT1 cells serves not only to replace lost
epithelium destroyed as a consequence of injury, but also as a mechanism to restore the
homeostatic alveolar architecture and that this architectural remodeling process would
become altered if the ratio of AT1:AT2 cells was perturbed. We found that the increase
in AT2 to AT1 cell differentiation, which results in an overall increase in AT1 cells in
Fgfr2-deficient lungs, did impact the alveolar architecture of mutant lungs (Figure 4.8G).
Because is difficult to know the extent of injury in normal zones where the tissue has
largely regenerated by 28 dpi, we focused our morphological analysis in damaged
zones. Morphologic analysis of damaged zones in Fgfr2-deficient versus control lungs at
28 dpi revealed an increase in the average alveolar area of mutant lungs resulting from
large, extended air spaces due to an increase AT1 cells (Figures 4.8H-I). This H1N1
influenza model does not commonly elicit a fibrotic response, and we confirmed there
was no obvious change in collagen deposition or infiltration of Acta2 expressing
myofibroblasts between control and mutant lungs (Figures 4.9C-D) (Kumar et al., 2011).
Moreover, while we did note the presence of airway epithelial cell-derived Krt5+ pods
common to severe influenza injury in both control and mutant lungs, we did not observe
an obvious difference between the size or frequency of these pods between control and
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mutant lungs (Figure 4.9E) (Kumar et al., 2011, Zacharias et al., 2018, Vaughan et al.,
2015). Together, these data demonstrate that Fgfr2 acts to restrain AT2 cell fate,
promote expansion of the AT2 cell pool, and regulate AT2 to AT1 cell differentiation to
drive restoration of the homeostatic alveolar architecture (Figure 4.8J).

4.8 AT2 cell division and differentiation are uncoupled processes
Because Fgfr2 regulates both AT2 cell proliferation and identity in a spatially restricted
manner, we sought to determine whether these two cellular processes were linked
during tissue regeneration in the lung. To investigate whether cell division and
differentiation are coupled processes in the lung alveolus, we employed an Ect2 genetic
deletion model to block cell division. Ect2 is essential for cytokinesis, and loss of Ect2
leads to a failure in cell division (Cook et al., 2011, Windmueller et al., 2020). We
hypothesized that genetic inactivation of Ect2 would leave AT2 cells receptive to
proliferative stimuli while preventing AT2 cell division, resulting in the generation of
binucleated cells during lung regeneration (Figure 4.10A). As expected, we confirmed
the presence of binucleated AT2 cells, containing lamellar bodies and indication of
functional surfactant production (Figure 4.10B). Both binucleated AT1 and AT2 cells are
present at 14 and 28 dpi, but binucleated AT1 cells are found exclusively in Damaged
zones at 14 dpi, consistent with AT2 cell differentiation occurring in these zones
(Figures 4.10C-D and 4.11A-F). Importantly, the presence of binucleated AT2 cellderived AT1 cells demonstrates that cell division is not required for differentiation to
occur. The presence of binucleated AT1 cells exclusively in damaged zones at 14 dpi
along with the appearance of binucleated AT2 cells in normal and severe zones at 28
dpi suggests that blocking cytokinesis alone is not sufficient to drive an AT2 cell to
differentiate into an AT1 cell (Figures 4.10C and 4.11C-F). However, Ect2-deficient AT2
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cells can become binucleated at any time during regeneration in any injury zone,
highlighting the importance of determining when these binucleated cells arise and
whether they stably maintain their identity. To address this point and to further determine
whether cytokinesis is required to maintain AT2 cell identity, we performed an EdU
pulse-chase experiment to mark cells that had undergone the S phase of the cell cycle,
including emerging binucleated cells, and followed their fate decisions. We pulsed mice
with EdU once a day for five consecutive days beginning at 9 dpi when AT2 cells should
be proliferating and chased for two weeks until 28 dpi (Figure 4.10E) (Katsura et al.,
2019). The presence of EdU+ binucleated AT1 and AT2 cells in damaged zones at 28
dpi confirms that binucleated AT2 cells can differentiate into and maintain an AT1 cell
fate, and these data show that AT2 cells can stably maintain their identity independent of
their ability to divide for at least two weeks after injury (Figures 4.10F-G). Our data
demonstrate that cell division is not required to maintain AT2 cell fate, demonstrating
that loss of the ability to undergo cytokinesis does not deterministically result in
differentiation of AT2 cells into an AT1 cell fate. To test this possibility further, we
investigated whether blockade of AT2 cell division would increase the number of AT1
cells as a percentage of the total alveolar epithelium during regeneration. Quantification
of the number of AT1 cells as a percentage of Nkx2.1+ cells in damaged zones in Ect2deficient and control lungs at 28 dpi shows that loss of AT2 cell division does not change
the overall number of AT1 cells as a percentage of the total alveolar epithelium (Figures
4.10H-I). Together, these data show that AT2 cell division and differentiation are
uncoupled processes and that cell fate is maintained independent of proliferative
competency.
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4.9 Discussion
Restoration of gas exchange after lung injury requires both replenishment of alveolar
epithelial cells and re-establishment of alveolar architecture. The major facultative
progenitor of the lung alveolus, the AT2 cell, is thought to play a critical role in these
processes through proliferating and differentiating into AT1 cells. However, it was
previously unclear how AT2 cells balance the decision to divide versus differentiate. Our
studies reveal that multifarious parallel pathways converge to drive AT2 cell proliferation
and that Fgfr2 acts to restrain AT2 cell identity in a spatially restricted manner to balance
proliferation versus differentiation to restore alveolar architecture and normal lung
function after lung injury (Figure 4.12).

Fgf signaling is essential for prenatal development in the lung and it serves to guide
branching morphogenesis and to maintain AT2 cell fate (also see Chapter 2) (Abler et
al., 2009, Chang et al., 2013, Lebeche et al., 1999, Li et al., 2018, Weaver et al., 2000,
Mori et al., 2019, Sekine et al., 1999, De Moerlooze et al., 2000). Our results
demonstrate that while Fgf signaling via Fgfr2 is likely not the only regulator of AT2 cell
identity, it remains critical during postnatal development to maintain AT2 cell fate long
after alveolar epithelial fate specification (Frank et al., 2019). Prior work has suggested
that Fgfr2 is important for adult lung epithelial cell homeostasis and repair after injury,
but whether Fgfr2 acts purely as a mitogenic signal transducer in the lung epithelium has
remained unclear (Dorry et al., 2020, Balasooriya et al., 2017, Yuan et al., 2019). During
airway homeostasis, loss of a single Fgfr2 allele leads to depletion of the basal cell
lineage into an immature luminal cell fate, while after injury overexpression of Fgf10
increases airway cell contribution to the AT2 cell lineage, suggesting a role for Fgfr2
signaling in regulating lung epithelial cell fate (Balasooriya et al., 2017, Yuan et al.,
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2019). While our data show that AT2 cell specific loss of Fgfr2 for up to one year did not
lead to any change in lung morphometry, AT2 cell survival, or AT2 to AT1 cell
differentiation, our results are consistent with Fgfr2 being critical for regulating AT2 cell
fate both during development and lung regeneration.

Our results reveal that Fgfr2-deficient AT2 cells remain competent to respond to other
mitogenic stimuli, in particular inflammatory cytokines. This is especially relevant in the
context of an influenza injury model, where the immune response plays an important role
in both injury resolution and regeneration. In particular, immune cytokines such as IL-1α
and IL-1β play key roles in promoting AT2 cell mediated alveolar regeneration (Katsura
et al., 2019). A recent study revealed that IL-1 receptor-expressing AT2 cells respond to
acute lung injury by proliferating, but chronic IL-1β stimulation decreased AT2 to AT1 cell
differentiation (Choi et al., 2020). These results demonstrate that multiple, parallel, and
possibly redundant proliferative stimuli encourage AT2 cell proliferation, highlighting the
importance of AT2 cell proliferation to promote rapid tissue regeneration in the lung.
Moreover, the similarity of our organoid results to the behavior of AT2 cells in Severe
versus damaged zones underscores the importance of comparing ex vivo experiments in
the context of in vivo biology. These results also suggest that additional advances in
culturing conditions will benefit organoid models (Katsura et al., 2020, Weiner et al.,
2019, Shiraishi et al., 2019a, Shiraishi et al., 2019b).

While cell proliferation is an essential aspect of robust tissue regeneration, how this
process is balanced by the need for differentiation has remained less clear in the lung.
We demonstrate that while AT2 cells do not require the ability to divide to differentiate
into AT1 cells, AT2 cells similarly do not require proliferative competency to maintain
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their identity. Indeed, the persistence of binucleated cells versus further multinucleation
or death as a result of blocking cytokinesis suggests that AT2 cells actively balance the
decision to divide versus differentiate. These findings suggest that not only division, but
also proliferation may be uncoupled from fate choice in AT2 cells during regeneration.
Moreover, the loss of the ability to divide does not perturb the balance between AT1 and
AT2 cells as with the loss of Fgfr2, suggesting that Fgfr2 acts to maintain AT2 cell
identity independently of its role in mitogenesis. Previous work showed that a Wnt
responsive alveolar epithelial progenitor (AEP) sublineage within the AT2 cell population
contributes primarily to the proliferative response of AT2 cells (Zacharias et al., 2018,
Nabhan et al., 2018). In light of our current findings, it is possible that the non-AEP
fraction of the AT2 cell population more readily converts into AT1 cells versus
undergoing cell division. This differential fate choice likely hinges both on the local
signaling niche as well cell intrinsic factors reinforcing a more or less plastic AT2 cell
identity, consistent with epithelial progenitor cell behavior in other organs like the skin
and intestine (Nabhan et al., 2018, Zepp et al., 2017, Xi et al., 2017, Rompolas et al.,
2013, Rompolas et al., 2012, Gehart and Clevers, 2019). Such a balance between
cellular responses within the AT2 cell population may allow for rapid regeneration to
occur, while maintaining the surfactant production required for alveolar homeostasis.

One of the challenges of defining the molecular mechanisms driving pro-regenerative
cellular behaviors during lung repair is the heterogeneous nature of lung injury. To
overcome this difficulty, we developed an unbiased computational imaging approach,
which takes advantage of the heterogenous architectural distortion typical to lung injury,
to bin different domains of injury and regeneration in the lung. Our analysis
demonstrates that most of the morphological remodeling of the tissue due to AT2 cell
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differentiation into AT1 cells occurs in areas separate from the formation of dysplastic
keratinized epithelium, consistent with previous reports (Zacharias et al., 2018). Our
studies underscore the importance of examining lung repair and regeneration in a
zonally specific manner as the AT2 cell response differs significantly across different
regions of injured tissue. Moreover, utilizing this imaging approach to analyze
morphological changes in specific zones allows unbiased assessment of secondary
defects and promotes reproducibility in comparison between conditions by controlling for
injury heterogeneity. Use of this lung damage assessment program may better define
and clarify future studies on the impact of severe injury and subsequent regeneration in
the lung.

Given the complex signaling milieu that occurs after severe lung injury, multiple parallel
and competing pathways are likely required to provide a robust balance between cell
proliferation and differentiation and to promote proper restoration of functional
homeostasis. Our findings reveal that a combination of pathways and inputs are required
for the proliferative response to acute injury in the lung alveolus. Moreover, we have
demonstrated that cytokinesis is uncoupled from AT2 to AT1 cell differentiation,
indicating a complex and flexible molecular response of the alveolar epithelium to injury.

4.10 Materials and methods
Materials availability
The RNAscope probe Fgfr2-O1 (Cat#: 806301) was generated by and is available from
Advanced Cell Diagnostics upon request.
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Data and software availability
Lung damage assessment software (LungDamage) is publicly available on Github
(https://github.com/WALIII/LungDamage).

Mouse lines
Development and genotyping information for mouse lines SftpcCreERT2, Fgfr2fl/fl (Jackson
Laboratory stock # 007569) , R26REYFP (Jackson Laboratory stock # 007903), Ai14(RCLtdT)-D (R26RtdTomato) (Jackson Laboratory stock # 007914), and Ect2fl/fl have been
previously described (Chapman et al., 2011, Madisen et al., 2010, Windmueller et al.,
2020, Yu et al., 2003). Fgfr2fl/fl, R26RtdTomato, and R26REYFP mouse lines were purchased
from the Jackson Laboratory. All mice were maintained on a mixed background
(C57BL/6 and CD1). No obvious defects were observed in heterozygous mice, so
SftpcCreERT2;Fgfr2fl/+;R26REYFP and SftpcCreERT2;Ect2fl/+;R26REYFP littermates were used as
controls for all experiments except for the organoid experiments in Figures 4.5-4.7
where SftpcCreERT2;R26RtdTomato mice were used and the adult one month or longer
influenza experiments in Figures 4.8C-I, 4.9C-E, 4.10B,D-I, and 4.11E-F where
SftpcCreERT2;R26REYFP mice, including littermates, were used. Experiments were all
performed with a minimum of n = 3 mice per condition of mixed gender, and unless
otherwise stated each dot on a graph represents one mouse. All procedures for animal
experiments were performed under the guidance of the University of Pennsylvania
Institutional Animal Care and Use Committee.

Lung alveolar organoid assay
Organoid assays were performed as previously described with modification (Barkauskas
et al., 2013, Frank et al., 2016, Peng et al., 2015, Zacharias et al., 2018, Zepp et al.,
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2017). In brief, single cell suspensions were made from SftpcCreERT2;R26RtdTomato or
SftpcCreERT2;Fgfr2fl/fl; R26RtdTomato mice by physical and enzymatic dissociation and
tdTomato+ cells were sorted into FACS buffer (Hanks Balanced Salt Solution (HBSS,
Gibco, catalog # 14175095), 25mM HEPES (Gibco, catalog # 15630080), 2mM EDTA
(Invitrogen, catalog # 15575020), and 2% Fetal Bovine Serum (FBS) (Deville, catalog #
FB5001). Live cell number was verified using a hemocytometer and Trypan Blue
Solution, 0.4% (Gibco, catalog # 15250061). In each technical replicate, 5x103
tdTomato+ cells were combined with 5x104 primary lung fibroblasts in 50% Matrigel
(Corning, catalog # 356231) and 50% MTEC-SAGM in a Falcon Cell Culture Insert
(Thermo Fisher Scientific, catalog # 08770). The MTEC-SAGM media was made as
previously described. In brief, Small Airway Epithelial Cell Growth Basal Media (SABM)
(Lonza, catalog # CC-3119) was mixed with selected Small Airway Epithelial Cell Growth
Medium supplements (SAGM) (Lonza, catalog # CC-4124): Insulin/Transferrin, Bovine
Pituitary Extract, Gentamycin, and Retinoic Acid as well as 0.1 μg/mL Cholera Toxin
(Millipore Sigma, catalog # C9903), 25ng/mL EGF (Peprotech, catalog # AF-100-15),
and 5% FBS (Zepp et al., 2017, Barkauskas et al., 2013). Cell/matrigel mixtures were
allowed to solidify for fifteen minutes before MTEC-SAGM media was added under the
transwell into the bottom of the well. Media was changed every other day. AntibioticAntimycotic (Gibco, catalog # 15240062) and 10μM rock inhibitor (Y-27632
dihydrochloride, Millpore Sigma, catalog # Y0503) were added to the media for the first
two days of culture. A Tgfbr1 inhibitor (SB431542, Abcam, catalog # ab120163) was
added to the media to a final concentration of 10μM for the first seven days of culture to
promote organoid formation (Katsura et al., 2019). Experiments involving IL-1α
(10ng/mL, BioLegend, catalog # 575002), IL-1β (10ng/mL, BioLegend, catalog #
575102), TNFα (10ng/mL, BioLegend, catalog # 575202), or mFGF7 (25ng/mL, R&D
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Systems, catalog # 5028-KG-025) treatment involved cytokine addition beginning after
the first seven days of culture. Concentrations may differ from endogenous levels but
were consistent with previous studies (Katsura et al., 2019, Zepp et al., 2017).
Treatment occurred during normal media changes and continued for the final two weeks
of culture. Images were captured over the course of culture using an EVOS FL Auto 2
Imaging System. On the final day of culture, organoids were removed from transwell
inserts, embedded in 4% UltraPure Low Melting Point Agarose (Invitrogen, catalog #
16520050) in HBSS, fixed in 2% paraformaldehyde solution (Thermo Fisher Scientific,
catalog # AAJ19943K2) for 30 minutes at room temperature, washed in Phosphate
Buffered Saline (PBS) (Quality Biological, catalog # 119-068-151), dehydrated in a
graded series of ethanol washes (30%, 50%, 70%, 95%, and 100%), embedded in
paraffin wax, and sectioned at a 6μm thickness. Results are reflective of three
independent experiments with at least three replicate wells per condition.

Tamoxifen delivery
Tamoxifen administration to P0 mice was performed by intraperitoneal injection of 20μL
of a 20mg/mL mixture of tamoxifen in ethanol (10%) and corn oil (90%). Tamoxifen
delivery to adults was performed by oral gavage at a dose of 200mg/kg for three
consecutive days. All adult experiments were performed on 6-12 week old mice. A two
week washout period was observed after the final tamoxifen dose for all in vivo adult
experiments.

EdU incorporation
EdU (Santa Cruz, catalog # sc-284628B) was dissolved in filtered H2O and given via
intraperitoneal injection at a dose of 50mg/kg. P5 mice treated with EdU were harvested
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four hours after treatment. Adult mice were given EdU once per day for five consecutive
days from 9 to 13 dpi. EdU staining was performed with the Click-iT EdU cell
proliferation kit (Invitrogen, catalog # C10340) according to the manufacturer’s
instructions.

Influenza infection
PR8 H1N1 influenza was a kind gift from Dr. John Wherry at the University of
Pennsylvania. Virus was diluted in cold PBS and 50uL was delivered to anesthetized
mice intranasally at a dose of approximately 1LD50 (determined experimentally by the
Wherry Lab based on delivery to six to eight week old C57BL/6 female mice).

Histology, immunohistochemistry, and RNAscope
Lungs were harvested at a constant pressure of 25cm H2O and were fixed overnight at
4°C in 2% paraformaldehyde. Lungs were washed, dehydrated, embedded, and
sectioned as stated above for organoids. Hematoxylin and eosin (H&E) and Masson’s
trichrome

staining

were

performed

according

to

standard

procedures.

Immunohistochemistry was performed with the following antibodies: Acta2 (mouse,
Millipore Sigma, A5228, 1:200), Ager (Rage) (rat, R&D Systems, MAB1179, 1:50),
cleaved Casp3 (rabbit, Cell Signaling, 9664s, 1:50), Lamp3 (DC-Lamp) (rat, Novus,
DDX0191P-100, 1:100), Cdh1 (E-Cadherin) (rabbit, Cell Signaling, 3195, 1:100), GFP
(chicken, Aves Labs, GFP-1020, 1:200), Hopx (mouse, Santa Cruz, sc-398703, 1:100),
Keratin 5 (Krt5) (rabbit, Abcam, ab52635, 1:500), Ki67 (mouse, BD Biosciences,
550609, 1:200), Nkx2.1 (Ttf1) (rabbit, Santa Cruz, sc-13040, 1:50), Nkx2.1 (Ttf1)
(mouse, Thermo Fisher Scientific, MS-699-P1, 1:25), Pdpn (hamster, Developmental
Studies Hybridoma Bank, 8.1.1., 1:100), and Sftpc, (rabbit, Millipore Sigma, AB3786,
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1:100). Slides were mounted in Vectashield Antifade Mounting Medium (Vector
Laboratories catalog # H-1000) or Slowfade Diamond Antifade Mountant (Invitrogen,
catalog # S36972). Slowfade Diamond Antifade Mountant was used to avoid the
quenching action of Vectashield on Alexa Fluor 647 secondary antibodies. RNAscope
was performed according to the manufacturer’s instructions using the following probes:
Mm-Fgf7-no-XHs (Catalog # 443521), Mm-Fgf10 (Catalog # 446371), Fgfr2-O1 (custom
probe designed to bind specifically within the floxed region of Fgfr2flox allele). H&E,
Masson’s trichrome, and widefield fluorescence images in Figures 4.9C-E were
acquired with either a Nikon Eclipse 80i or an EVOS FL Auto 2 Imaging System. All
other fluorescence images, including all images used for quantification, were captured
using a Zeiss LSM 710 confocal microscope. Tile scanned images were stitched using
Fiji software.

Transmission Electron microscopy
Influenza infected lungs 34 dpi were digested as for the lung alveolar organoid assay
and total Epcam+ cells were isolated using the Dynabeads FlowComp Flexi Kit
according to the manufacturer’s instructions. Briefly, a purified Epcam antibody (Rat,
Thermo Fisher Scientific, 14-5791-85) was biotinylated and incubated with digested lung
tissue for 20 minutes at 4°C. The cells were subsequently washed with FACS buffer and
incubated with FlowComp Dynabeads on a rotating platform for 15 minutes at 4°C
before being placed on a magnetic stand. The cells were washed with FACS buffer, then
were released from the beads by adding Release Buffer for 20 minutes at 4°C. The
magnetic beads were removed using the magnetic stand, and the cells were fixed in
2.5% glutaraldehyde, 2.0% paraformaldehyde in 0.1M sodium cacodylate buffer, pH 7.4
overnight at 4°C. Samples were washed, post-fixed in 2.0% osmium tetroxide with 1.5%
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K3Fe(CN)6 for 1 hour at room temperature, and rinsed in dH2O. After dehydration
through a graded acetone series, the samples were infiltrated and embedded in EMbed812 (Electron Microscopy Sciences, Fort Washington, PA). Thin sections were cut then
stained with uranyl acetate and SATO lead and were subsequently imaged on a JEOL
1010 electron microscope fitted with a Hamamatsu digital camera using AMT Advantage
NanoSprint500 software.

Immunohistochemistry quantification
All image quantification was performed on confocal acquired z-stack images through 610μm thick tissue sections. For a given stain, at least 200 cells or five confocal stacks
taken at 40x magnification were used for quantification for each individual mouse.

Mean linear intercept
Morphometric analysis of mean linear intercept was performed on images acquired
automatically from a scan of an entire lobe using an EVOS FL Auto 2 Imaging System at
20x. Images were manually sorted to avoid large airways and vessels to concentrate
analysis on alveolar regions. At least seven images were randomly selected per mouse
for analysis. Quantification was performed using custom Matlab software described
previously (Paris et al., 2020, Obraztsova et al., 2020).

Organoid size and colony forming efficiency
Organoid images were captured using endogenous fluorescence on an EVOS FL Auto 2
Imaging System. Images were processed in Fiji using simple thresholding, and were
then binarized, subjected to dilation and erosion to remove background. To enable
proper visualization of whole organoids, images were subjected to the fill holes function
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followed by watershedding to prevent organoid overlap. Organoids were then quantified
in Fiji using the analyze particles function with a cutoff of 1000μm2. Organoid areas were
pooled from three to four replicate wells per mouse to calculate average size per
condition. Colony number was divided by the number of input tdTomato+ cells to
determine colony forming efficiency.

Lung damage assessment program
Our lung damage assessment program was developed to enable the direct comparison
of similarly injured areas in tissue sections from the same mouse and between different
mice. We leveraged previous work from our lab where we identified and binned injured
regions by the level of morphological perturbation to develop an unbiased method of
mapping the severity of damaged regions across tissue sections (Zacharias et al., 2018).
Our Matlab software utilizes a K-means clustering algorithm to rank and sort points on
H&E slides according to staining intensity and density which varies with injury severity
(Zacharias et al., 2018). We independently sort all pixels from the tissue images into four
clusters. We find that pixels are reproducibly well-sorted into clusters comprised of a
background component and three clusters that highly correlate with injury zones, as
compared to manual curation. To account for the possibility of bias in the relative
clustering of heterogeneously injured tissue into distinct clusters, an image of a single
lobe is defined as a means of comparison and each image is clustered together with that
image. To further ensure reproducibility, sections from whole lobes were tile-scanned
using an EVOS FL Auto 2 Imaging System at 20x, and tissue sections were only
compared if they were acquired from the same slide and from a single imaging session
to control for differences in acquisition settings or staining. We are able to use the pixelwise labeling of tissue to identify locations of overlap of clusters that correlate with the
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two most damaged regions (false-colored in red and green, each region is displayed
surrounded by a boundary line). We demarcate the areas of maximal damage (red) as
severe zones, the areas of active morphological remodeling (green) as damaged zones,
and the homeostatic appearing regions (blue) as normal zones. Once the maps are
generated, they are used to identify the corresponding zones on immediately adjacent
slides, stained for various markers of interest.

Alveolar area measurement
Alveolar area analysis was performed on z-stack images of Pdpn stained slides captured
using a Zeiss LSM 710 confocal microscope. Maximum projections were created from
these stacks in Fiji to produce 2D images with sharp alveolar boundaries. These images
were further processed in Fiji using simple thresholding. Images were then binarized,
inverted, and subjected to dilation and erosion to remove background. Quantification
was performed in Fiji using the analyze particles function with a cutoff of 10μm2 and a
circularity cutoff of 0.2.

Statistics
All results are reported as mean ± SEM. Comparisons were made using two-tailed ttests with p ≤ 0.05 considered significant. Statistical tests were conducted in Graphpad
Prism8 software.
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Table 4.1: Key resources table
REAGENT or RESOURCE
Antibodies
Acta2

SOURCE

IDENTIFIER

Millipore Sigma

Rat anti-Ager (Rage)

R&D Systems

Rabbit anti-Cleaved Casp3

Cell Signaling

Rat anti-Lamp3 (DC-Lamp)

Novus

Rabbit anti-Cdh1 (E-Cadherin)

Cell Signaling

Chicken anti-GFP

Aves Labs

Mouse anti-Hopx

Santa Cruz

Rabbit anti-Keratin 5

Abcam

Mouse anti-Ki67

BD Biosciences

Rabbit anti-Nkx2.1 (TTF1)

Santa Cruz

Mouse anti-Nkx2.1 (TTF1)

Thermo Fisher
Scientific
Developmental
Studies
Hybridoma Bank
Millipore Sigma

Cat#: A5228
RRID: AB_262054
Cat#: MAB1179 RRID:
AB_2289349
Cat#: 9664s RRID:
AB_2070042
Cat#: DDX0191P-100
RRID: AB_2827532)
Cat#: 3195 RRID:
AB_2291471
Cat#: GFP-1020
RRID: AB_10000240
Cat#: sc-398703
RRID: AB_2687966
Cat#: ab52635 RRID:
AB_869890
Cat#: 550609 RRID:
AB_393778
Cat#: sc-13040 RRID:
AB_793532
Cat#: MS-699-P1
RRID: AB_142087
Cat#: 8.1.1.
RRID: AB_531893

Syrian hamster anti-Pdpn
Rabbit anti-Sftpc
Rat anti-Epcam
Mm-Fgf7-no-XHs (RNA FISH
probe)
Mm-Fgf10 (RNA FISH probe)
Fgfr2-O1 (RNA FISH probe)

Thermo Fisher
Scientific
Advanced Cell
Diagnostics
Advanced Cell
Diagnostics
Advanced Cell
Diagnostics

Cat#: AB3786 RRID:
AB_91588
Cat#: 14-5791-85
RRID: AB_953626
Cat#: 443521
Cat#: 446371
Cat#: 806301

Bacterial and Virus Strains
H1N1 Pr8

John Wherry Lab
(University of
Pennsylvania)
Chemicals, Peptides, and Recombinant Proteins
Fgf7
R&D Systems
IL-1α
BioLegend
IL-1β
BioLegend
TNFα
BioLegend
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Cat#: 5028-KG-025
Cat#: 575002
Cat#: 575102
Cat#: 575202

Small Airway Epithelial Cell
Lonza
Growth Medium (SAGM)
supplements
Small airway epithelial cell growth Lonza
basal media (SABM)
Cholera toxin
Millipore Sigma
EGF
Peprotech
Y-27632
Millipore Sigma
Antibiotic-Antimycotic
Gibco
Fetal Bovine Serum
Denville
Matrigel
Corning
EdU
Santa Cruz
Vectashield Antifade Mounting
Vector
Medium
Laboratories
Slowfade Diamond Antifade
Invitrogen
Mountant
Critical Commercial Assays
Click-iT EdU Cell Proliferation Kit
Invitrogen
Experimental Models: Organisms/Strains
Sftpc-CreERT2
PMCID:
PMC3223845
Fgfr2-flox
Jackson
Laboratories
Ect2-Flox
PMCID:
PMC7194103
R26R-EYFP
Jackson
Laboratories
Ai14(RCL-tdT)-D (R26RJackson
tdTomato)
Laboratories
Software and Algorithms
LungDamage program
This paper
Graphpad Prism8

GraphPad

Illustrator

Adobe

MATLAB

MathWorks

Fiji
Other
Falcon Cell Culture Insert

PMID: 22743772
Thermo Fisher
Scientific
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Cat#: CC-4124
Cat#: CC-3119
Cat#: C9903
Cat#: AF-100-15
Cat#: Y0503
Cat#: 15240062
Cat#: FB5001
Cat#: 356231
Cat#: sc-284628B
Cat#: H-1000
Cat#: S36972
Cat#: C10340
N/A
Cat#: 007569
N/A
Cat#: 007903
Cat#: 007914
https://github.com/WA
LIII/LungDamage
https://www.graphpad.
com/scientificsoftware/prism/
https://www.adobe.co
m/products/illustrator.
html
https://www.mathwork
s.com/products/matlab
.html
https://fiji.sc/
Cat#: 08770
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Figure 4.1: Fgfr2 maintains AT2 cell identity during alveologenesis
(A) Immunohistochemistry (IHC) for SftpcCreERT2 lineage marker EYFP, HOPX, and
SFTPC, from P5, P15, and P28 lungs in control and Fgfr2 mutant (KO) lungs. Dashed
white boxes mark zoomed in regions, dashed white circles demarcate AT2 cells, dashed
yellow circles and arrows indicate HOPX+ cells. (B) Quantification of the percentage of
SFTPC+HOPX+ lineage traced cells at P5, P15, and P28 between control and KO cells.
(C) Quantification of the percentage of HOPX+ lineage traced cells at P5, P15, and P28
between control and KO cells. (D) RNA fluorescence in situ hybridization (FISH) staining
for Fgfr2 and IHC for lineage marker EYFP in control and mutant lungs. Dashed white
lines demarcate AT2 cells. (E) IHC for lineage marker EYFP, HOPX, and EdU at P5.
Dashed white boxes mark zoomed in regions, dashed white circles and arrows
demarcate AT2 cells, yellow arrow indicates an AT1 cell. (F) Quantification of the
percentage of EdU+ control and KO AT2 cells. (G) IHC for lineage marker EYFP and
cleaved CASP3 at P5. (H-I) Morphometric analysis measuring mean linear intercept
(MLI) on P28 hematoxylin and eosin (H&E) stained slides. (J-L) IHC for lineage marker
EYFP and HOPX and small images also show NKX2.1. Quantification of AT1 cells as a
percentage of total alveolar epithelium and of lineage labeled cells per mm3 of tissue.
White boxes demarcate zoomed in region, white circles mark an AT2 cell, yellow circles
indicate an AT1 cell. All quantification data are represented as mean ± SEM. Two-tailed
t-tests: ns: not significant, * P ≤ 0.05, ** P ≤ 0.01; n = 4-7 mice per group. All scale bars:
50 μm.
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Figure 4.2: Fgfr2 is not required to maintain AT2 cell identity during adult
homeostasis
(A) H&E staining of control and Fgfr2-deficient lungs one month, six months, and one
year post tamoxifen induction. (B) Morphometric analysis of MLI between control and
mutant lungs. (C) IHC for lineage trace marker EYFP, HOPX, and SFTPC at one month,
six months, and one year post tamoxifen induction. Dashed white boxes demarcate
zoomed in regions, dashed white circles mark AT2 cells, and dashed yellow circles
demarcate AT1 cells. (D-E) Quantification of the number of lineage traced cells per mm3
and the percentage of lineage traced AT1 cells in control and Fgfr2-deficient lungs. All
quantification data are represented as mean ± SEM. Two-tailed t-tests: ns: not
significant; n = 4-5 mice per group. All scale bars: 50 μm.
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Figure 4.3: Fgfr2 drives AT2 cell proliferation in a spatially restricted manner
(A) Experimental schematic showing lungs were harvested 14 days post influenza
infection (dpi). (B) Representative images of the lung damage assessment program
workflow run on an tile scanned image of an H&E stained control mouse lung section at
14 dpi. (C) Left image: zoom in from the clustered image in (B). White lines demarcate
the border between the severe and damaged clusters encircling the severe zone. Right
image: representative IHC for lineage marker EYFP, KI67, and SFTPC in the severe
zone. White arrows indicate KI67+ lineage traced AT2 cells. (D) Left image: zoom in
from the clustered image in (B). White lines demarcate the border between the damaged
and normal clusters encircling the damaged zone. Right image: representative IHC for
lineage marker EYFP, HOPX, and SFTPC in the damaged zone. The dashed white box
demarcates zoomed in area, dashed white circles mark a lineage traced AT2 cell, and
dashed yellow circles mark a lineage traced AT1 cell. (E-G”) IHC for KRT5, PDPN, and
SFTPC in (E-G) severe, (E’-G’) damaged, and (E’’-G”) normal zones. (H) IHC for lineage
marker EYFP, KI67, and SFTPC in control and Fgfr2-deficient lungs in both damaged
and severe zones. White dashed lines mark KI67+ lineage traced AT2 cells. (I)
Quantification of the percentage of KI67+ lineage traced AT2 cells shows a statistically
significant decrease in Fgfr2-deficient lungs compared to controls specifically in
damaged zones and not in severe zones. (J) Summary diagram showing the distribution
of AT2 cells (green, proliferating AT2 cells drawn with pink nuclei and segregating
chromosomes) and AT1 cells (red) across severe, damaged, and normal zones. Dashed
white box outlines a single AT2 cell in a damaged zone. Expanded dashed white box
demonstrates that Fgfr2 drives AT2 cell proliferation in damaged zones. All quantification
data are represented as mean ± SEM. Two-tailed t-tests: ns: not significant, * P ≤ 0.05; n
= 5-6 mice per group. All scale bars: 50 μm.
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Figure 4.4: Fgf signaling varies across injured areas
(A) RNA FISH demonstrating the enrichment of Fgf7 and Fgf10 in injured areas of the
lung. Dashed white box indicates a non-morphologically perturbed region, dashed green
box indicates a morphologically perturbed region (scale bar: 50 μm). (A’) Zoomed in view
of the dashed white box region. (A’’) Zoomed in view of the dashed green box region. (B)
RNA FISH for Fgfr2 and IHC for the lineage marker EYFP, showing the loss of Fgfr2 in
SftpcCreERT2;Fgfr2fl/fl;R26REYFP animals in both damaged and severe zones. Dashed white
lines demarcate lineage labelled AT2 cells (scale bars: 50 μm). (C) IHC for lineage trace
marker EYFP, KI67, and SFTPC in control and Fgfr2-deficient lungs in normal zones.
Dashed white lines mark KI67+ lineage traced AT2 cells (scale bar: 50 μm). (D)
Quantification of the percentage of KI67+ AT2 cells reveals no difference between
control and mutant lungs. All quantification data are represented as mean ± SEM. Twotailed t-test: ns: not significant; n = 5-6 mice per group.
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Figure 4.5: Isolation of Fgfr2-deficient and control AT2 cells for organoid culture
(A) Representative sort gates used to isolate AT2 cells using the SftpcCreERT2 driven
R26RtdTomato reporter (SSC: side scatter; FSC: forward scatter).
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Figure 4.6: Fgfr2 is not required for AT2 cell proliferation
(A) Left: images using endogenous fluorescence of a representative well of AT2 cell
derived

organoids

from

SftpcCreERT2;R26RtdTomato

either

(top)

or

SftpcCreERT2;Fgfr2fl/fl;R26RtdTomato (bottom) mice at 21 days of culture, white arrows
indicate a single organoid (scale bar: 500 μm). Middle: RNA FISH for Fgfr2 on
representative control (top) and Fgfr2-deficient (bottom) AT2 cell-derived organoids.
Dashed white boxes mark zoomed in regions. Right: IHC for AGER and SFTPC on
representative control (top) and Fgfr2-deficient (bottom) AT2 cell-derived organoids. (B)
Analysis of organoid size from 11 to 21 days of culture. Each dot represents the average
of organoids derived from three individual mice. Dashed black box demarcates 21 days
of culture highlighted in panel C. (C-D) Analysis of organoid size and colony forming
efficiency at 21 days of culture. Each dot represents the average of at least three
replicate wells from one mouse for a total of n = 3 mice per group. (E) Experimental
schematic outlining the timing of cytokine treatment. TGFβ inhibitor was added for the
first week of culture. At seven days of culture, cytokines were added for the remainder of
the experiment. (F) Left: images using endogenous fluorescence of a representative well
of

AT2

cell

derived

organoids

from

either

SftpcCreERT2;R26RtdTomato (top)

or

SftpcCreERT2;Fgfr2fl/fl;R26RtdTomato (bottom) mice at 21 days of culture after treatment with
FGF7 for the last 14 days, white arrows indicate a single organoid (scale bar: 500 μm).
Middle: RNA FISH for Fgfr2 on representative control (top) and Fgfr2-deficient (bottom)
AT2 cell-derived organoids. Dashed white boxes mark zoomed in regions. Right: IHC for
AGER and SFTPC on representative control (top) and Fgfr2-deficient (bottom) AT2 cellderived organoids. (G) Analysis of organoid size from 11 to 21 days of culture. Each dot
on this graph represents the average from three individual mice, n = 3. Dashed black
box demarcates 14 days of culture. (H-I) Analysis of organoid size in untreated versus
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FGF7 treated control and Fgfr2-deficient (KO) organoids at 14 days of culture
highlighted in panel G. Each dot represents the average of at least three replicate wells
from one mouse for a total of n = 3 mice per group. (J) Representative images of AT2
cell-derived

organoids

from

either

SftpcCreERT2;R26RtdTomato

(top)

or

SftpcCreERT2;Fgfr2fl/fl;R26RtdTomato (bottom) mice at 21 days of culture after treatment with
IL-1α, +IL-1β, or TNFα for the last 14 days of culture (scale bar: 500 μm). (K) Organoid
size at 21 days of culture. Each dot represents the average of at least three replicate
wells from one mouse for a total of n = 3 mice per group. All quantification data are
represented as mean ± SEM. Two-tailed t-tests: ns: not significant, * P ≤ 0.05, ** P ≤
0.01. Scale bars: 50 μm unless otherwise noted.
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Figure 4.7: Comparison of isolated Fgfr2-deficient and control AT2 cells treated
with inflammatory cytokines
(A-C) Organoid size at 21 days of culture after 14 days of cytokine treatment. All
quantification data are represented as mean ± SEM. Two-tailed t-tests: ns: not
significant; n = 3 mice per group.
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Figure 4.8: Fgfr2 maintains AT2 cell identity
(A-D) IHC for lineage trace marker EYFP, HOPX, and SFTPC 14 and 28 dpi in
Damaged zones and quantification of the percentage of lineage labeled AT1 cells
(marked by yellow arrows and dashed yellow circles). Zoomed in regions marked by
dashed white boxes. (E-F) IHC for HOPX and NKX2.1 at 28 dpi shows a statistically
significant increase in AT1 cells (marked by yellow arrows and dashed yellow circles) as
a percentage of total epithelium in damaged zones. Zoomed in regions marked by white
boxes. (G) H&E staining at 28 dpi demonstrates stark morphological differences
between control and Fgfr2-deficient lungs. Zoomed in regions marked by dashed black
boxes (scale bars: 500 μm and 100 μm). (H-I) Morphological analysis of alveolar area in
damaged zones using IHC for PDPN to outline alveoli shows a statistically significant
increase in average alveolar area in Fgfr2-deficient versus control lungs. Zoomed in
regions marked by dashed white boxes. (J) Summary diagram showing the distribution
of AT2 cells (green, proliferating AT2 cells drawn with pink nuclei and segregating
chromosomes) and AT1 cells (red) across severe, damaged, and normal zones. Dashed
white box outlines a single AT2 cell in a damaged zone. Expanded dashed white box
demonstrates that Fgfr2 maintains AT2 cell identity in damaged zones. All quantification
data are represented as mean ± SEM. Two-tailed t-tests: * P ≤ 0.05, ** P ≤ 0.01; n = 5-6
mice per group. Scale bars: 50 μm unless otherwise noted.
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Figure 4.9: Fgfr2-deficiency does not impact AT2-AT1 cell differentiation in normal
zones at 14 dpi or emergency repair processes at 28 dpi
(A) IHC for lineage trace marker EYFP, HOPX, and SFTPC in control and Fgfr2-deficient
lungs in normal zones at 14 dpi. White dashed lines mark SFTPC+ lineage traced AT2
cells (scale bar: 50 μm). (B) Quantification reveals almost no lineage traced AT1 cells in
normal zones and no difference between control and mutant lungs. (C) Masson’s
trichrome staining of control and mutant lungs 28 dpi (scale bar: 100 μm). (D-E) IHC for
ACTA2 and KRT5 in control and mutant lungs at 28 dpi (scale bars: 100 μm). All
quantification data are represented as mean ± SEM. Two-tailed t-test: ns: not significant;
n = 5-6 mice per group.

116

117

Figure 4.10: Cell division is not required to maintain AT2 cell identity during
regeneration
(A) Model showing Ect2 is required for cytokinesis. (B) Electron micrographs of a normal
AT2 cell (top) and a binucleated AT2 cell (bottom) from EPCAM sorted cells from
SftpcCreERT2;Ect2fl/fl mice 34 dpi (n: nucleus, scale bars: 2 μm). (C) IHC for NKX2.1,
CDH1, and LAMP3 (left) and NKX2.1, HOPX, and AGER (right) at 14 dpi in damaged
zones. Zoomed in regions marked by dashed white boxes and individual nuclei marked
by dashed white circles (AT2 cells) or dashed yellow circles (AT1 cells). (D) IHC for
lineage trace marker EYFP, CDH1, and LAMP3 (left) and lineage trace marker EYFP,
HOPX, and AGER (right) at 28 dpi in damaged zones. Zoomed in regions marked by
dashed white boxes and individual nuclei marked by dashed white circles (AT2 cells) or
dashed yellow circles (AT1 cells). (E) Experimental schematic showing five EdU pulses
between 9 and 13 dpi followed by a two-week chase. (F) Staining for AGER, HOPX, and
EdU (top) and CDH1, LAMP3, and EdU (bottom) at 28 dpi in damaged zones. Zoomed
in regions marked by dashed white boxes and individual nuclei marked by white arrows
(AT2 cells) or yellow arrows (AT1 cells). (G) Model showing, despite loss of the ability to
divide, AT2 cells can either maintain their fate or differentiate into AT1 cells. (H) IHC for
lineage trace marker EYFP, HOPX, and SFTPC (left) and NKX2.1, HOPX, and AGER
(right) at 28 dpi in damaged zones. Zoomed in regions marked by dashed white boxes,
AT2 cells marked by white arrows, AT1 cells indicated by yellow arrows, and individual
AT1 cell nuclei marked by dashed yellow circles. (I) Quantification shows no change
between control and Ect2-deficient (KO) lungs in the number of AT1 cells as a
percentage of total epithelium in damaged zones. Quantification data are represented as
mean ± SEM. Two-tailed t-test: ns: not significant; n = 3 mice per group. Scale bars: 50
μm unless otherwise noted.
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Figure 4.11: Analysis of AT2 and AT2 cell-derived AT1 cell binucleation at 14 and
28 dpi
(A-B) IHC for CDH1 and LAMP3 at 14 dpi. Quantification of the percentage of
binucleated AT2 cells in damaged zones in control and Ect2-deficient lungs. Zoomed in
regions marked by dashed white boxes and individual AT2 cell nuclei marked by dashed
white circles (scale bar: 50 μm). (C-D) IHC for HOPX and AGER at 14 dpi. Quantification
shows the percentage of binucleated AT1 cells in damaged zones in Ect2-deficient and
control lungs. Zoomed in regions marked by dashed white boxes, yellow arrow indicates
binucleated AT1 cell, and individual AT1 cell nuclei marked by dashed yellow circles
(scale bar: 50 μm). (E-F) IHC for lineage marker EYFP, CDH1, and LAMP3 in Ect2deficient lungs at 28 dpi in (E) normal and (F) severe zones. Zoomed in regions marked
by dashed white boxes and individual AT2 cell nuclei marked by dashed white circles
(scale bars: 50 μm). All quantification data are represented as mean ± SEM. Two-tailed
t-tests: **** P ≤ 0.0001; n = 3 mice per group.
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Figure 4.12: Fgfr2 balances AT2 cell proliferation and differentiation during lung
regeneration
Summary figure showing Fgfr2 maintains AT2 cell identity in damaged zones, promoting
proliferation over differentiation to balance cell replacement versus alveolar remodeling
during lung regeneration. Loss of Ect2 leads to generation of binucleated AT2 cells,
which do not deterministically differentiate into AT1 cells, but can instead maintain AT2
cell identity or differentiate depending on local niche signals.
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CHAPTER 5: ALVEOLAR EPITHELIAL TYPE 1 CELL PLASTICITY

This chapter is partially adapted from work published in Cell Stem Cell and was
performed in collaboration with Ian J. Penkala (Penkala et al., 2021). Joshua Pankin,
Aravind Sivakumar, Madison M. Kremp, Sowmya Jayachandran, and Katherine Stolz
assisted in data acquisition and analysis. Rebecca Windmueller aided in figure design.
Su Zhou provided histological support.

5.1 Summary
Injury to the architecturally complex lung alveolar niche can permanently reduce gas
exchange surface area and respiratory function. Lung regeneration requires precise
temporal and spatial control of epithelial cell behavior. Alveolar epithelial type 2 (AT2)
cells are thought to drive lung regeneration through proliferation and differentiation into
alveolar epithelial type 1 (AT1) cells. Using mouse models, we show that alveolar type 1
(AT1) cell plasticity is an unappreciated mechanism of lung regeneration. Upon acute
neonatal lung injury, AT1 cells reprogram into AT2 cells to replenish the AT2 cell
population. In contrast, the ability of AT2 cells to differentiate into AT1 cells is restricted
to the mature lung. After adult injury, AT1 cells can reprogram into AT2 cells. However,
this behavior appears restricted to specific injury contexts. Thus, cellular plasticity is a
temporally acquired trait of the alveolar epithelium and presents an alternative mode of
lung regeneration.

5.2 Introduction
A myriad of cells comprises the lung alveolus, arranged in a complex architecture to
maximize the surface area for gas exchange between the blood and inspired air. The
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alveolar epithelium consists of two highly specialized cell types: alveolar type 1 (AT1)
cells and alveolar type 2 (AT2) cells (Zepp and Morrisey, 2019, Hogan et al., 2014). AT1
cells are extraordinarily large, thin, and flat, covering roughly 90% of the alveolar
surface, and are intimately aligned with the rich capillary plexus of the lung for efficient
gas exchange (Haies et al., 1981, Crapo et al., 1980, Williams, 2003, Stone et al., 1992).
AT2 cells are smaller, cuboidal cells that produce pulmonary surfactant. AT2 cells also
serve as facultative progenitors, proliferating and differentiating into AT1 cells after injury
in the adult lung (Barkauskas et al., 2013, Adamson and Bowden, 1974). This behavior
has established the current paradigm of the AT2 cell as the major driver of alveolar
regeneration in the postnatal lung.

AT1 and AT2 cells are specified in early lung development, and as they mature over the
course of development, they promote remodeling of the alveolar architecture to
maximize the gas exchange interface (Yang et al., 2016, Frank et al., 2019). The early
postnatal period, called alveologenesis, is a vulnerable time for the alveolus when
significant damage can be incurred through infectious disease or environmental insult.
Injury at this time can result in long term consequences, including pathological AT2 cell
hyperplasia and a lack of proper maturation and remodeling, leading to respiratory
diseases of prematurity such as bronchopulmonary dysplasia (BPD) and other
congenital neonatal lung diseases (Sucre et al., 2020, Whitsett et al., 2010, Surate
Solaligue et al., 2017). It remains unclear whether the regenerative responses during
alveologenesis are similar to, or distinct from, those displayed in the mature lung. In
some instances, neonatal and pediatric patients present with different clinical responses
to injury, such as in hyperoxic injury and COVID-19 infection (Ludvigsson, 2020, Lu et
al., 2020, Kallet and Matthay, 2013). Moreover, in certain infectious diseases such as
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influenza, the immature lung appears to be more susceptible to injury (Lines et al.,
2010).

Regeneration of the mature alveolus is driven by expansion of the AT2 cell population
and differentiation into AT1 cells (Barkauskas et al., 2013). This unidirectional paradigm
is controlled, in part, by pathways such as Wnt and Fgf signaling, which have been
shown to regulate AT2 cell proliferation and differentiation (also see Chapter 4)
(Zacharias et al., 2018, Quantius et al., 2016, Zepp et al., 2017, Frank et al., 2016,
Nabhan et al., 2018). While plasticity may be possible in the reverse direction, this
phenomenon has only been demonstrated at low levels and under specific conditions,
such as in regrowth after pneumonectomy (Jain et al., 2015). Thus, it remains unclear
whether AT1 cell plasticity is a robust response to injury and whether it plays an
important role in alveolar regeneration after acute injury to the lung.

In the present study, we show that alveolar epithelial cell plasticity is a temporally
regulated phenomenon. During early postnatal alveologenesis, AT2 cells do not
efficiently regenerate AT1 cells after acute lung injury. Rather, AT1 cells exhibit the
capacity to reprogram into AT2 cells after neonatal injury. This plasticity is retained to a
lesser degree in the adult lung where AT1 cells can replenish the AT2 cell progenitor
pool. However, this plasticity appears to be context dependent, as not all insults elicit
this plastic AT1 cell response. Nevertheless, this plasticity reveals previously
unappreciated age-dependent cellular responses to injury in the alveolus.
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5.3 Neonatal hyperoxia results in an imbalance between AT1 and AT2 cells
Neonatal lung injury can result in a permanent loss of respiratory function (Yee et al.,
2009, Sozo et al., 2015). To better understand the cell-specific consequences of
neonatal injury during postnatal alveologenesis, we exposed newborn mice to five days
of hyperoxia to cause hyperoxia-induced acute lung injury (HALI) and assessed the
effects immediately afterwards at postnatal day 5 (P5), during recovery at P14, and in
the mature lung at P42 (Figure 5.1A). Consistent with previous reports, neonatal HALI
leads to alveolar damage as demonstrated by morphological simplification of the alveoli
(Figures 5.1B-H) (Buczynski et al., 2012). The effects of HALI were apparent by P14
and persisted into adulthood (Figure 5.1B-H). We next assessed the effects of HALI on
the number of AT1 cells. Using Hopx3XFLAG-GFP mice to label and track AT1 cells, we
determined that AT1 cell numbers are reduced as a percentage of total alveolar
epithelium after HALI, leading to an AT1:AT2 imbalance that persists into adulthood
(Figures 5.1I-M and 5.2A) (Jain et al., 2015). This change in the ratio of AT1:AT2 cells
after HALI is not caused by an increase in AT1 cell death as expression of cleaved
Casp3 was not observed (Figure 5.2B).

5.4 AT1 cells rather than AT2 cells exhibit enhanced plasticity after neonatal injury
to promote alveolar regeneration
To assess whether neonatal injury altered AT1 or AT2 cell fate, we first performed
extensive temporal lineage tracing of these cell types using the SftpcCreERT2;R26REYFP
mouse line. These cell fate studies revealed that AT2 cells lacked the capacity to
effectively regenerate lost AT1 cells after HALI in the neonatal lung, despite their ability
to do so in adult animals (Figures 5.3A-C and 5.4A) (Barkauskas et al., 2013).
Immediately after injury, traced AT2 cells do not efficiently proliferate to regenerate the
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damaged epithelium (Figure 5.3D). Moreover, at P14, there is no statistically significant
difference in proliferation between lineage-traced AT2 cells exposed to hyperoxia and
normoxia, consistent with previous reports (Figure 5.4B) (Frank et al., 2016, Yee et al.,
2006, Yee et al., 2014). Instead, AT2 cell proliferation at P5 occurred primarily in AT2
cells lacking the YFP lineage mark from SftpcCreERT2;R26REYFP mice (Figure 5.3E).
Together, our data show that AT2 cells do not respond robustly to regenerate the
neonatal lung after HALI (Figure 5.3F).

To determine the response of AT1 cells to HALI, we lineage traced AT1 cells using
HopxCreERT2;R26REYFP mice (Figure 5.3G). Lineage tracing revealed a statistically
significant increase in AT1 cell-derived AT2 cells during and after HALI, and these AT2
cells persisted into adulthood (Figures 5.3H-I and 5.4C-D). Similar results were
obtained using an alternative tool to label AT1 cells, AgerCreERT2, but this tool was found
to be less lineage restricted than the HopxCreERT2 in the alveolar space (Figures 5.4E-H)
(Chung and Hogan, 2018). Similar results were also found using a separate injury
model, hypoxia (Figure 5.4I). These data suggest that AT1 cells possess sufficient
plasticity to regenerate AT2 cells after neonatal HALI.

We next assessed whether these AT1 cell-derived AT2 cells contributed to the
proliferative response in the AT2 cell population after neonatal injury. We found that
reprogrammed AT2 cells preferentially proliferate after neonatal injury in comparison to
non-AT1 cell-derived AT2 cells (Figures 5.3J and 5.4J). Indeed, little proliferation
occurs in AT2 cells during HALI, suggesting that AT1 cell plasticity at least in part
repopulates lost AT2 cells after neonatal lung injury (Figure 5.4K). Taken together,
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these results reveal that AT1-AT2 cell plasticity is a major driver of AT2 cell regeneration
in the neonatal lung (Figure 5.3K).

5.5 AT1 cells contribute to regeneration after adult HALI
To examine whether the AT1 cell plasticity observed in neonates was conserved in adult
mice, we performed HALI in adult mice. Unlike neonatal hyperoxia, adult mice are more
sensitive to changes in oxygen concentration, so we exposed adult mice to 95% oxygen
for 3 days (Figure 5.5A) (Crapo et al., 1980, Evans et al., 1968, Bowden et al., 1968).
Seven days post injury (dpi) we observed marked lung fibrosis (Figure 5.5B). Both AT1
and AT2 cells were present in damaged regions of tissue, and clusters of AT2 cells
indicated active regeneration typical of the adult lung (Figure 5.5C) (Barkauskas et al.,
2013). To assess the relative contributions of AT2 and AT1 cells to tissue regeneration
after HALI, we lineage traced AT2 and AT1 cells using the SftpcCreERT2;R26REYFP and
HopxCreERT2;R26REYFP mouse lines, respectively. As expected, AT2 cells differentiated
robustly into AT1 cells to regenerate the lung after HALI (Figures 5.5D-E) (Barkauskas
et al., 2013). A previous study demonstrated that AT1 cells can reprogram into AT2 cells
in a limited fashion in a model of compensatory regrowth (Jain et al., 2015). Consistent
with these findings, we observed an increase in AT1 cell-derived AT2 cells after HALI
compared to normoxia controls (Figures 5.5F-G). This finding could not be confirmed
with the AgerCreERT2 due to the lack of sufficient specificity of this reporter in the adult, as
nearly 50% of lineage traced cells were AT2 cells under normoxic conditions (Figure
5.4G-H) (Chung and Hogan, 2018). Together, our data show that AT1 cells retain some
plasticity to reprogram into AT2 cells in the adult after injury.
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5.6 Adult AT1 cell plasticity in an AT2 cell depletion model
To determine the extent of AT1 cell plasticity during adult regeneration, we employed an
AT2 cell depletion model to dramatically reduce the number of AT2 cells and
simultaneously lineage trace AT1 cells to observe whether loss of AT2 cells was
sufficient to drive AT1-AT2 cell reprogramming. Generating SftpcCreERT2;R26REYFP;
HopxFlpOERT2;R26RtdTomato mice, we observe that the majority of AT2 and AT1 cells are
lineage traced with 3 doses of 200mg/kg tamoxifen in adult mice (Figure 5.6A-B).
Consistent with previous reports, a week after delivering the last dose of tamoxifen to
SftpcCreERT2;R26RDTA;HopxFlpOERT2;R26RtdTomato

mice,

we

observed

no

obvious

inflammation or changes to tissue morphology (Figure 5.6B) (Barkauskas et al., 2013).
However, we did not observe lethality even at a much higher dose of tamoxifen,
suggesting different recombination efficiencies of the alleles used (Figure 5.6B)
(Barkauskas et al., 2013). Ultimately, we did not observe AT1-AT2 cell reprogramming,
suggesting that acute loss of AT2 cells is not sufficient to drive adult AT1 cell plasticity.

5.7 AT1 cell plasticity after influenza
In contrast to our AT2 cell depletion model, HALI induces AT1-AT2 cell reprogramming,
suggesting that inflammation or tissue architectural changes may drive AT1 cell
plasticity. To determine whether other adult injuries result in AT1 cell plasticity, we
sought to assess AT1 cell plasticity in an influenza infection model. However, as
mentioned in previous Chapters, airway epithelial cells are capable of migrating into the
alveolar space after some injuries, like influenza. Moreover, HopxCreERT2 and HopxFlpOERT2
mice are known to label secretory cells in the airways. Using Sox2CreERT2;R26REYFP mice,
we observed minimal evidence of airway epithelial-derived cells in the alveolar
compartment with no evidence of Krt5+ pods after HALI (Figure 5.7A-F). Moreover, this
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minimal airway epithelial cell migration is only observed in close proximity to the
bronchoalveolar duct junction where it was physically perturbed by HALI induced fibrosis
(Figure 5.7C-D). However, these airway responses are common and more extensive
after influenza (Figure 5.7G-J) (Kumar et al., 2011, Vaughan et al., 2015). To preclude
airway epithelial cell behavior from complicating analysis of AT1 cell plasticity, we
generated Sox2CreERT2;R26REYFP;HopxFlpOERT2;R26RtdTomato mice. Using these mice, we
were able to trace the fates of both airway epithelial and AT1 cells after influenza
infection (Figure 5.8A). While we did observe AT1 cell-derived AT2 cells, these cells
were rare and only present in areas including airway infiltration into the alveolar
compartment at 14 dpi (Figure 5.8B). These data suggest that AT1 cell plasticity is
restricted to only the worst areas of influenza damage (Figure 5.8B). Ultimately, AT1
cells exhibit plasticity in neonates and adults during lung regeneration, and, like adult
AT2 cells, adult AT1 cell plasticity is restricted to specific injury contexts (see Chapter 4)
(Figure 5.9).

5.8 Discussion
Our study reveals a new paradigm for alveolar regeneration driven by temporal
acquisition of epithelial cell plasticity. We show that AT1 cells exhibit a previously
unappreciated level of plasticity in response to neonatal and adult injury, while AT2 cell
differentiation into AT1 cells is solely a characteristic of adult lung regeneration in vivo.
These data suggest that the temporally distinct regenerative mechanisms in the alveolar
epithelium may be one reason for the discrepant responses to acute lung injury between
pediatric and adult patients.
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While a previous study suggested a low level of AT1-AT2 conversion after adult
pneumonectomy regrowth, no studies to date have demonstrated a regenerative role for
AT1 cells after injury (Jain et al., 2015). We now show that AT1 cells exhibit plasticity to
regenerate both the neonatal and adult lung, suggesting this mechanism is a conserved
AT1 cell response to injury. AT1 cell plasticity may provide the alveolar niche with
enhanced flexibility to respond to insult by at least partially replenishing the facultative
progenitor (AT2) cell pool. This activity could conserve surfactant production to prevent
respiratory failure after acute injury and in a chronic disease setting. Moreover, the
existence of AT1-AT2 cell reprogramming suggests that alveolar epithelial plasticity may
be more bidirectional than previously appreciated. However, AT2 cells remain the
predominant facultative progenitors of the adult lung, as AT1 cell plasticity is limited in
the adult lung. This limited plasticity could be due to the robust responses of other
epithelial lineages to injury. For example, the adult injury response to severe influenza
infection includes airway-mediated repair/regeneration mechanisms, such as the
infiltration into and expansion of p63+ progenitor-derived Krt5+ pods and airway
secretory cell-derived AT1 and AT2 cells in the alveolar space. Thus, AT1 cell plasticity
may occur only after severe injury or injuries with fewer alternative repair/regenerative
options. This could explain why acute depletion of AT2 cells is not sufficient to activate
AT1-AT2 cell reprogramming. AT2 cells proliferate rapidly to replenish their numbers
after acute depletion (Barkauskas et al., 2013). It is possible more chronic AT2 cell
depletion could stimulate AT1-AT2 cell reprogramming. Alternatively, AT1-AT2 cell
reprogramming could require inflammation or tissue architectural damage as we see
after HALI and influenza. Additional studies will be needed to determine how common
this AT1-AT2 reprogramming is in different injury and disease states.
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One of the hallmark phenotypes observed in COVID-19 disease is acute respiratory
distress syndrome (Fan et al., 2020, Gattinoni et al., 2020). Single cell RNA sequencing
analyses have indicated that the ACE2 receptor used by SARS-CoV-2 to invade cells is
differentially expressed in AT2 cells across the lifespan (Sungnak et al., 2020, Hoffmann
et al., 2020). Moreover, there are significant differences between pediatric and adult
patient responses to COVID-19 (Dong et al., 2020, Ludvigsson, 2020, Zhang et al.,
2020b). However, the differential epithelial regenerative responses between the pediatric
and adult lung have remained largely unclear. Our data show that the response of the
lung epithelium to acute injury is different between neonates and adults. Additionally, our
finding that AT2 cells are unable to efficiently differentiate into AT1 cells during early
postnatal life suggests that this response is acquired during alveologenesis. The ability
of AT2 cells to differentiate into AT1 cells is likely tied to the mesenchymal niche, which
undergoes dramatic changes at this time and after injury (Zepp et al., 2021, Riccetti et
al., 2022, Zepp et al., 2017). Ultimately, this new paradigm for lung regeneration should
provide important insight into pediatric and adult respiratory diseases and allow for the
development of more targeted clinical interventions.
.
5.9 Materials and methods
Animal models
HopxCreERT2, SftpcCreERT2, AgerCreERT2, Sox2CreERT2, HopxFlpOERT2, SftpcEGFP, Hopx3XFLAG-GFP,
R26Rtdtomato (Ai65), R26RDTA, and R26REYFP mice have all been previously reported
(Chapman et al., 2011, Takeda et al., 2011, Vanderbilt et al., 2015, Xin et al., 2013,
Chung and Hogan, 2018, Dow et al., 2014, Gao et al., 2013, Reginensi et al., 2013,
Arnold et al., 2011, Madisen et al., 2015, Frank et al., 2019, Voehringer et al., 2008).
SftpcCreERT2 mice were a kind gift from the Chapman lab. The HopxFlpOERT2 mice were a
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kind gift from the Jain lab. The Jain lab recombined the loxp sites of the R26Rtdtomato mice
with a constitutive cre mouse making them a specific reporter line for FlpO mice. All
other strains were obtained from Jackson Laboratories. All animal husbandry and
experiments were approved by the University of Pennsylvania Institutional Animal Care
and Use Committee. Animal husbandry and veterinary care was provided by University
Laboratory Animal Resources (ULAR). Mice were provided clean bedding, ad libitum
water and food, and nestlets. Sheppard shacks, trail mix, and wood stick enrichment
were provided to encourage normal mouse behavior. Additionally, mice were grouphoused under controlled conditions of temperature (70˚F), humidity (<70%), and light
(12h light cycle). Neonatal animals of appropriate lineage tracing genotypes for each
experiment were assigned to experimental or control groups randomly as entire litters at
birth, ensuring a random mix of sex and, critically, maternal care in generating the HALI
data. For adult KO experiments, animals were genotyped to determine their control vs.
KO status and allocated accordingly at weaning. Ages of animals for each experiment
are available in the figures, the figure legends, and the results text. At least n = 3 mice
were used for all experiments.

Lineage tracing
Lineage tracing was induced by delivery of tamoxifen (Sigma-Aldrich, T5648) suspended
in 100% Ethanol and diluted with corn oil (Sigma-Aldrich, C8267) to 10% final volume of
ethanol and 90% final volume of corn oil. Tamoxifen dissolved in corn oil (200mg/kg)
was delivered to mice via oral gavage in adults or intraperitoneal injections in neonates,
as previously described (Frank et al., 2019, Zepp et al., 2017, Zacharias et al., 2018).
Neonates were given a single injection of tamoxifen at birth. Adults underwent oral
gavage daily for three days to induce lineage tracing.
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Neonatal hyperoxic lung injury
At birth, pups were injected intraperitoneally with 200mg/kg tamoxifen, dissolved in corn
oil and immediately placed in the hyperoxia chamber (BioSpherix), which contained
sodium bicarbonate as an odor adsorbent. The chamber was attached to a medical
oxygen source, controlled by a ProOx360 single gas controller (BioSpherix), and was set
to a final concentration of 95% under proportional-integral control. Chambers were
checked daily, mouse mentation, temperature, and humidity were monitored, and dams
were swapped with lactating surrogates to prevent injury to the adult mice. When in the
chamber, mice were provided an additional nestlet and wood enrichment.

Adult hyperoxic lung injury
Adult (6-12 week old) mice were given 200mg/kg tamoxifen, dissolved in corn oil, by oral
gavage for 3 days consecutively 2 weeks prior to hyperoxia exposure. Mice were then
exposed to hyperoxia for 3 days at 95% oxygen as described above for neonatal
hyperoxia. After 3 days, mice were removed from hyperoxia and allowed to recover at
room air for 7 days before harvesting the lungs.

Lung harvest
Animals were euthanized with CO2 until cessation of breathing. Lungs were exposed
through a midline incision caudal to the sternum, and subsequent elevation and removal
of the skin cranially to the mandible. The trachea was isolated through dissection and
removal of muscle and fascia and removal of the cervical portion of the esophagus for
clear visualization. Next, a midline sternotomy was performed, and ribs were removed as
far dorsally as possible. Elevating the lungs, the caudal vena cava was cut, followed by
removal of the thymus. The right atrium was cut to relieve pressure during perfusion, and
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the heart was gently perfused with PBS through the right ventricle until the lungs were
cleared of blood. A surgeon’s knot was tied loosely around the trachea with size 0 silk
suture, and the trachea was cannulated with a needle attached to tubing leading to a
vessel filled with cold 2% paraformaldehyde in PBS. This vessel was pressurized to
20cm H2O for P0 and P5 lung inflation and 25-30cm H2O for P14 and adult inflation.
After the lung equilibrated to the inflation pressure, determined by a lack of additional
changes in size and protrusion of the point of the accessory lobe, the needle cannulating
the trachea was removed with immediate tightening of the surgeon’s knot. The lungs
were removed by careful dissection of structures and attachments dorsally and placed in
a vial of cold 2% paraformaldehyde in PBS overnight at 4˚C on an orbital rocker with
gentle rotation.

Histology and immunohistochemistry
Lungs were inflated with 2% paraformaldehyde under constant pressure of 20cm (age ≤
P14) or 30 cm H2O (age > P14) and allowed to fix overnight. Tissue was embedded in
paraffin and sectioned. Hematoxylin and eosin (H&E) staining was performed to
examine tissue morphology and for MLI analysis. Immunohistochemistry (IHC) was
performed to detect protein expression using the following antibodies: GFP (chicken,
Aves, 1:200), RFP (rabbit, Abcam, 1:50), Ager (Rage) (rat, R&D Systems, 1:50), Nkx2.1
(rabbit, abcam, 1:50), Nkx2.1 (mouse, Thermo Fisher Scientific, 1:50), Lamp3 (rat,
NovusBio, 1:100), Sftpc (rabbit, Millipore, 1:100), Ki67 (rabbit, Abcam, 1:50), Hopx
(mouse, Santa Cruz, 1:100), and cleaved CASP3 (rabbit, Cell Signaling Technology,
1:100). All combinations of fluorescently tagged secondary antibodies were used at a
concentration of 1:200. Mean linear intercept analysis was performed on hematoxylin
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and eosin stained slides using automatic MATLAB software as previously described
(Paris et al., 2020).

Single cell suspension
For single cell suspension, the same technique in exposing the lung and perfusion of the
heart with cold phosphate buffered saline (PBS) was performed; however, the lungs
were removed immediately after perfusion and placed in a dish. They were dissected
into individual lobes and minced with a razor blade, washed in digestion buffer (1.8
mg/mL Collagenase I [Gibco], 1:10 Dispase [Corning], 1:500 RQ1 RNase-free Dnase
[Promega] in PBS) at 37˚C in a 15mL conical tube, and placed into a 37˚C water bath
with vigorous shaking every 5 minutes until the lungs were adequately digested,
characterized by loss of gross structure when shaken, about 15 minutes for neonatal
lungs and 30 minutes for adult lungs. Lung suspensions were then triturated vigorously 6
times with a 5mL serological pipet and filtered through a 100µm cell strainer into a fresh
50mL conical tube containing 1 mL of fetal bovine serum (FBS) for enzyme
neutralization. These tubes were then centrifuged at 300xg at 4˚C for 5 minutes.
Supernatant was removed, the pellet resuspended in 2mL ACK lysing buffer (Quality
Biological), and the tube was incubated at room temperature for 2 minutes. Then 2mL
FACS buffer (1% FBS, 10mM EDTA diluted in 1X phosphate-buffered saline) was added
to each tube and the resulting suspension triturated vigorously 9 times with a 5mL pipet,
optimized to reduce bubbling, and fed through a 40µm topped FACS tube. The FACS
tubs were spun at 300xg at 4˚C for 5 minutes. The supernatant was removed, and the
pellet was resuspended in 200 µL FACS buffer containing conjugated antibodies for
FACS and incubated for 10 minutes at 4˚C in the dark. Cells were washed by addition of
3mL cold FACS buffer, followed by inversion and centrifugation at 300xg at 4˚C for 5
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minutes. Supernatant was removed, and the pellet was resuspended in 2mL FACS
buffer and kept on ice until sorted.

Fluorescence-activated cell sorting
Single cell suspensions were analyzed and sorted using a BD FACSJazz (Becton
Dickinson) sorter as previously described. (Frank et al., 2016, Zacharias et al., 2018,
Zepp et al., 2017) Briefly, single cell suspensions were stained with CD45-PerCP-Cy5.5
(eBioscience), CD31-PE (eBioscience) and EpCAM-APC (eBioscience) each at 1:1000.
Cells were sorted into cold FACS Buffer and kept on ice for downstream applications.
Flow cytometry analysis was performed on recorded events using FlowJo 10.

Cell counting
For all cell counting experiments, pictures were taken of stained slides or whole mounted
tissue using a Leica SP8 Laser Scanning Confocal microscope or a Zeiss LSM 710
Confocal microscope. Images were taken with a 40X water-immersion objective at
random microscope fields across the lung lobe in five locations or equivalent at different
magnification. These images were processed with ImageJ (Fiji) software (Rueden et al.,
2017, Schindelin et al., 2012) and colocalized signals for marked cells were counted
manually with the multi-point counting tool with images saved of representative fields
counted in this manner. Counting was performed blinded to the sample’s genotype or
exposure, and counts were tabulated for each field in Microsoft Excel. These average
counts were then imported into Prism for graphing and statistical analyses. For all count
data, student’s t-tests were performed, except where One-Way ANOVA with Dunnett’s
correction for multiple comparisons was statistically appropriate in comparing normoxia,
hyperoxia, and AT1Yap/Taz

KO

count data at P5 and P42 (Figures 2I and 5C,G). These
135

tests were all performed using the built-in analysis software in Prism 8.0 with statistical
significance graded accordingly: * = p<0.05, ** = p<0.01, *** = p<0.005, **** = p<0.001.
Each graphed point corresponds to a single biological replicate consisting of multiple
fields counted of a single animal.
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Table 5.1: Key resources table
REAGENT or RESOURCE
Antibodies
Anti-GFP, chicken
Anti-RFP, rabbit
Rat anti-Ager (Rage)
Anti-Lamp3, rat

SOURCE

RRID/Cat#

Aves
Abcam
R&D Systems
NovusBio

AB_2307313
AB_945213
AB_2289349
AB_1929892

Anti-Sftpc, rabbit
Millipore
Anti-Hopx, mouse
Santa Cruz
Anti-Nkx2.1, rabbit
Abcam
Anti-Nkx2.1, mouse
Thermo Fisher Scientific
Anti-Ki67, rabbit
Abcam
Cleaved Casp3, rabbit
Cell Signaling Technology
Anti-CD31-PE
Thermo Fisher Scientific
Anti-EpCAM-APC
eBioscience
Anti-CD45-PerCP-Cy5.5
eBioscience
Chemicals, Peptides, and Recombinant Proteins
Tamoxifen
Sigma Aldrich
Experimental Models: Organisms/Strains
HopxCreERT2
The Jackson Laboratory
HopxFlpOERT2
Rajan Jain, Frank et al., 2019
SftpcCreERT2
Harold Chapman, Chapman
et al., 2011
Sox2CreERT2
The Jackson Laboratory
AgerCreERT2
The Jackson Laboratory
3XFLAG-GFP
Hopx
The Jackson Laboratory
SftpcEGFP
The Jackson Laboratory
R26REYFP
The Jackson Laboratory
tdTomato
R26R
The Jackson Laboratory
R26RDTA
The Jackson Laboratory
Software and Algorithms
ImageJ
MLI Analysis

https://imagej.nih.gov/ij/
Schneider et al., 2012
Paris, et al., 2020 and
Obraztsova, et al., 2020
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AB_91588
AB_2687966
AB_1310784
AB_142087
AB_443209
AB_2070042
AB_465632
AB_2716944
AB_1107002
T5648, CAS
10540-29-1
JAX: 017606

JAX: 017593
JAX: 032771
JAX: 029271
JAX: 028356
JAX: 006148
JAX: 021875
JAX: 009669
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Figure 5.1: Neonatal hyperoxic injury results in alveolar simplification and a
persistent loss of AT1 cells
(A) Experimental schematic showing neonatal mice were exposed to hyperoxia-induce
acute lung injury (HALI) from P0 to P5 and harvested at P5, P14, or P42 for analysis. (BG) H&E staining demonstrates alveolar complexity at P5 (B-C), P14 (D-E), and P42 (FG) (scale bars: 50μm). (H) Mean linear intercept (MLI) quantification of alveolar
simplification P5, P14, and P42. (I) Experimental schematic showing Hopx3XFLAG-GFP mice
were subjected to HALI and samples were collected at P5, P14, and P42. (J-K) Flow
cytometry quantification of Hopx+ AT1 cells as a percentage of total EPCAM+ epithelial
cells shows a decrease in the percentage of AT1 cells after HALI. (L-M). The ratio of
AT1:AT2 cells was quantified using immunohistochemistry (IHC) to mark AT1 cells
(HOPX) and NKX2.1 to mark nuclei of all lung alveolar epithelial cells. Yellow arrows
mark HOPX+/NKX2.1+ cells and white arrows mark HOPX−/NKX2.1+ cells (scale bars:
10μm). Data are represented as mean ± SEM. Statistical significance: n.s., not
significant; ∗∗p < 0.01, ∗∗∗p < 0.005, and ∗∗∗∗p < 0.001.

139

140

Figure 5.2: IHC for NKX2.1 counts and cell death after HALI
(A) Individual IHC channels from Figure 5.1M: DAPI (blue), NKX2.1 (green), and HOPX
(red). (B) IHC for HopxCreERT2 lineage marker EYFP cleaved CASP3 at P5 after
hyperoxia exposure (scale bars: 20μm).
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Figure 5.3: AT1, not AT2, cells exhibit enhanced plasticity after neonatal injury to
promote regeneration
(A) Experimental schematic showing SftpcCreERT2;R26REYFP mice were induced with
tamoxifen (TAM) at P0, exposed to hyperoxic conditions for 5 days, and examined at P5,
P14, and P42. (B) IHC was performed on lung sections to detect the contribution of
lineage

labelled

AT2

cells

(EYFP+SFTPC+HOPX-)

to

regenerate

AT1

cells

(EYFP+SFTPC-HOPX+) after injury. White arrows and circles mark lineage traced AT2
cells after normoxia and HALI respectively. (C) Quantification of lineage traced cells in
(B), using a 1-way ANOVA with Dunnett’s correction for multiple testing applied for
normoxia/hyperoxia comparisons at P5 and P42. (D) Percentage of KI67+ lineage
labelled AT2 cells. (E) Percentage of KI67+ lineage negative AT2 cells. (F) Summary
diagram showing AT2 cells do not differentiate into AT1 cells after HALI. (G)
Experimental schematic showing HopxCreERT2;R26REYFP mice were induced with TAM at
P0, exposed to hyperoxic conditions for 5 days, and examined at P5, P14, and P42. (H)
IHC was performed on lung sections to detect the contribution of lineage labelled AT1
cells (EYFP+SFTPC-HOPX+) to regenerate AT2 cells (EYFP+SFTPC+HOPX-) after
injury. White arrows mark lineage-traced AT2 cells in normoxia, yellow arrows mark
lineage-traced AT1 cells, and white circles mark AT1 cell-derived AT2 cells after HALI.
(I) Quantification of AT1 cell-derived AT2 cells in (H). (J) Quantification of the percentage
of KI67+ AT1 cell-derived AT2 cells and IHC for lineage marker EYFP, KI67, and LAMP3
(AT2 cell marker). White circle marks a non-proliferating AT2 cell, and the yellow circle
marks a KI67+ AT1 cell-derived AT2 cells. (K) Summary diagram demonstrating after
HALI AT1 cells can reprogram into AT2 cells that then proliferate to promote lung
regeneration. All scale bars denote 10μm. Data are represented as mean ± SEM.
Statistical significance: n.s., not significant; ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.005.
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Figure 5.4: IHC individual channels, AT2 cell proliferation, AT1 cell reprogramming
time course, and hypoxic injury data
(A) Individual channels of IHC for AT2 cell lineage marker EYFP, SFTPC, and HOPX for
Figure 5.3B. Lineage traced cells marked by white dashed circles. (B) Quantification of
KI67+ SftpcCreERT2 traced AT2 cells in control mice or after HALI from P0-P5, assessed at
P14. (C) Quantification of HopxCreERT2 lineage traced AT2 cells during HALI at P2 and
P3, with data from P5 replicated from Figure 5.3I. (D) Individual channels of IHC for AT1
cell lineage marker EYFP, SFTPC, and HOPX for Figure 5.3H. Lineage traced cells
marked by white dashed circles. (E) IHC for AgerCreERT2 lineage marker EYFP, HOPX,
and LAMP3 at P5 after exposure to normoxia or HALI (scale bar: 20μm). (F)
Quantification of AgerCreERT2 lineage derived AT2 cells during HALI at P2, P3, and P5.
(G) IHC of adult AgerCreERT2 lungs traced for one month at homeostasis for lineage
marker EYFP, HOPX, and SFTPC. White arrows mark lineage labeled AT2 cells and
yellow arrows mark lineage labeled AT1 cells. The white dashed box indicates the
zoomed in region for the breakout channels on the right where a lineage labeled AT2 cell
is marked by a white dashed circle and a lineage labeled AT1 cell is marked by a yellow
dashed circle (Scale bar: 20μm). (H) Quantification of the percentage of lineage traced
AT2 cells in (G). (I) Quantification of the percentage of lineage traced AT2 cells after
hypoxia. (J) Individual channels of IHC for AT1 cell lineage marker EYFP, KI67, and
LAMP3 for Figure 5.3J. White dashed circles mark a lineage traced AT2 cell and yellow
dashed circles mark an unlabeled AT2 cell. (K) Quantification of KI67+ HopxCreERT2
lineage traced AT2 cells during HALI at P3. Error bars represent mean ± SEM. Statistical
significance *p<0.05, **p<0.01, ***p<0.001. n.s. denotes not significant results, or
p>0.05.

145

146

Figure 5.5: AT1 cells exhibit plasticity after adult HALI
(A) Experimental schematic showing TAM induction of adult SftpcCreERT2;R26REYFP or
HopxCreERT2;R26REYFP mice to label AT2 or AT1 cells, respectively. Following a 2-week
washout period, these animals remained in normoxic conditions until harvest or
experienced 3 days of hyperoxia and were examined at 7 days post injury (dpi). (B) H&E
image of a lung at 7 dpi. Dashed black box in the left image indicates the magnified area
shown in the right image. (C) IHC for AGER, an AT1 cell marker, NKX2.1, and SFTPC
shows the distribution of epithelial cells across damaged lungs at 7 dpi. Dashed white
box indicates location of magnified image on the right. (D) IHC for AT2 cell lineage
marker EYFP, HOPX, and SFTPC demonstrates AT2-AT1 cell differentiation after HALI.
The magnified regions are marked by dashed white boxes. Yellow arrows mark AT2 cellderived AT1 cells. (E) Summary diagram shows lineage traced AT2 cells differentiating
into AT1 cells. Quantification of the percentage of lineage traced AT2 cell-derived AT1
cells in (D). (F) IHC for AT1 cell lineage marker EYFP, HOPX, and SFTPC demonstrates
AT1-AT2 cell reprogramming after HALI. The magnified regions are marked by dashed
white boxes. The white arrow marks a lineage traced AT1 cell-derived AT2 cell after
HALI. (G) Summary diagram shows AT1-AT2 cell reprogramming. Quantification of the
percentage of AT1 cell-derived AT2 cells in (F). All scale bars denote 50μm. Data are
represented as mean ± SEM. Statistical significance: ∗p < 0.05, ∗∗p < 0.01,
and ∗∗∗∗p < 0.0005.
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∗∗∗p

< 0.005,

Figure 5.6: No evidence of AT1-AT2 cell reprogramming after AT2 cell depletion
(A)

Experimental

schematic

showing

R26REYFP;HopxFlpOERT2;R26RtdTomato

and

TAM

induction

of

adult

SftpcCreERT2;

SftpcCreERT2;R26RDTA;HopxFlpOERT2;R26RtdTomato

mice to label AT2 and AT1 cells and selectively deplete AT2 cells. Lungs were examined
at 7 days after the last TAM induction. (B) (Left images) IHC for AT2 cell lineage marker
EYFP, HOPX, and SFTPC showing high efficiency of AT2 cell labelling. (Right images)
AT1 cell lineage marker tdTomato, HOPX, and LAMP3 demonstrating loss of AT2 cells
does not induce AT1-AT2 cell reprogramming.
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Figure 5.7: Airway epithelial cell responses to HALI and influenza
(A) Experimental schematic showing TAM induction of adult Sox2CreERT2;R26REYFP mice
to label airway epithelial cells. Following a 2-week washout period, these animals
experienced 3 days of hyperoxia and were examined at 7 dpi. (B) H&E image of fibrotic
region resulting from HALI. (C) IHC for the lineage marker EYFP showing the minimal
infiltration of airway epithelial cells into the alveolar space. (D-F) IHC for the lineage
marker EYFP, HOPX, and LAMP3 showing rare airway epithelial cells giving rise to AT1
and AT2 cells. (G) Experimental schematic showing TAM induction of adult
Sox2CreERT2;R26REYFP mice to label airway epithelial cells. Following a 2-week washout
period, these animals were exposed to influenza and were examined at 14 dpi. (H) IHC
for the lineage marker EYFP and SFTPC showing the characteristic pattern of dysplastic
emergency barrier maintenance by airway epithelial cells after influenza and (I-J) the
contribution of airway epithelial cells to alveolar regeneration.
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Figure 5.8: AT1 cell plasticity after influenza
(A) Experimental schematic showing TAM induction of adult Sox2CreERT2;R26REYFP;
HopxFlpOERT2;R26RtdTomato mice to label airway epithelial and AT1 cells. Following a 2week washout period, these animals were exposed to influenza and were examined at
14 dpi. (B) IHC for airway epithelial linage marker EYFP, AT1 cell lineage marker
tdTomato, and SFTPC, showing that HopxFlpOERT2 does label some airway cells and that
while AT1 cells rarely appear to reprogram into AT2 cells, this phenomenon is only
observed in areas of airway infiltration into the alveolar space.
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Figure 5.9: AT1 cells contribute to injury repair after neonatal and adult injury
Summary diagram illustrating that in neonates, AT1-AT2 reprogramming replenishes the
AT2 cell pool after injury and AT2-AT1 cell differentiation does not occur. After adult
injury, AT2-AT1 cell differentiation and AT1-AT2 cell reprogramming are both observed.
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CHAPTER 6: KLF5 REGULATES ALVEOLAR EPITHELIAL TYPE 1 CELL LINEAGE
COMMITMENT DURING DEVELOPMENT AND REGENERATION

This chapter is adapted from work currently under review at Developmental Cell. William
A. Liberti provided support for the spatial injury mapping software. Madison M. Kremp
and Rafael J. Fernandez validated histological data analysis. Ian J. Penkala provided
technical support with experiments and mouse husbandry. Fabian L. Cardenas-Diaz
extracted RNA and assisted with RNA sequencing preparation. Michael P. Morley and
Apoorva Babu aided in bioinformatic analysis. Su Zhou assisted with histological
preparation.

6.1 Summary
Alveolar epithelial cell fate decisions drive lung development and regeneration. Using
transcriptomic and epigenetic profiling coupled with genetic mouse and organoid
models, we identified the transcription factor Klf5 as a critical regulator of alveolar
epithelial cell fate across the lifespan. We show that, while dispensable for both adult
alveolar epithelial type 1 (AT1) and alveolar epithelial type 2 (AT2) cell homeostasis, Klf5
enforces AT1 cell lineage fidelity during development. Using infectious and noninfectious models of acute respiratory distress syndrome, we demonstrate that Klf5
represses AT2 cell proliferation and enhances AT2-AT1 cell differentiation in a spatially
restricted manner during lung regeneration. Moreover, ex vivo organoid assays reveal
that Klf5 reduces AT2 cell sensitivity to inflammatory signaling to drive AT2-AT1 cell
differentiation. These data define the roll of a major transcriptional regulator of AT1 cell
lineage commitment and of the AT2 cell response to inflammatory crosstalk during lung
regeneration.
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6.2 Introduction
The complex structure of the adult lung arises from tightly regulated developmental
processes,

including

appropriate

lineage

specification,

specialized

niche

compartmentalization, and active maintenance of cell identity. Disruption of these
processes is not only detrimental to the gas exchange capabilities of the lung but is also
often incompatible with postnatal life (also see Chapter 2) (Morrisey and Hogan, 2010,
Zepp and Morrisey, 2019, Sivakumar and Frank, 2019, Snitow et al., 2016, Wang et al.,
2016b, Wang et al., 2013, Snitow et al., 2015, Goss et al., 2009). In particular,
respiration depends on the proper development and function of the distal alveolar
epithelial type 1 (AT1) and type 2 (AT2) cells, which are required for gas exchange and
for maintaining the structural integrity of the lung alveoli. While alveolar epithelial cells
serve critical functions during normal adult homeostasis, they also play key roles in
regenerating the lung. After lung injury, AT2 cells robustly expand and differentiate into
AT1 cells in adult mice to restore lost cells and tissue architecture across the
heterogeneously damaged tissue (Barkauskas et al., 2013). Moreover, recent work
shows that AT1 cells can contribute to the AT2 cell population during compensatory
regrowth after pneumonectomy in adult mice and during lung regeneration in both adult
and neonatal mice (also see Chapter 5) (Penkala et al., 2021, Jain et al., 2015).
Understanding the developmental signals driving the lineage determination of AT1 and
AT2 cells may provide insight into the essential regulators of alveolar epithelial plasticity
across the lifespan.

Kruppel-like factor 5 (Klf5) is a master transcription factor with a variety of known
functions, particularly in epithelial progenitor cells, including regulation of proliferation
and differentiation in both development and regeneration across multiple organs (Dong
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and Chen, 2009, Bialkowska et al., 2017, Turner and Crossley, 1999, Shi et al., 1999,
Sogawa et al., 1993, Bell et al., 2013, Bell et al., 2011, Zhang et al., 2020a, Kim et al.,
2020, Okada et al., 2018, Ge et al., 2017, Liu et al., 2018). Early prenatal deletion of Klf5
in the lung epithelium leads to a loss of AT1 cells, a gain of immature AT2 cells, and
disruption airway epithelial cell differentiation (Li et al., 2022, Wan et al., 2008).
However, it remains unclear whether Klf5 is required for AT1 cell survival or lineage
determination or whether Klf5 plays a role in alveolar regeneration. Klf5 is an essential
regulator of cell fate during early embryonic development, and it can also be used to
generate pluripotent stem cells and to maintain their potency and self-renewal properties
(Ema et al., 2008, Lin et al., 2010, Kinisu et al., 2021, Nakagawa et al., 2008, Jiang et
al., 2008, Parisi et al., 2010, Hall et al., 2009, Bourillot et al., 2009, Parisi et al., 2008,
Parisi and Russo, 2011). Additionally, recent work suggests a role for Klf5 in chromatin
remodeling (Jiang et al., 2020, Liu et al., 2020, Paranjapye et al., 2022). Reports on the
transcriptional regulatory function of Klf5 have suggested that Klf5 can act as either an
activator or repressor depending on the context (Diakiw et al., 2013). Klf5 binding activity
can also be altered by extracellular signaling induced post translational modification
(Guo et al., 2009, Zhang et al., 2020a). Together, these studies highlight Klf5 as a
flexible regulator of cell behavior, particularly of stem cell self-renewal and differentiation.

Using transcriptomic and epigenetic profiling, in vivo mouse genetic and injury models,
and ex vivo organoid assays, we investigated the role of Klf5 in a cell type specific
manner in the developing lung epithelium and in multiple injury contexts to determine its
role in lineage determination and cell fate commitment. We show that both Klf5
expression and accessible genomic binding sites are enriched in AT1 versus AT2 cells
during development. Moreover, AT1 cell loss of Klf5 during both prenatal and postnatal
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development results in AT1-AT2 cell reprogramming, demonstrating that Klf5 is required
for AT1 cell lineage fidelity. While Klf5 inactivation does not impact adult AT1 or AT2 cell
homeostasis, Klf5 loss leads to increased AT2 cell proliferation and decreased AT2-AT1
cell differentiation in a spatially specific manner after both infectious and non-infectious
acute injuries. Analysis of accessible genomic Klf5 binding sites in homeostatic adult
AT2 cells suggests that Klf5 regulates a variety of cellular processes in AT2 cells, and
transcriptomic analysis of adult AT2 cells after injury reveals that Klf5 affects AT2 cell
responsiveness to inflammatory signaling. Organoid assays show that while Klf5 is not
essential for AT2 cell proliferation or differentiation, it is critical for blunting the
responsiveness of AT2 cells to inflammatory signaling to promote efficient AT2-AT1 cell
differentiation. Thus, our data show that Klf5 is essential for early AT1 cell lineage
commitment and that it regulates AT2 cell fate choice in a spatially restricted manner
across multiple injury models.

6.3 Klf5 is required for AT1 cell lineage fidelity during prenatal development
Klf5 expression is largely restricted to epithelial cells in the developing mouse lung at
embryonic day 15.5 (E15.5), by which time the majority of distal lung epithelial cells have
been specified (Figure 6.1A) (Frank et al., 2019). However, while Klf5 is expressed in
both AT1 and AT2 cells, its expression in higher in AT1 cells during development
(Figure 6.1B). To determine the cell type specific role of Klf5 in AT1 cell development,
we functionally inactivated Klf5 in specified AT1 progenitors and lineage labelled these
cells at E15.5, using HopxCreERT2;Klf5fl/fl;R26EYFP mice. We found that AT1 precursorspecific loss of Klf5 perturbed lung morphology as early as E17.5, leading to a
statistically significant increase in septal wall thickness at E18.5 (Figures 6.1C-D).
Moreover, we observed an increase in the percentage of AT1 cell-derived AT2 cells,
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identified by both gain of the AT2 cell marker Sftpc and loss of the AT1 cell marker
Hopx, in Klf5-deficient animals at E18.5 (Figures 6.1E-F). This result suggests that, in
the absence of Klf5, specified AT1 precursors are unable to maintain their lineage
identity and instead convert to AT2 cells. To test this hypothesis, we first confirmed that
AT1 precursors survived loss of Klf5, using a custom RNA fluorescence in situ
hybridization (FISH) probe designed to bind within the floxed region of Klf5 (Figure
6.1G). Note that Klf5 deletion was not complete in all AT1 precursors, potentially
explaining why our Klf5-deficient mice do not die at birth in contrast to previous results
with more broad loss of Klf5 (Figure 6.1G) (Wan et al., 2008). While loss of Klf5 in AT1
precursors did not impact their survival, it disrupted endothelial cell development, as
previously reported (Figures 6.1H) (Wan et al., 2008). Additionally, we observed a
decrease

in

Car4+

endothelial

cells

(Figures

6.1H-I).

We

then

generated

SftpcCreERT2;Klf5fl/fl;R26EYFP mice to assess whether Klf5 was required for AT2 cell
development. Functionally inactivating Klf5 in specified AT2 precursors and lineage
labelling these cells at E15.5, we confirmed that Klf5 is not necessary for AT2 precursor
survival, as previously reported (Figure 6.2A) (Wan et al., 2008). In contrast to AT1
precursors, loss of Klf5 in AT2 precursors did not impact lung morphology by E18.5
(Figures 6.2B-C). Consistent with the survival of Klf5-deficient AT1 and AT2-derived
cells at E18.5, we did not observe any change in cell death between control and
HopxCreERT2;Klf5fl/fl;R26EYFP lungs at E17.5 (Figure 6.2D). Moreover, proliferation of Klf5deficient AT1 precursor-derived AT2 cells was not different from that of normal AT2 cells
at E17.5 (Figures 6.2E-F). Previous work showed that Klf5 plays an important role in
airway secretory cell development (Wan et al., 2008, Li et al., 2022). Consistent with this
report, we observed decreased numbers of SCGB1A1+ cells at E18.5 after functional
inactivation

of

Klf5

specifically

in

the
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airway

epithelium

at

E16.5

using

Sox2CreERT2;Klf5fl/fl;R26EYFP mice (Figure 6.2G). Together, our data show that Klf5 is
required to maintain AT1 cell fate during prenatal development (Figure 6.1J).

6.4 Klf5 maintains AT1 cell lineage fidelity during postnatal development
Klf5 expression remains restricted to epithelial cells during alveologenesis at postnatal
day 3 (P3) (Figure 6.3A). Moreover, assay for transposase-accessible chromatin
(ATAC) sequencing analysis revealed that the Klf5 motif is the most enriched
transcription factor binding motif in accessible promoters in AT1 cells compared to AT2
cells at P3 (Figure 6.3B). While Klf/Sp family genes share their zinc-finger structure and
bind similar motifs, representing 6 of the top 10 motifs from this analysis, they have
distinct functions (McConnell and Yang, 2010). To determine whether Klf5 is required to
maintain AT1 cell identity during alveologenesis, we inactivated Klf5 in AT1 cells and
lineage traced these cells starting at P0. Klf5-deficient AT1 cells survived, and we
observed an increase in AT1 cell-derived AT2 cells at P5 (Figures 6.3C-E). This
increase in AT2 cells persisted through the termination of alveologenesis at P42 and
resulted in a minor increase in the total number of AT2 cells as a percentage of all
alveolar epithelium (Figures 6.3F-G). This increase did not impact overall lung
morphology at P42 (Figure 6.4A). We next investigated whether cell death or
proliferation were altered by loss of Klf5. Consistent with our previous findings in
prenatal lungs, we did not observe any obvious change in cell death after AT1 or AT2
cell-specific loss of Klf5 (Figures 6.4B-D). Further, we did not observe a statistically
significant change in Klf5-deficient AT2 cell proliferation (Figures 6.4C-D). YAP
localization also appeared unchanged between control and mutant AT1 cells and
between control AT2 cells and Klf5-deficient AT1 cell-derived AT2 cells (Figures 6.4E).
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Thus, the gain of AT1 cell-derived AT2 cells suggests that Klf5 constrains AT1 cell
lineage identity, leading to Klf5-deficient AT1 cells converting into AT2 cells.

We recently reported that AT1 cells can reprogram into AT2 cells after neonatal
hyperoxia

exposure

(see

Chapter

5)

(Penkala

et

al.,

2021).

When

HopxCreERT2;Klf5fl/fl;R26EYFP mutants were subjected to the same injury, we did not
observe any difference in the AT1-AT2 reprogramming efficiency between control and
mutant conditions (Figures 6.3H-I). Together, our data show that Klf5 is required during
postnatal development to maintain AT1 cell lineage commitment (Figure 6.3J).

6.5 Klf5 represses AT2 cell proliferation and regulates AT2-AT1 cell differentiation
after infectious lung injury
To determine whether Klf5 is required to maintain mature AT1 cell identity, we
functionally inactivated Klf5 in AT1 cells and lineage traced these cells during adult
homeostasis. We did not observe any obvious changes in lung morphology or AT1 cell
identity in mutant lungs, suggesting Klf5 is dispensable for mature AT1 cell homeostasis
(Figures 6.5A-B). Because Klf5 appears to be involved in early AT1 cell lineage
commitment, we surmised that Klf5 may promote AT2-AT1 cell differentiation in the adult
lung. To investigate whether Klf5 is required for mature AT2 cell homeostasis or long
term homeostatic AT2-AT1 cell differentiation, we functionally inactivated Klf5 in AT2
cells in adult mice and lineage traced these cells for 1, 6, and 12 months. We did not
observe any obvious changes in lung morphology or in long term homeostatic AT2-AT1
cell differentiation in control versus mutant lungs (Figures 6.6A-B).
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To further examine the role of Klf5 in AT2 cell fate choice, we employed an influenza
injury model to drive AT2 cell-mediated lung regeneration (Figure 6.6C). Influenza is an
acute infectious disease that results in heterogeneous tissue injury and spatially
restricted epithelial responses, including AT2 cell self-renewal and AT2-AT1 cell
differentiation, that occur in morphologically distinct areas (Figures 6.6D-E) (also see
Chapters 3-5) (Zacharias et al., 2018, Xi et al., 2017, Katsura et al., 2019). Using our
previously described unbiased computational imaging approach, we binned this
heterogeneous regenerative landscape into three distinct zones based on the severity of
tissue damage: 1. severe zones are sites of maximal tissue damage that contain few,
highly proliferative AT2 cells, 2. damaged zones are sites of active morphological
remodeling where AT2 cells both proliferate and differentiate into AT1 cells, and 3.
normal zones are areas consisting of largely homeostatic tissue morphology with highly
variable levels of AT2 cell proliferation dependent on the extent of overall lung injury
(Figures 6.6D-E) (see Chapters 3-4). Klf5-deficient AT2 cells are present in all zones 14
days post injury (dpi), demonstrating that many of these cells survive this injury (Figures
6.6F-G). Klf5-deficient AT2 cells exhibit increased proliferative capacity compared to
controls specifically in severe zones at 14 dpi (Figures 6.6H-I and 6.7A-B). Additionally,
Klf5-deficient AT2 cells differentiate less efficiently into AT1 cells compared to controls in
damaged zones at 14 dpi (Figures 6.6H and J). Together, these data show that Klf5
inhibits AT2 cell proliferation and regulates AT2-AT1 cell differentiation in a spatially
restricted manner in adult mice after acute infectious lung injury (Figure 6.6K).

160

6.6 Klf5 represses AT2 cell proliferation and regulates AT2-AT1 cell differentiation
after non-infectious lung injury.
To determine whether Klf5 regulates alveolar epithelial cell fate decisions in different
injury contexts, we employed a non-infectious hyperoxia-induced acute lung injury
(HALI) model (also see Chapter 5) (Penkala et al., 2021, Amarelle et al., 2021, Mach et
al., 2011, Matute-Bello et al., 2008). After exposure to hyperoxic conditions for 3 days,
mice were harvested 7 days after their return to normoxia (7 dpi) (Figure 6.8A). Using
the same unbiased computational imaging approach employed for characterization of
influenza injury, we found that HALI results in distinct injury zones at 7 dpi similar to what
we observe after influenza at 14 dpi (Figure 6.8B). However, in contrast to influenza
injury, HALI results in the stochastic emergence of fibrotic lesions (Figures 6.8B-C).
Thus, we characterize HALI as follows: 1. severe zones are alveolar deserts marked by
Acta2+ fibrotic lesions, 2. damaged zones are sites of active morphological remodeling
where AT2 cells both proliferate and differentiate into AT1 cells, marked by Ager, and 3.
normal zones contain largely homeostatic tissue architecture with highly variable levels
of AT2 cell proliferation (Figures 6.8B-D). Control and Klf5-deficient AT2 cells are
present in both normal and damaged zones at 7 dpi, revealing that Klf5 is not absolutely
required for AT2 cell survival after HALI (Figure 6.8E). Moreover, Klf5-deficient AT2
cells demonstrate increased proliferative capacity and reduced AT1 cell differentiation
efficiency in damaged zones compared to controls at 7 dpi (Figures 6.8F-H). In contrast,
Klf5 appears dispensable for adult AT1-AT2 cell reprogramming (Figures 6.9A-B). To
determine whether the loss of Klf5-deficient AT2-AT1 cell differentiation represents a
delay or permanent deficiency, we assessed mice at 28 dpi. HALI induced morphological
changes are dramatically reduced at 28 dpi in control mice, and while Klf5-deficient mice
appear to have more and larger legions, this result could be due to survivorship bias
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(Figure 6.9C). In damaged zones at 28 dpi, AT2-AT1 cell differentiation levels are no
longer statistically different, suggesting that Klf5 is not absolutely required for AT2-AT1
cell differentiation, consistent with our observations during adult homeostasis (Figures
6.6A-B and 6.9D-E). Together, these data show that Klf5 inhibits AT2 cell proliferation
and regulates AT2-AT1 cell differentiation in spatiotemporal manner in adult mice after
acute lung injury (Figure 6.8I).

6.7 Klf5 mediates the AT2 cell response to inflammatory signaling
To understand how Klf5 regulates AT2 cell fate decisions, we investigated an earlier
timepoint after HALI (Figure 6.10A). At 3 dpi, lungs exhibited dramatic inflammation with
evident tertiary lymphoid structures, small fibroblastic foci preceding the later onset of
widespread fibrosis, and ultimately less clear injury zone distinction across the tissue
(Figures 6.10B-C). While AT2 cells are highly proliferative at 3 dpi, they exhibit rare
evidence of AT2-AT1 cell differentiation at this injury stage, making this time point ideal
to study the early effects of loss of Klf5 on AT2 cell behavior (Figure 6.10D). The first 3
days following the return to normoxia mark a critical recovery window where some, but
not all, mice survive, and mice that survive past this critical window recover. Importantly,
we observed a survival benefit in Klf5-deficient mice compared to controls (Figure
6.10E). To determine how Klf5 might regulate AT2 cell behavior, we assessed ATAC
sequencing data from adult AT2 cells, identified genes in areas of open chromatin with
Klf5 binding motifs in their promoters, and performed gene ontology (GO) analysis. We
identified an enrichment of genes associated with cell adhesion, migration,
developmental processes, differentiation, and signal transduction pathways consistent
with known roles of Klf5 (Figure 6.10F) (Dong and Chen, 2009). However, we also
identified genes involved in cellular defense response and cytokine binding, which
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suggests an undescribed role of Klf5 in regulating alveolar epithelial cell responsiveness
to external stimuli, perhaps from infiltrating immune cells (Figure 6.10F). To determine
the downstream signaling effects of loss of Klf5 in AT2 cells, we performed RNA
sequencing on AT2 cells isolated at 3 dpi. AT1 and AT2 cell marker gene expression
was unchanged between control and Klf5-deficient mice (Figures 6.11A-B). Differential
gene expression analysis revealed downregulated genes associated with tumor
suppression (Endod1, S100a14, and Vsig1), interferon response (Irf7, Isg15, and
Rsad2), apoptosis (Irf7), and oxidative stress (Gsta1) (Qiu et al., 2017, Chen et al.,
2009, Bernal et al., 2020, Zhang et al., 2018, Zhang et al., 2015, Fan and Zhang, 2013,
Yuan et al., 2020, Honda et al., 2005) (Figures 6.10G). Differential gene expression
analysis of upregulated genes highlighted genes involved in inflammatory response
regulation (Rgs16, Kcnj15, Ntn1, Slc10a6, Proz, and Tnfsf9), coagulation (Proz),
inhibition of apoptosis (Ntn1), and negative regulation of differentiation (Enc1) (Fujita et
al., 2001, Kosters et al., 2016, Pascual et al., 2005, Andrei et al., 2004, Patten et al.,
2003, Mirakaj et al., 2010, Butschkau et al., 2014, Fong et al., 2000, Suurväli et al.,
2015, Bethea et al., 1992) (Figure 6.10G). Further, Rgs16 has a putative role in
maintenance of the undifferentiated state in pluripotent stem cells (Bourillot et al., 2009)
(Figure 6.10G). These data suggest that Klf5 regulates AT2 cell responsiveness to
inflammation and cellular stress, inhibits proliferation, and promotes differentiation. Gene
set enrichment analysis of all differentially expressed genes between control and Klf5deficient AT2 cells highlighted pathways involved in interferon alpha response and TNFα
signaling via NF-kB, further implicating Klf5 as a modulator of AT2 cell responsiveness
to inflammatory signaling (Figures 6.10H and 6.11C-D). In contrast, E2f and Myc target
pathways did not appear to be driven by statistically differentially expressed genes
(Figures 6.11E-F). Together, these data suggest that Klf5 regulates the AT2 cell
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response to cellular stress and inflammatory signaling, ultimately inhibiting proliferation,
promoting AT2-AT1 cell differentiation, and impeding short term survival of the animal
after lung injury.

6.8 Klf5 inhibits inflammatory signaling-induced AT2 cell fate maintenance and
proliferation to promote differentiation
To understand how Klf5 impacts AT2 cell proliferation and differentiation, we employed
an ex vivo organoid assay to assess AT2 cell behavior in an isolated environment that
mimics aspects of tissue injury (Figure 6.12A) (see Chapters 1, 4, and 7). Neither
control and Klf5-deficient AT2 cell-derived organoid size nor growth rate were
statistically significantly different (Figures 6.12B-D). Further, there was no statistically
significant difference in colony forming efficiency between control and Klf5-deficient AT2
cells (Figures 6.12B and E). Klf5 deletion was confirmed in mutant organoid cultures
(Figure 6.12F). Additionally, differentiation capacity appeared similar between Klf5deficient and control organoids (Figures 6.12F-G).

Since our genomic analysis implicated a role for Klf5 in regulating AT2 cell
responsiveness to inflammatory signaling, we examined whether Klf5-deficient AT2 cells
would respond differently to inflammatory cytokines such as IL-1β, which is known to
drive AT2 cell proliferation (Katsura et al., 2019, Choi et al., 2020, Katsura et al., 2020).
Examination of IL-1β stimulated organoids revealed that Klf5-deficient AT2 cells were
more sensitive to IL-1β (Figures 6.12H-I). Moreover, we noticed that, in the presence of
IL-1β, Klf5-deficient AT2 cells did not differentiate as efficiently into AT1 cells (Figures
6.12H and J). Together, these results show that IL-1β stimulation is sufficient to
recapitulate the increase in Klf5-deficient AT2 cell proliferation and the decrease in Klf5164

deficient AT2-AT1 cell differentiation seen during in vivo regeneration in both infectious
and non-infectious acute lung injury models. In contrast, we did not detect the same
transcriptional differences in our organoid assays as we observed in the HALI model at 3
dpi (Figures 6.13A-H). This is likely due to differences in the cellular niche complexity
and timing of in vivo injury versus our ex vivo organoid model. Thus, our data suggest
that Klf5 acts to suppress immune cytokine-induced AT2 cell fate maintenance to reduce
proliferation and promote differentiation (Figure 6.12K).

6.9 Discussion
Cell fate decisions and lineage commitment of AT1 and AT2 cells drive morphogenesis
to establish the complex gas diffusible niche in the lung. Moreover, these processes
guide the regenerative cycle to restore homeostatic lung architecture and respiratory
function after acute injury. However, the essential factors that establish and maintain
AT1 and AT2 cell lineage fidelity across the lifespan and during tissue regeneration
remain unclear. Our studies illustrate that Klf5 is critical for AT1 cell lineage
determination during development and for repressing inflammatory signals that promote
maintenance of AT2 cell identity, inhibiting proliferation and driving AT2-AT1 cell
differentiation in multiple regenerative contexts.

Previous work demonstrated that deletion of Klf5 in the respiratory epithelium during
early lung organogenesis resulted in morphologic defects after E15.5, loss of AT1 cells,
and gain of immature AT2 cells by E18.5 (Wan et al., 2008). These results suggested
that Klf5 is required for AT1 precursor development after alveolar epithelial cell
specification. Using lineage restricted inducible genetic tools, we now show that Klf5 is
required in specified AT1 precursors prenatally to maintain their lineage fidelity. During
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development, Klf5-deficient AT1 precursors convert to AT2 cells, leading to
morphological defects similar to those observed upon broader epithelial cell loss of Klf5.
A recent study suggested that Klf5 is an important regulator of alveolar epithelial cell
development postnatally in combination with Yap, Tead1, Nfib, and Nkx2.1 (Gokey et al.,
2021). Our data confirm that Klf5 remains important for maintenance of AT1 cell lineage
fidelity during alveologenesis. However, Klf5 is dispensable for maintenance of adult
AT1 cell homeostasis in contrast to Yap/Taz, which have recently been identified as
essential for maintenance of AT1 cell identity across the lifespan (also see Chapter 7)
(Penkala et al., 2021). Indeed, our results demonstrate that as development progresses,
Klf5, unlike Yap/Taz, becomes less important for maintenance of AT1 cell identity.
Instead, Klf5 appears to restrict the limited plasticity of early postnatal AT1 cells to
reprogram into AT2 cells, suggesting Yap/Taz act upstream of Klf5 during development.
Additionally, as levels of nuclear Yap/Taz increase after injury to regulate AT2 cell
mediated regeneration, it is possible that Yap/Taz interact with Klf5 during adult
regeneration (LaCanna et al., 2019). Future studies focused on uncoupling the
mechanical and extracellular signaling aspects of AT1 cell fate acquisition and
maintenance will be necessary to fully understand whether and how independent and
redundant mechanisms of AT1 cell identity maintenance arise over the course of the
development and control AT1 cell injury response.

Loss of Klf5 in AT1 cells also disrupts the development of the endothelium. Endothelial
cell development and lung vascularization rely in part on Vegfa expression, which is
expressed in multiple cell types in the lung (Lagercrantz et al., 1998, Miquerol et al.,
1999, Healy et al., 2000). Recent work suggests that epithelial Vegfa, particularly from
AT1 cells, is required for specification of a subset of endothelial cells marked by
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expression of Car4 in mice (Vila Ellis et al., 2020). Moreover, Vegfa is a direct target of
Klf5 (Wan et al., 2008). We observed both perturbed endothelial cell development and a
loss of Car4 expressing cells in lungs with Klf5-deficient AT1 cells, demonstrating a
critical role for Klf5 in AT1-endothelial cell crosstalk during lung angiogenesis. It is
unclear whether the loss of Car4 expressing cells is due to the reprogramming of AT1AT2 cells upon loss of Klf5, the loss of Vegfa expression, or a combination of factors.
However, this finding supports the emerging paradigm that AT1 cells act as signaling
hubs during development (Zepp et al., 2021). Future work employing ex vivo organoid
models incorporating multiple cell types may further illustrate the complex intercellular
communication between these two compartments (see Chapter 7).

We demonstrate that Klf5 regulates AT2 cell-mediated lung regeneration after acute
injury. Loss of Klf5 delays AT2-AT1 cell differentiation and increases proliferation. These
findings suggest that Klf5 regulates AT2 cell niche responsiveness, impacting AT2 cell
fate in a context dependent manner. Our data show that loss of Klf5 sensitizes AT2 cells
to inflammatory signaling, particularly to IL-1β, which reinforces AT2 cell identity in a
spatially restricted manner. This result is consistent with recent findings that Klf5 motifs
are enriched in AT2 cells with higher IL-1R signaling and that chronic inflammatory
signaling reinforces AT2 cell identity (Choi et al., 2020). Moreover, loss of Klf5 has been
shown to promote proliferation and immune signaling in cultured airway epithelial cells,
consistent with our results in AT2 cells after injury in vivo and after IL-1β stimulation ex
vivo (Paranjapye et al., 2021). IL-1β has also been shown to act directly on AT2 cells
and induce Klf5 expression in other cell types, suggesting a potential negative feedback
loop between inflammation and Klf5 signaling (Xie et al., 2018, Katsura et al., 2020).
While IL-1β can act directly on AT2 cells, it could also impact the fibroblasts in our
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organoid assay, indirectly impacting AT2 cell growth. Ultimately, these data suggest that
Klf5 represses signaling related to AT2 cell identity maintenance to promote
differentiation and that, without Klf5, AT2 cells are more likely to maintain their identity
and respond to proliferative stimuli than to differentiate.

These results contribute to the growing paradigm that alveolar epithelial cell identity is
actively maintained during regeneration and across the lifespan (also see Chapters 4
and 7) (Penkala et al., 2021). Moreover, the findings that Klf5 regulates AT1 cell lineage
commitment from a specified AT1 precursor during development or a mature AT2 cell
during regeneration expand this paradigm, showing that certain aspects of
developmental alveolar epithelial cell fate acquisition are similar to adult alveolar
epithelial cell differentiation. Together, these studies illustrate the extent of cellular
plasticity in the lung alveolus, where the injury niche recapitulates mechanical and
signaling aspects of the developmental niche, weakening cellular identity to promote
regeneration. This paradigm highlights the importance of further exploration of the
developmental regulators of cell fate specification and lineage determination to uncover
the key signals driving adult lung regeneration.

6.10 Materials and methods
Materials availability
The RNAscope probe mM-Klf5-O1-C1 (Cat#: 1085261-C1) was generated by and is
available from Advanced Cell Diagnostics upon request.
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Data and software availability
Lung damage assessment software has been previously described and is publicly
available on Github (https://github.com/WALIII/LungDamage) (also see Chapters 3-4)
(Liberti et al., 2021). The RNA sequencing data generated by this study was deposited
to GEO with the accession number GSE190676. All other sequencing data was obtained
from GEO under the following accession numbers: E15.5 scRNA sequencing:
GSM4504960, Bulk RNA sequencing time course: GSE148487, P3 scRNA sequencing:
GSM4504962, P3 scATAC sequencing: GSM4504968, adult AT2 cell ATAC sequencing:
GSM2550589 (Zacharias et al., 2018, Zepp et al., 2021).

Mouse lines
Generation and genotyping information for mouse lines SftpcCreERT2, HopxCreERT2
(Jackson Laboratory stock # 017606), Sox2CreERT2(Jackson Laboratory stock # 017593),
Klf5flox (Jackson Laboratory stock # 029787), R26REYFP (Jackson Laboratory stock #
007903), and Ai14(RCL-tdT)-D (R26RtdTomato) (Jackson Laboratory stock # 007914) have
been described previously (Chapman et al., 2011, Wan et al., 2008, Madisen et al.,
2010, Takeda et al., 2011, Arnold et al., 2011). The SftpcCreERT2 mouse line was a kind
gift from the Chapman lab and the Klf5flox mice were a kind gift from the Whitsett lab. The
remaining mouse lines were obtained from the Jackson Laboratory and all mice were
maintained on a mixed background (C57BL/6 and CD1). The efficiency and cell type
specificity of the SftpcCreERT2 and HopxCreERT2 mouse lines have been well described in
the lung (Frank et al., 2019, Jain et al., 2015, Penkala et al., 2021, Chapman et al.,
2011). The Klf5fl/+ mice exhibited no obvious defects after Cre recombination, so these or
Klf5+/+ animals were used as experimental controls as noted in the figure legends. All
experiments were performed with at least n = 3 mice per condition of mixed gender,
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including littermates, and unless otherwise stated, each point on a graph represents data
from a single mouse. All animal procedures were performed under the guidance of the
University of Pennsylvania Institutional Animal Care and Use Committee.

Lung alveolar organoid assay
Organoid assays were performed as previously described with slight modification (also
see Chapter 4) (Barkauskas et al., 2013, Frank et al., 2016). Briefly, single cell
suspensions were generated from SftpcCreERT2;R26RtdTomato or SftpcCreERT2;Klf5fl/fl;
R26RtdTomato mice by a combination of physical and enzymatic dissociation . tdTomato+
cells were then isolated by fluorescence activated cell sorting (FACS) into FACS buffer
(Hanks Balanced Salt Solution (HBSS, Gibco, catalog # 14175095), 25mM HEPES
(Gibco, catalog # 15630080), 2mM EDTA (Invitrogen, catalog # 15575020), and 2%
Fetal Bovine Serum (FBS) (Deville, catalog # FB5001). A hemocytometer and Trypan
Blue Solution, 0.4% (Gibco, catalog # 15250061) were used to verify live cell number for
plating. Each technical replicate contained a mixture of 5x103 tdTomato+ cells and 5x104
primary lung fibroblasts in a solution of 50% Matrigel (Corning, catalog # 356231) and
50% MTEC-SAGM media plated in a Falcon Cell Culture Insert (Thermo Fisher
Scientific, catalog # 08770). MTEC-SAGM media was prepared as previously described
with slight modification (see Chapter 4). Briefly, Small Airway Epithelial Cell Growth
Basal Media (Lonza, catalog # CC-3119) was combined with specific Small Airway
Epithelial

Cell

Growth

Medium

supplements

(Lonza,

catalog

#

CC-4124):

Insulin/Transferrin, Bovine Pituitary Extract, Gentamycin, and Retinoic Acid as well as
0.1 μg/mL Cholera Toxin (Millipore Sigma, catalog # C9903), 25ng/mL EGF (Peprotech,
catalog # AF-100-15), 10μM SB431542 (Abcam, catalog # ab120163), and 5% FBS.
Matrigel was allowed to solidify for fifteen minutes before the addition of MTEC-SAGM
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media, which was refreshed every other day. For the first 48 hours of culture, AntibioticAntimycotic (Gibco, catalog # 15240062) and 10μM rock inhibitor (Y-27632
dihydrochloride, Millpore Sigma, catalog # Y0503) were added as supplements to the
media. IL-1β (10ng/mL, BioLegend, catalog # 575102) treatment began after 48 hours
and continued during normal media changes for the remaining culture period in select
experiments noted in the text. Cultures were imaged with an EVOS FL Auto 2 Imaging
System. Organoids were harvested, embedded in 4% UltraPure Low Melting Point
Agarose (Invitrogen, catalog # 16520050) in HBSS, and fixed at room temperature in 2%
paraformaldehyde solution (Thermo Fisher Scientific, catalog # AAJ19943K2) diluted in
Phosphate Buffered Saline (PBS) (Quality Biological, catalog # 119-068-151) for 30
minutes. After 3-5 washes in PBS, organoids were dehydrated in a series of ethanol
washes from 30-100%, embedded in paraffin wax, and sectioned at a thickness of 6μm.
Results are from four independent experiments and each experimental condition was
performed with at least three replicate wells.

Tamoxifen delivery
Tamoxifen administration was performed as previously described (see Chapters 4-5).
Tamoxifen was reconstituted in a mixture of ethanol (10%) and corn oil (90%) to a
20mg/mL concentration. For P0 mice, tamoxifen was administered by intraperitoneal
injection of 20μL (at 20mg/mL) tamoxifen using a 30G needle. For pregnant dams,
tamoxifen was administered once by oral gavage at a dose of 200mg/kg at E15.5. For
adults, tamoxifen was administered by oral gavage at a dose of 200mg/kg for three
consecutive days. 6-14 week old mice were used for all adult in vivo experiments, and
injury experiments involving lineage tracing included a 2 week washout period after the
final tamoxifen dose before injury implementation.
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Hyperoxia-induced acute lung injury
Neonatal and adult hyperoxia experiments were performed as previously described (see
Chapter 5). Briefly, animals were placed into a hyperoxia chamber (BioSpherix),
containing sodium bicarbonate for odor mitigation. A ProOx360 single gas controller
(BioSpherix) was used to add oxygen from a medical oxygen source to maintain a level
of 95% oxygen within the chamber. Neonates were exposed to hyperoxia for 5 days with
dams alternated daily with lactating surrogates. Adult mice were exposed to hyperoxia
for 3 days.

Influenza infection
PR8 H1N1 influenza was a kind gift from Dr. John Wherry at the University of
Pennsylvania and it was diluted in cold PBS to allow intranasal administration of 50uL to
anesthetized mice at a dose of approximately 1LD50 (determined experimentally based
on delivery to 6-8 week old C57BL/6 female mice) as previously described (see
Chapters 3-4).

Histology, immunohistochemistry, and RNA fluorescence in situ hybridization
(FISH)
Embryonic lungs were harvested into 2% paraformaldehyde and were fixed overnight at
4°C. Postnatal lungs were harvested at a constant pressure of 25cm H2O before fixation
in 2% paraformaldehyde overnight at 4°C. Lungs were washed, dehydrated, embedded
in paraffin wax, and sectioned at 6μm thickness. Hematoxylin and eosin (H&E) staining
was

performed

according

to

standard

procedures

(see

Chapter

3).

Immunohistochemistry was performed using the following antibodies: Acta2 (mouse,
Millipore Sigma, A5228, 1:200), Ager (Rage) (rat, R&D Systems, MAB1179, 1:50),
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cleaved Caspase 3 (rabbit, Cell Signaling, 9664s, 1:50 or rabbit, R&D Systems,
MAB835, 1:100), Lamp3 (DC-Lamp) (rat, Novus, DDX0191P-100, 1:100), Emcn (goat,
R&D Systems, AF4666, 1:500), Foxj1 (mouse, Invitrogen, 14-9965-80, 1:200), GFP
(chicken, Aves Labs, GFP-1020, 1:200 or goat, Abcam, ab6673, 1:200), Hopx (mouse,
Santa Cruz, sc-398703, 1:100), Ki67 (mouse, BD Biosciences, 550609, 1:200), Klf5
(rabbit, Abcam, ab137676, 1:50), Nkx2.1 (Ttf1) (rabbit, Abcam, ab76013, 1:50 or mouse,
Thermo Fisher Scientific, MS-699-P1, 1:25), Scgb1a1 (rabbit, Thermo Fisher Scientific,
MA5-29780, 1:100), Sftpc, (rabbit, Millipore Sigma, AB3786, 1:100), and Yap (rabbit,
Cell Signaling, 4912). After staining, slides were mounted using Slowfade Diamond
Antifade Mountant (Invitrogen, catalog # S36972). RNA FISH was performed using the
RNAscope system following the manufacturer’s instructions with the following probes:
Mm-Car4-C3 (catalog # 468421-C3), mm-Ntn1 (catalog # 407621), mm-Rgs16 (catalog
# 539201), mm-Slc10a6 (catalog # 550031), mm-Tnfsf9 (catalog # 504021), and MmKlf5-O1 (catalog # 1085261-C1, this custom probe was designed to bind specifically
within the floxed region of the Klf5flox allele: 534-1021 base pairs of NM_009769.4). H&E
and widefield fluorescence images were acquired with either a Nikon Eclipse 80i or an
EVOS FL Auto 2 Imaging System. All other fluorescence images, including all images
used for quantification, were captured using a Zeiss LSM 710 confocal microscope and
processed using Fiji software. Tile scan images were stitched using Fiji or NIS-Elements
software.

Immunohistochemistry and RNA FISH quantification
All image analysis for IHC quantifications was performed as previously described (see
Chapters 4-5). Briefly, image analysis was performed on z-stack images acquired
through 6-10μm thick tissue sections using a Zeiss LSM 710 confocal microscope. For a
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given stain, at least 200 cells or five confocal stacks taken at 40x magnification were
used per mouse. To measure the number of transcripts per nucleus, control and Klf5deficient organoids on the same slide were compared using the Matlab software,
dotdotdot, described previously (Maynard et al., 2020).

Septal wall thickness
Morphometric analysis of septal wall thickness was performed on images acquired using
an EVOS FL Auto 2 Imaging System. Images were manually curated to concentrate on
alveolar areas, avoiding large airways and vessels. The mean was calculated from at
least seven 20x images, which were randomly selected from each mouse for analysis.
Analysis was performed with custom Matlab software described previously (Paris et al.,
2020, Obraztsova et al., 2020).

Organoid size and colony forming efficiency
Organoid measurements were performed as previously described (see Chapter 4).
Briefly, images of whole organoid culture wells were obtained using endogenous
fluorescence from the R26RtdTomato reporter allele on an EVOS FL Auto 2 Imaging
System. In Fiji, images were converted to 32bit, processed using simple thresholding,
binarized, and subjected to erosion and dilation to minimize background. Subsequently,
the fill holes and watershedding functions were applied to aid in visualization of
individual organoids. Organoid size and number were quantified using the analyze
particles function with a minimum size cutoff of 1000μm2. Organoid sizes from replicate
wells were pooled to calculate average organoid size per mouse for each condition.
Colony forming efficiency was obtained by dividing colony number by the number of
input tdTomato+ cells.
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Lung damage assessment program
The lung damage assessment program methodology was described previously (see
Chapters

3-4).

Briefly,

we

employed

custom

Matlab

software

(https://github.com/WALIII/LungDamage) to rank and sort points from images of H&E
stained sections according to staining intensity and density to identify morphologically
distinct injury zones to enable rigorous, reproducible analysis of the heterogenous
regenerative landscape across mice and experimental conditions. We generated maps
to demarcate areas of maximal damage (red, severe zones), areas of active
morphological remodeling (green, damage zones), and homeostatic appearing regions
(blue, normal zones), and we used these maps to identify regions of interest for IHC
analysis on immediately adjacent slides.

RNA sequencing
Developmental RNA sequencing time course data was generated as described
previously (Penkala et al., 2021). For the RNA sequencing analysis of adult AT2 cells,
control and Klf5-deficient AT2 cells were isolated after hyperoxia at 3 dpi by FACS as
described above for the alveolar organoid assay. RNA isolation was performed using the
PureLink RNA Mini Kit (Thermo Fisher Scientific, catalog # 12183018A), following the
manufacturer’s instructions. Library preparation was performed using the NEBNext
Single Cell/Low Input RNA Library Prep Kit for Illumina (New England Biolabs, catalog #
E6420) following the manufacturer’s instructions. Libraries were sequenced using the
Illumina HiSeq. Analysis was performed as previously described (see Chapter 2). Briefly,
the FastQC program was used to assess quality of Fastq files before aligning the files to
the mouse reference genome (GRCm39) using the STAR aligner (Dobin et al., 2013).
The MarkDuplicates program from Picard tools was used to flag duplicate reads.
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Duplicates were excluded before computing per gene read counts for Ensembl (v104)
gene annotations, using the Rsubread R package. The TMM method in the edge R
package was used to nominalize gene counts, represented as counts per million (CPM),
and genes with 25% of samples with a CPM < 1 were deemed low expressed and
removed (Robinson et al., 2010). Expression levels in counts per million (CPM) were
transformed using VOOM in the limma R package. Surrogate variables to account for
sources of latent variation were calculated using the svaseq function from the R SVA
package. The limma R package was used to generate a linear model to perform
differential gene expression analysis using linear models (Law et al., 2014). Given the
small sample size of the experiment, we used the empirical Bayes procedure as
implemented in limma to adjust the linear model fit and to calculate P values. These P
values were adjusted for multiple comparisons using the Benjamini-Hochberg procedure.
Plots were generated in R or in Graphpad Prism9 software and GO enrichment was
performed using the GAGE R package.

Single cell RNA sequencing (scRNA-seq)
ScRNAseq data from E15.5 and P3 lungs were generated and processed as previously
described (Zepp et al., 2021). We performed non-linear dimension reduction using
Uniform Manifold Approximation and Projection (UMAP) to display the data using
Seurat.

ATAC sequencing (ATAC-seq)
ATAC-seq data from adult AT2 cells were generated and processed as previously
described (Zacharias et al., 2018). MACS2 was used to call peaks and Bedtools was
used to identify the intersection of gene promoter regions (-5kb, +600bp, Ensembl v67)
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with identified peaks, creating a Fastfa file of mouse genome reference mm9 promoter
peaks. Promoter peaks were scanned for the Klf5 motif using HOMER, and a list was
generated of genes associated with these peaks (Grant et al., 2011, Heinz et al., 2010).
GO enrichment was performed on this gene list using the GAGE R package.

Single cell ATAC sequencing (scATAC-seq)
ScATAC-seq data from P3 lungs were generated and processed as previously described
(Zepp et al., 2021). AT1 versus AT2 cell motif enrichment was performed in Signac
using the FindMarkers function and a logistic regression framework as the test
procedure.

Statistics
All image quantification results are reported as mean ± SEM and comparisons were
made using two-tailed paired (Figure 6.13 B, D, F, and H only) and unpaired Student’s ttests with p ≤ 0.05 considered significant. Survival curves were compared using the Logrank Mantel-Cox test. These statistical tests were conducted in Graphpad Prism9
software. Details concerning statistical analyses for bioinformatic data sets are described
above.
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Table 6.1: Key resources table
REAGENT or RESOURCE
Antibodies

SOURCE

IDENTIFIER

Mouse anti-Acta2

Millipore Sigma

Rat anti-Ager (Rage)

R&D Systems

Rabbit anti-Cleaved Caspase 3

Cell Signaling

Rabbit anti-Cleaved Caspase 3

R&D Systems

Rat anti-Lamp3 (DC-Lamp)

Novus

Goat anti-Emcn

R&D Systems

Mouse anti-Foxj1

Invitrogen

Chicken anti-GFP

Aves Labs

Goat anti-GFP

Abcam

Mouse anti-Hopx

Santa Cruz

Mouse anti-Ki67

BD Biosciences

Rabbit anti-Klf5

Abcam

Rabbit anti-Nkx2.1 (TTF1)

Abcam

Mouse anti-Nkx2.1 (TTF1)

Rabbit anti-Sftpc

Thermo Fisher
Scientific
Thermo Fisher
Scientific
Millipore Sigma

Rabbit anti-Yap

Cell Signaling

Mm-Car4 (RNA FISH probe)

Advanced Cell
Diagnostics
Advanced Cell
Diagnostics
Advanced Cell
Diagnostics

Cat#: A5228
RRID: AB_262054
Cat#: MAB1179
RRID: AB_2289349
Cat#: 9664s RRID:
AB_2070042
Cat#: MAB835
RRID: AB_2243951
Cat#: DDX0191P100 RRID:
AB_2827532
Cat#: AF4666 RRID:
AB_2100035
Cat#: 14-9965-80
RRID: AB_1548836
Cat#: GFP-1020
RRID:
AB_10000240
Cat#: ab6673
RRID: AB_305643
Cat#: sc-398703
RRID: AB_2687966
Cat#: 550609 RRID:
AB_393778
Cat#: ab137676
RRID: AB_2744553
Cat#: ab76013
RRID: AB_1310784
Cat#: MS-699-P1
RRID: AB_142087
Cat#: MA5-29780
RRID: AB_2785602
Cat#: AB3786 RRID:
AB_91588
Cat#: 4912 RRID:
RRID: AB_2218911
Cat#: 468421

Rabbit anti-Scgb1a1

Mm-Klf5-O1 (RNA FISH probe)
mm-Ntn1 (RNA FISH probe)
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Cat#: 1085261
Cat#: 407621

mm-Rgs16 (RNA FISH probe)
mm-Slc10a6 (RNA FISH probe)
mm-Tnfsf9 (RNA FISH probe)

Advanced Cell
Diagnostics
Advanced Cell
Diagnostics
Advanced Cell
Diagnostics

Cat#: 539201
Cat#: 550031
Cat#: 504021

Bacterial and Virus Strains
H1N1 Pr8

John Wherry Lab
(University of
Pennsylvania)
Chemicals, Peptides, and Recombinant Proteins
IL-1β
BioLegend
Small Airway Epithelial Cell Growth Lonza
Medium (SAGM) supplements
Small airway epithelial cell growth
Lonza
basal media (SABM)
Cholera toxin
Millipore Sigma
EGF
Peprotech
Y-27632
Millipore Sigma
Antibiotic-Antimycotic
Gibco
Fetal Bovine Serum
Denville
Matrigel
Corning
Slowfade Diamond Antifade
Invitrogen
Mountant
Critical Commercial Assays
PureLink RNA Mini Kit
Invitrogen
NEBNext Single Cell/Low Input
New England Biolabs
RNA Library Prep Kit for Illumina
Experimental Models: Organisms/Strains
Sftpc-CreERT2
PMCID:
PMC3223845
Hopx-CreERT2
Jackson Laboratories
Sox2-CreERT2
Jackson Laboratories
Klf5-flox
Jackson Laboratories
R26R-EYFP
Jackson Laboratories
Ai14(RCL-tdT)-D (R26R-tdTomato) Jackson Laboratories
Software and Algorithms
LungDamage program
PMID: 33979629
Graphpad Prism9

GraphPad

Illustrator

Adobe
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Cat#: 575102
Cat#: CC-4124
Cat#: CC-3119
Cat#: C9903
Cat#: AF-100-15
Cat#: Y0503
Cat#: 15240062
Cat#: FB5001
Cat#: 356231
Cat#: S36972
Cat#: 12183018A
Cat#: E6420

N/A
Cat#: 017606
Cat#: 017593
Cat#: 029787
Cat#: 007903
Cat#: 007914
https://github.com/W
ALIII/LungDamage
https://www.graphpa
d.com/scientificsoftware/prism/
https://www.adobe.c
om/products/illustrat
or.html

MATLAB

MathWorks

Fiji
R 4.0.5

PMID: 22743772
R Project

STAR

PMID: 23104886

HOMER

PMID: 20513432

Seurat 4.0.2

PMID: 31178118

Signac 1.5.0

PMID: 34725479

Other
Falcon Cell Culture Insert
UltraPure Low Melting Point
Agarose

Thermo Fisher
Scientific
Invitrogen
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https://www.mathwo
rks.com/products/m
atlab.html
https://fiji.sc/
https://www.rproject.org/
https://github.com/al
exdobin/STAR
http://homer.ucsd.ed
u/homer/index.html
https://satijalab.org/s
eurat/authors.html
https://satijalab.org/s
ignac/
Cat#: 08770
Cat#: 16520050
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Figure 6.1: Klf5 is required for AT1 cell lineage fidelity during prenatal
development
(A) Left image: single cell RNA sequencing data UMAP plot of the lung at E15.5. Right
image: the same plot showing the distribution and expression level of Klf5 (expression
represented as log2(UMI), n = 1). Data from (Zepp et al., 2021). (B) RNA sequencing
data time course of Klf5 expression in both AT1 and AT2 cells (VOOM adjusted
log2(CPM), n = 2 mice per group). Data from (Penkala et al., 2021). (C) Hematoxylin &
eosin (H&E) stains of control and Klf5-deficient lungs at E17.5 (left) and E18.5 (right).
(D) Quantification of mean septal wall thickness between control and Klf5-deficient (KO)
lungs at E18.5. (E) Immunohistochemistry (IHC) for AT1 cell lineage marker EYFP,
HOPX, and SFTPC at E18.5. Dashed white boxes demarcate zoomed in images. White
arrows mark AT2 cells and dashed yellow circles mark AT1 cells. (F) Quantification of
the percentage of lineage traced AT2 cells between control and Klf5-deficient lungs at
E18.5. (G) IHC for AT1 cell lineage marker EYFP and RNA fluorescence in situ
hybridization (FISH) for Klf5 in control and Klf5-deficient lungs at E18.5. Dashed yellow
boxes demarcate zoomed in images and dashed yellow circles mark AT1 cells. (H) IHC
for EMNC and RNA FISH for Car4 in control and Klf5-deficient lungs at E18.5. (I)
Quantification of the number of Car4+ cells per mm3 tissue in control and Klf5-deficient
lungs at E18.5. (J) Model diagram: AT1 precursors (red) require Klf5 to maintain their
commitment to the AT1 cell lineage. Loss of Klf5 leads to a loss of AT1 precursors into
the AT2 cell (green) lineage. All quantification data are represented as mean ± SEM.
Two-tailed t-tests: ns, not significant; *p ≤ 0.05, ***p ≤ 0.001; n = 4–5 mice per group
unless otherwise stated. All scale bars: 50μm. Control: HopxCreERT2;Klf5fl/+;R26EYFP.
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Figure 6.2: Klf5 is required for airway secretory cell but not AT2 cell development
(A) IHC for the AT2 cell lineage marker EYFP and RNA FISH for Klf5 in control and Klf5deficient lungs at E18.5. Dashed white boxes demarcate zoomed in images and dashed
white circles mark AT2 cells. Control: SftpcCreERT2;R26EYFP. (B) H&E stains of control and
Klf5-deficient lungs at E18.5. Control: SftpcCreERT2;Klf5fl/+;R26EYFP. (C) Quantification of
mean septal wall thickness between control and Klf5-deficient (KO) lungs at E18.5.
Control: SftpcCreERT2;Klf5fl/+;R26EYFP. (D) IHC for NKX2.1 and cleaved CASP3 in control
and Klf5-deficient lungs at E17.5. Control: HopxCreERT2;Klf5fl/+;R26EYFP. (E) IHC for the
AT1 cell lineage marker EYFP, KI67, and SFTPC in control and Klf5-deficient lungs at
E17.5. Control: HopxCreERT2;Klf5fl/+;R26EYFP. (F) Comparison of the percentage of all
proliferating AT2 cells from control mice versus the percentage of proliferating Klf5deficient AT1 precursor-derived AT2 cells. (G) IHC for the airway epithelial cell lineage
marker EYFP, KLF5, SFTPC, FOXJ1, and SCGB1A1 and RNA FISH for Klf5 in control
and Klf5-deficient lungs. Left panels are tile scanned and stitched images (scale bar:
200μm). Dashed white boxes mark zoomed in regions. Dashed white lines demarcate
the airways. Control: Sox2CreERT2;Klf5fl/+;R26EYFP. All quantification data are represented
as mean ± SEM. Two-tailed t-tests: ns, not significant; n = 3–5 mice per group. All scale
bars: 50μm unless otherwise stated.
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Figure 6.3: Klf5 is required for AT1 cell lineage fidelity during postnatal
development
(A) Left image: single cell RNA sequencing data UMAP plot of the lung at postnatal day
3 (P3). Right image: the same plot showing the distribution and expression level of Klf5
(expression represented as log2(UMI), n = 1). Data from (Zepp et al., 2021). (B) Top 10
most enriched transcription factor (TF) binding motifs in accessible promoters of genes
in AT1 cells versus AT2 cells at P3 from single cell ATAC sequencing data (n = 1). The
results are listed by p value to demonstrate which transcription factor binding cites were
most differentially enriched. Data from (Zepp et al., 2021). (C) IHC for AT1 cell lineage
marker EYFP and RNA FISH for Klf5 in control and Klf5-deficient lungs at P5. Dashed
yellow boxes demarcate zoomed in images and dashed yellow circles mark AT1 cells.
(D) IHC for AT1 cell lineage marker EYFP, HOPX, and SFTPC at P5 and P42. Dashed
white and yellow boxes demarcate zoomed in images. White arrows mark AT2 cells and
dashed yellow circles mark AT1 cells. (E) Top: experimental schematic detailing
tamoxifen (TAM) was delivered at P0 and mice were harvested at P5 or P42 for
analysis. Bottom: Quantification of the percentage of AT1 cell-derived AT2 cells at P5
and P42 in control and mutant lungs. (F) IHC for NKX2.1 and LAMP3 in control and
mutant lungs. (G) Quantification of the percentage of AT2 cells of the total alveolar
epithelium. (H) IHC for AT1 cell lineage marker EYFP, HOPX, and SFTPC at P5 in
control and Klf5-deficient lungs after hyperoxic lung injury. Dashed white boxes mark
zoomed in images and white arrows mark AT2 cells. (I) Left: experimental schematic
detailing TAM was delivered at P0 and mice were exposed to hyperoxic conditions until
they were harvested at P5 for analysis. Right: quantification of the percentage of AT1
cell-derived AT2 cells in control and mutant lungs after hyperoxic lung injury. (J) Model
diagram: immature AT1 cells (red) require Klf5 to maintain their commitment to the AT1
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cell lineage. Loss of Klf5 leads to a loss of immature AT1 cells into the AT2 cell (green)
lineage. All quantification data are represented as mean ± SEM. Two-tailed t-tests: ns,
not significant; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001; n = 3–5 mice per group
unless

otherwise

stated.

All

scale

bars:

50μm.

Control

HopxCreERT2;Klf5fl/+;R26EYFP, (D-E(P42), F-I): HopxCreERT2;R26EYFP.
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(C,

D-E(P5)):
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Figure 6.4: Postnatal loss of Klf5 does not impact lung morphology, cell death,
AT2 cell proliferation, or YAP localization
(A) H&E stains of control and Klf5-deficient lungs at P42 (scale bar: 200μm). Control:
HopxCreERT2;R26EYFP. (B) IHC for the AT1 cell lineage marker EYFP and cleaved CASP3
in control and Klf5-deficient lungs at P5. Control: HopxCreERT2;Klf5fl/+;R26EYFP. (C) IHC for
the AT2 cell lineage marker EYFP, cleaved CASP3, KI67, and SFTPC in control and
Klf5-deficient lungs at P5. Dashed white boxes mark zoomed in images and white
arrows mark proliferating AT2 cells. Control: SftpcCreERT2;R26EYFP. (D) Quantification of
the percentage of AT1 cell-derived AT2 cells in control and Klf5-deficient lungs at P5.
Control: SftpcCreERT2;R26EYFP. (E) IHC for the AT1 cell lineage marker EYFP, YAP, and
LAMP3 in control and Klf5-deficient lungs at P5. Dashed white boxes mark zoomed in
images of AT2 cells and white arrows mark AT2 cells. Dashed yellow boxes mark
zoomed in images of AT1 cells and dashed yellow circles mark AT1 cells. Control:
HopxCreERT2;Klf5fl/+;R26EYFP. All quantification data are represented as mean ± SEM. Twotailed t-tests: ns, not significant; n = 4 mice per group. All scale bars: 50μm unless
otherwise stated.
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Figure 6.5: Klf5 is dispensable for adult AT1 cell homeostasis
(A) IHC for the AT1 cell lineage marker EYFP, HOPX, and SFTPC 1 month post
tamoxifen induction. Dashed yellow boxes demarcate zoomed in images of AT1 cells.
Dashed yellow circles mark AT1 cells. Control: HopxCreERT2;R26EYFP. Scale bar: 50μm.
(B) Quantification of the percentage of AT1 cell-derived AT2 cells in control and Klf5deficient lungs. Control: HopxCreERT2;R26EYFP. Quantification data are represented as
mean ± SEM. Two-tailed t-test: ns, not significant; n = 3 mice per group.
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Figure 6.6: Klf5 represses AT2 cell proliferation and regulates AT2-AT1 cell
differentiation after infectious lung injury
(A) IHC for AT2 cell lineage marker EYFP, HOPX, and SFTPC at 1, 6, and 12 months
post tamoxifen induction. Dashed boxes demarcate zoomed in images of AT2 cells
(white) or AT1 cells (yellow). White arrows mark AT2 cells and dashed yellow circles
mark AT1 cells. (B) Quantification of the percentage of lineage traced AT1 cells at 1, 6,
and 12 months post tamoxifen induction. (C) Experimental schematic showing control
and Klf5-deficient mice were treated with tamoxifen, infected with influenza 2 weeks
later, and their lungs were harvested 14 days post influenza infection or days post injury
(dpi). (D) Top: tile scanned and stitched image of H&E stain demonstrating the
heterogenous nature of influenza injury at 14 dpi with arrows marking different injury
zones (red: severe, green: damaged, blue: normal; scale bar: 500μm). Bottom: clustered
injury zone map produced from the above H&E image. (E) Tile scanned and stitched
image of IHC for AT2 cell lineage marker EYFP of the equivalent injured area in panel D
from the adjacent slide. Boxes mark different injury zones (red: severe, green: damaged,
blue: normal; scale bar: 500μm). (F) IHC for AT2 cell lineage marker EYFP and RNA
FISH for Klf5 in control mice in severe, damaged, and normal zones corresponding to
the demarcated areas in panels D and E. Dashed white boxes indicated zoomed in
areas and white arrows mark lineage traced AT2 cells. (G) IHC for AT2 cell lineage
marker EYFP and RNA FISH for Klf5 in severe, damaged, and normal zones in Klf5deficient mice at 14 dpi. Dashed white boxes indicated zoomed in areas and white
arrows mark lineage traced AT2 cells. (H) Left: IHC for AT2 cell lineage marker EYFP,
KI67, and SFTPC in severe zones of control and mutant lungs at 14 dpi. Dashed white
boxes demarcate zoomed in areas and white arrows mark proliferating AT2 cells. Right:
IHC for the AT2 cell lineage marker EYFP, HOPX, and SFTPC in damaged zones of
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control and mutant lungs at 14 dpi. Dashed yellow boxes demarcate zoomed in areas
and yellow arrows and dashed yellow circles mark AT2 cell-derived AT1 cells. (I)
Quantification of AT2 cell proliferation in severe zones of control and mutant lungs at 14
dpi. (J) Quantification of AT2-AT1 cell differentiation in damaged zones of control and
mutant lungs at 14 dpi. (K) Summary diagram demonstrating that Klf5 represses AT2
cell proliferation in severe zones and regulates AT2-AT1 cell differentiation in damaged
zones after influenza (AT2 cells: green, AT1 cells: red, KRT5+ cells: blue). All
quantification data are represented as mean ± SEM. Two-tailed t-tests: ns, not
significant; *p ≤ 0.05; n = 3–5 mice per group. All scale bars: 50μm unless otherwise
stated. Control: SftpcCreERT2;R26EYFP.
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Figure 6.7: Klf5 is dispensable for adult AT2 cell proliferation in damaged zones
after influenza
(A) IHC for the AT2 cell lineage marker EYFP, KI67, and SFTPC in damaged zones of
control and Klf5-deficient mice at 14 dpi. Dashed white boxes demarcate zoomed in
areas and white arrows mark proliferating lineage traced AT2 cells. Control:
SftpcCreERT2;Klf5fl/+;R26EYFP. Scale bar: 50μm. (B) Quantification of the percentage of
KI67+ lineage labelled AT2 cells in control and Klf5-deficient lungs in damaged zones at
14 dpi. Control: SftpcCreERT2;Klf5fl/+;R26EYFP. Quantification data are represented as mean
± SEM. Two-tailed t-test: ns, not significant; n = 3 mice per group.
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Figure 6.8: Klf5 represses AT2 cell proliferation and regulates AT2-AT1 cell
differentiation after non-infectious lung injury
(A) Experimental schematic showing control and Klf5-deficient mice were treated with
tamoxifen, exposed to hyperoxic conditions for 3 days, and their lungs were harvested 7
days after removal from hyperoxic conditions or 7 days post injury (dpi). (B) Top: tile
scanned and stitched image of H&E stain from a representative control mouse at 7 dpi.
Boxes mark different injury zones (red: severe, green: damaged, blue: normal; scale bar:
1000μm). Bottom: clustered injury zone map produced from the above H&E image. (C)
Left: zoomed in images from the demarcated boxes in panel B. Dashed white boxes
mark the location of the images to the right. Right: H&E stain and IHC from the slide
adjacent to the H&E stained slide for ATCA2, AGER, and SFTPC in severe, damaged,
and normal zones. (D) Left: IHC for AT2 cell lineage marker EYFP, KI67, and SFTPC in
damaged and normal zones of control mice at 7 dpi. Dashed white boxes demarcate
zoomed in areas and white arrows mark proliferating AT2 cells. Right: IHC for AT2 cell
lineage marker EYFP, HOPX, and SFTPC in damaged and normal zones of control mice
at 7 dpi. Dashed yellow boxes demarcate zoomed in areas and dashed yellow circles
mark AT2 cell-derived AT1 cells. (E) IHC for AT2 cell lineage marker EYFP and RNA
FISH for Klf5 in damaged and normal zones in control and mutant lungs at 7 dpi.
Dashed white boxes indicated zoomed in areas and white arrows mark lineage traced
AT2 cells (scale bars: 25μm). (F) Left: IHC for AT2 cell lineage marker EYFP, KI67, and
SFTPC in damaged zones of control and mutant lungs at 7 dpi. Dashed white boxes
demarcate zoomed in areas and white arrows mark proliferating AT2 cells. Right: IHC for
AT2 cell lineage marker EYFP, HOPX, and SFTPC in damaged zones of control and
mutant lungs at 7 dpi. Dashed yellow boxes demarcate zoomed in areas and yellow
arrows and dashed yellow circles mark AT2 cell-derived AT1 cells. (G) Quantification of
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AT2 cell proliferation in damaged zones of control and mutant lungs at 7 dpi. (H)
Quantification of AT2-AT1 cell differentiation in damaged zones of control and mutant
lungs at 7 dpi. (I) Summary diagram demonstrating that Klf5 represses proliferation and
regulates differentiation in damaged zones after hyperoxic acute lung injury (AT2 cells:
green, AT1 cells: red, ACTA2+ cells: blue). All quantification data are represented as
mean ± SEM. Two-tailed t-tests: ns, not significant; *p ≤ 0.05; n = 3 mice per group. All
scale bars, 50μm unless otherwise stated. Control (E): SftpcCreERT2;R26EYFP, (F-H):
SftpcCreERT2;Klf5fl/+;R26EYFP.
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Figure 6.9: Klf5 is not required for adult AT1-AT2 cell reprogramming and Klf5deficient AT2 cells differentiate into AT1 cells as injury resolves
(A) Experimental schematic shown for HALI. IHC for the AT1 cell lineage marker EYFP,
HOPX, and SFTPC at 7 dpi. Dashed white boxes demarcate zoomed in images of AT1
cell-derived AT2 cells (marked by white arrows). Control: HopxCreERT2;R26EYFP. (B)
Quantification of the percentage of AT1 cell-derived AT2 cells in control and Klf5deficient lungs at 7 dpi in damaged zones. Control: HopxCreERT2;R26EYFP. (C)
Experimental schematic shown for HALI. Tile scanned and stitched images of H&E
stains of control and Klf5-deficient lungs at 28 dpi (scale bar: 1000μm). The n number
represents number of animals with visible legions over total number of animals in the
experiment. Control: SftpcCreERT2;Klf5fl/+;R26EYFP. (D) IHC for the AT2 cell lineage marker
EYFP, HOPX, and SFTPC at 28 dpi. Dashed white boxes demarcate zoomed in images.
Dashed
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circles

mark
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cell-derived

AT1

cells.

Control:

SftpcCreERT2;Klf5fl/+;R26EYFP. (E) Quantification of the percentage of AT2 cell-derived AT1
cells in control and Klf5-deficient lungs at 28 dpi. Control: SftpcCreERT2;Klf5fl/+;R26EYFP. All
quantification data are represented as mean ± SEM. Two-tailed t-tests: ns, not
significant; n = 3-12 mice per group. All scale bars: 50μm unless otherwise stated.
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Figure 6.10: Klf5 mediates the AT2 cell response to inflammatory signaling.
(A) Experimental schematic showing control and Klf5-deficient mice were treated with
tamoxifen, were exposed to hyperoxic conditions for 3 days and lungs were harvested 3
days after removal from hyperoxic conditions or 3 dpi. (B) Top: tile scanned and stitched
image of H&E stain from a representative control mouse at 3 dpi. Colored boxes mark
different injury zones (red: severe, green: damaged, blue: normal; scale bar: 1000μm).
Dashed black box marks zoomed in equivalent area shown in panel D. Bottom: clustered
injury zone map produced from the above H&E image. (C) Zoomed in images from the
demarcated colored boxes in panel B. Red arrow marks an early fibroblastic focus and
the black arrow marks a tertiary lymphoid structure (scale bar: 50μm). (D) Left: tile
scanned and stitched image of IHC for the AT2 cell lineage marker EYFP from the
adjacent slide of the equivalent injured area in panel B demarcated by the dashed black
box. Dashed white box indicates the zoomed in area for the right images (scale bar:
250μm). Right (top): IHC for AT2 cell lineage marker EYFP, KI67, and SFTPC. Dashed
white box indicates the zoomed in area and white arrows mark proliferating AT2 cells.
Right (bottom): IHC for AT2 cell lineage marker EYFP, HOPX, and SFTPC. Dashed
yellow box indicates the zoomed in area and dashed white circle indicates a putative
early AT1 cell (scale bar: 50μm). (E) Survival curve of WT: SftpcCreERT2;R26REYFP and
KO: SftpcCreERT2;Klf5fl/fl;R26REYFP mice for 3 days following removal from hyperoxia (Dpi:
days post injury, WT: n = 9, KO: n = 13). Log-rank Mantel-Cox test, p = 0.0217. (F)
ATAC sequencing data from adult AT2 cells during homeostasis showing gene ontology
(GO) analysis of genes in areas of open chromatin containing a Klf5 binding motif in their
promoter. Cytokine binding and defense response are highlighted in red. Data from
(Zacharias et al., 2018). (G) Volcano plot generated from RNA sequencing data from
control and Klf5-deficient AT2 cells at 3 dpi. Red dots represent statistically significant
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differentially expressed genes (adjusted p value < 0.05) and grey dots are not
statistically significantly different between control and mutant conditions (control
(SftpcCreERT2;R26EYFP): n = 3, KO: n = 6). (H) Hallmark database gene set enrichment
analysis of all differentially expressed genes between control and Klf5-deficient mice at 3
dpi (pathways with FDR < 0.1 displayed).
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Figure 6.11: Transcriptional changes in Klf5-deficient AT2 cells after HALI at 3 dpi
(A-B) RNA sequencing data from control (SftpcCreERT2;R26EYFP) and Klf5-deficient AT2
cells after HALI at 3 dpi. AT1 cell marker genes are shown in (A) and AT2 cell marker
genes are shown in (B) (VOOM adjusted log2(CPM), n = 3-6 mice per group). (C-F) RNA
sequencing data from control (WT, SftpcCreERT2;R26EYFP) and Klf5-deficient AT2 cells
after HALI at 3 dpi. Heatmaps of top genes from gene set enrichment analysis of
Hallmark database pathways (scale is z score, n = 3-6 mice per group). Statistically
significant genes are highlighted in red.
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(A) Representative flow cytometry plots of AT2 cell isolation and experimental schematic
of organoid assay. (B) Representative whole well images of organoids (marked by white
arrows) using tdTomato lineage marker expression from control or Klf5-deficient AT2
cells (scale bar: 1000μm). (C) Quantification of fold change in organoid size over time.
Organoid size was normalized to the size on day 10 of culture. Black box outlines day 21
of culture assessed in panels D and E. Each dot represents the mean of 4 independent
experiments. (D) Quantification of fold change in organoid size at day 21 of culture. (E)
Quantification of colony forming efficiency at day 21 of culture. (F) IHC for KLF5,
NKX2.1, LAMP3, AGER, and HOPX. Yellow boxes indicate the zoomed in areas and
yellow circles mark AT1 cells. (G) Quantification of the percentage of AT1 cells of total
NKX2.1+ cells at 21 days of culture in control and mutant conditions. (H) IL-1β treatment
condition. Representative whole well images of organoids (marked by white arrows)
derived from control or mutant AT2 cells (scale bar: 1000μm) and IHC for NKX2.1,
AGER, and HOPX. Yellow boxes indicate the zoomed in areas and yellow circles mark
AT1 cells. (I) Quantification of fold change in organoid size. Organoid size was
normalized to the size on day 10 of culture. Each dot represents the mean of 4
independent experiments. (J) Quantification of the percentage of AT1 cells of total
NKX2.1+ cells at 21 days of culture in control and mutant conditions. (K) Summary
diagram showing that Klf5 inhibits inflammatory signaling to reduce proliferation and AT2
cell lineage commitment to regulate AT2-AT1 cell differentiation. All quantification data
are represented as mean ± SEM. Two-tailed t-tests: ns, not significant; *p ≤ 0.05, **p ≤
0.01; n = 4 mice per group. All scale bars: 50μm. Control: SftpcCreERT2;R26EYFP.
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Figure 6.13: Assessment of enriched transcripts, identified in Klf5-deficient AT2
cells in early HALI, in organoids
(A-G) RNA FISH for Ntn1 (A-B), Rgs16 (C-D), Slc10a6 (E-F), and Tnfsf9 (G-H) in control
and Klf5-deficient AT2 cell-derived organoids at day 21 of culture. Dashed white boxes
demarcate zoomed in images. Control: SftpcCreERT2;R26EYFP. All quantification data are
represented as mean number of transcripts (dots) per cell. Two-tailed paired t-tests: ns,
not significant; n = 4 mice per group. All scale bars: 50μm.
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CHAPTER 7: CONCLUSIONS AND FUTURE DIRECTIONS
This chapter is partially adapted from work published in Trends in Molecular Medicine
and Cell Stem Cell (Penkala et al., 2021, Liberti and Morrisey, 2021).

7.1 Summary
The sophisticated structural organization of the lung belies its remarkable regenerative
capacity. From emergency barrier repair to restoration of functional alveoli, the lung
possesses multiple mechanisms to prevent catastrophic compromise of its essential
function: gas exchange. A major driver of lung regeneration is alveolar epithelial cell
plasticity. Thus, to determine how to enhance lung regeneration, it is necessary to
identify the extent of this plasticity and the determinants of alveolar epithelial cell fate
choice. In this dissertation, I investigate alveolar epithelial cell plasticity across both lung
development and multiple regenerative contexts. Additionally, I explore the epigenetic,
transcriptomic, and intercellular signaling mechanisms reinforcing cell identity or
promoting plasticity to solidify or weaken lineage commitment. Together, this work
illustrates differences in alveolar epithelial cell plasticity across distinct age and injury
contexts and identifies essential regulators of epithelial cell fate choice and the
consequences of their disruption. These data highlight how insight from studies of
developmental specification and lineage determination drives the discovery of key
mediators of lung regeneration.

In Chapter 2, I identified Dnmt1 as an essential regulator of lung development. Using in
vivo genetic mouse models, ex vivo live imaging, and transcriptomic analysis, I showed
that loss of Dnmt1 disrupts proximal-distal patterning and polarity, resulting in impaired
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branching morphogenesis and, ultimately, hypoplastic lungs. Further, I demonstrated
that Dnmt1 restricts AT2 cell specification and continues to maintain the proximal-distal
boundary even after the majority of alveolar epithelial cells have been specified. This
work suggests that lung development relies on specific epigenetic cues that restrict
precocious cell fate specification to promote the proper ratio and compartmentalization
of proximal and distal progenitors from the multipotent early lung endoderm.

In Chapter 3, I described the generation of an automated imaging tool for the
segmentation of heterogeneously damaged lung tissue. I demonstrated the utility of this
tool on mouse influenza injured tissue to reproducibly identify three injury zones with
distinct epithelial, endothelial, and mesenchymal behaviors. I then showed similar results
from the application of this tool to human influenza, idiopathic pulmonary fibrosis, and
COVID-19 patient tissue. This open source method of tissue comparison enables the
unbiased assessment of cell behavior across various injury contexts, including different
diseases, to improve our understanding of the signals driving these behaviors during
lung regeneration.

In Chapter 4, I used in vivo mouse genetic and injury models as well as ex vivo organoid
assays to determine how AT2 cells balance the decision to divide versus differentiate. I
showed that Fgfr2 is required to maintain AT2 cell fate during development but is
dispensable for adult AT2 cell homeostasis. Using my automated lung damage
assessment approach described in Chapter 3, I determined that AT2 cell fate choice is
made in a spatially restricted manner during lung regeneration and that this choice is, in
part, controlled by Fgfr2. Moreover, treating Fgfr2-deficient and control organoids with
inflammatory cytokines, I showed that multiple parallel inputs regulate AT2 cell
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proliferation. Finally, blockade of AT2 cell division through inactivation of Ect2 revealed
that AT2 cell differentiation is a distinct choice regulated by niche signaling rather than
the deterministic result of the inability to divide. This work illustrates the role of Fgfr2 in
both promoting AT2 cell proliferation and restricting AT2 cell fate. Additionally, it
highlights that AT2 cell identity is actively maintained during lung regeneration.

In Chapter 5, I explored neonatal and adult AT1 cell plasticity using in vivo mouse
genetic and injury models. Challenging the dogma in the field, I observed AT1-AT2 cell
reprogramming rather than AT2-AT1 cell differentiation after neonatal injury. AT1-AT2
cell reprogramming was also observed after adult injury, but it appeared to be less
robust and context dependent. For instance, acute loss of AT2 cells was not sufficient to
stimulate AT1 cell plasticity, while hyperoxia-induced acute lung injury (HALI), and to a
lesser degree influenza infection, resulted in AT1-AT2 cell reprogramming. This
paradigm shift in our understanding of alveolar epithelial cell plasticity in neonates and
adults should stimulate future work to further investigate the mechanisms maintaining
alveolar epithelial cell identity and how these can be overcome to promote lung
regeneration.

Finally, in Chapter 6, I used transcriptomic and epigenetic profiling, in vivo mouse
genetic and injury models, and ex vivo organoid assays to determine the role of Klf5 in
AT1 cell lineage commitment in both lung development and regeneration. I showed that
Klf5 expression is restricted to epithelial cells in the lung throughout life and that it is
enriched in AT1 cells during development. I demonstrated that Klf5 is required to
maintain AT1 cell lineage fidelity during lung development but is dispensable for adult
AT1 cell homeostasis and AT1-AT2 cell reprogramming after injury. While Klf5 is not
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required for AT2 cell development, it represses AT2 cell proliferation and promotes AT2AT1 cell differentiation in a spatially restricted manner after both infectious and noninfectious injuries. Klf5 also appeared to repress AT2 cell receptivity to inflammatory
signaling. Together, these data show that Klf5 regulates AT1 cell lineage commitment
during lung development and adult regeneration. These results support the emerging
paradigm that alveolar epithelial cell identity is actively maintained throughout life and
during lung regeneration.

This work describes several essential mediators of alveolar epithelial cell fate choice and
provides key insight into the extent of alveolar epithelial cell plasticity during
development and adult regeneration. However, many questions remain, particularly in
relation to the role of the homeostatic niche, mechanobiology, and inflammatory
signaling in cell fate maintenance and lineage determination. In this chapter, I will
discuss opportunities for future exploration of the regulators of alveolar epithelial cell
identity and areas of tool development that could improve our ability to answer these
outstanding questions.

7.2 Lung epithelial cell identity: barriers to plasticity
In Chapter 2, I showed that there is an epigenetic barrier maintaining the proximal-distal
boundary during lung development. It remains unclear how this barrier is established.
However, establishment of the proximal-distal axis is not only essential for proper
branching morphogenesis, but it also ultimately leads to physical separation of the
proximal airways from the distal alveolar compartment, each with quite different
organizational and niche signaling requirements. While loss of some signaling factors,
like Ctnnb1 or Fgfr2, leads to lung agenesis, loss of the major maintenance DNA
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methylation factor, Dnmt1, leads to precocious specification of distal alveolar epithelial,
specifically AT2, cell fate (Mori et al., 2019, De Moerlooze et al., 2000, Sekine et al.,
1999, Harris-Johnson et al., 2009, Goss et al., 2009). The most likely explanation for this
involves methylation mediated suppression of signaling pathways, like Wnt and Fgf,
which are expressed at high levels at this time and are known to drive and maintain AT2
cell fate (also see Chapter 4) (Frank et al., 2016, Li et al., 2018, Jacob et al., 2017).
Thus, upon loss of Dnmt1, these signals could bias lung progenitor cell fate toward the
AT2 cell lineage.

The idea that Dnmt1 suppresses signaling driving AT2 cell fate calls attention to the
strength of niche signals to direct fate choice, especially in cells within a more “plastic”
state, such as uncommitted progenitor cells. As these niche signals differ in the adult
airway versus alveolar compartments, it is curious that some cells are able to transit
compartments and maintain their fate while others are not. For example, as mentioned in
Chapter 1, bronchoalveolar stem cells (BASCs) exist at the mouse bronchioalveolar duct
junction (BADJ) where the airways meet the alveolar compartment, and they are capable
of entering the alveolar compartment after injury and contributing to both the AT1 and
AT2 cell lineages (Kim et al., 2005). This finding suggests that the alveolar niche
promotes alveolar epithelial cell fate commitment. In contrast, p63+ progenitor cells from
the airway are capable of transiting into the alveolar compartment after injury, largely
without contributing to the AT1 or AT2 cell lineages (Fernanda de Mello Costa et al.,
2020). Thus, while niche signals contribute to cell fate choice, there are likely other cell
intrinsic barriers to lung epithelial lineage plasticity. Indeed, it remains unclear whether
physical disruption of the BADJ, a chemoattractant signal, or some alternative
mechanism drives airway epithelial cell migration into the alveolar space and why some
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injuries, like influenza, result in robust airway infiltration while others, like HALI, do not.
Future work investigating the role of Dnmt1 in the adult airway could provide insight into
the epigenetic regulation of adult airway epithelial cell identity and the physical versus
molecular boundaries between the airway and alveolar compartments. Functionally
inactivating

Dnmt1
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and
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cells

using

Sox2CreERT2;R26REYFP;Dnmt1fl/fl mice would address whether Dnmt1 is required for
maintaining the proximal-distal boundary in adult mice. Analysis of genetic programs
suppressed by Dnmt1 mediated DNA methylation would allow further dissection of the
cell intrinsic epigenetic and transcriptomic barriers to lineage plasticity in mice.
Moreover, using these tools in combination with influenza and HALI would provide
insight into whether physical, epigenetic, or a combination of mechanisms maintain the
integrity of the proximal versus distal compartments.

The stem/progenitor cell function of both basal and AT2 cells is consistent between
humans and mice. Functional regeneration of the proximal airways is driven by basal
cells, which replenish the luminal epithelial lineages lining the airway tree (Davis and
Wypych, 2021). Similarly, distal lung regeneration is largely driven by AT2 cell
proliferation and differentiation into AT1 cells (Barkauskas et al., 2013). However, in
humans, the BADJ region is replaced by the respiratory airway region, containing
respiratory bronchioles, where airway and alveolar epithelial cells occupy the same
niche (Basil and Morrisey, 2021). In mice, the basal cell and alveolar niches are
separated by a vast branched network of airways where basal cells occupy the trachea
and main stem bronchi and AT2 cells are found in the alveoli, the most distal region of
the lung following the termination of the smallest airways. In contrast, human basal cells
can be found as distal as the respiratory airways where they are interdigitated with AT2
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cells (Basil and Morrisey, 2021, Barkauskas et al., 2013, Evans et al., 2001, Rock et al.,
2010). Recent work suggests some plasticity between human AT2 and basal cells
(Kathiriya et al., 2022). Yet, the coexistence of these cells within human respiratory
airways at homeostasis suggests either that human basal and AT2 cells can maintain
their cell identities in different niches or that a specialized niche exists that allows them
both to maintain their respective identities. Understanding the signals that restrict basal
and AT2 cell identity would inform our understanding of how niche alterations impact
their regenerative responses.

7.3 The role of mechanotransduction in alveolar epithelial cell fate
In Chapters 5 and 6, I show that AT1 cells are capable of reprogramming into AT2 cells
after injury and that this reprogramming can be induced during development by
functionally inactivating Klf5. However, acute loss of AT2 cells in adult mice is not
sufficient to drive AT1-AT2 cell reprogramming, suggesting that physical perturbation or
active remodeling of the niche may play a role in AT1 cell plasticity and lineage
commitment. Some of the work presented in Chapter 5 also appears in a recently
published study showing that AT1 cell fate is actively maintained by Yap and Taz and
that loss of these factors is sufficient to induce AT1 cell plasticity throughout life (Penkala
et al., 2021). While Hippo signaling is known to play a role in early lung development, its
role in postnatal lung maturation or adult AT1 cell homeostasis had not been described
(Yang et al., 2016, Mahoney et al., 2014, Nantie et al., 2018). AT1 cells have an
expansive cell body and spread across multiple alveoli to contact various cell types
during development (Yang et al., 2016). Additionally, a recent study investigated the role
of fetal breathing movements on prenatal alveolar epithelial development, demonstrating
that the pressure of the fluid in the developing airspaces is related to the differentiation
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of AT1 and AT2 cells (Li et al., 2018). Specifically, manipulation of the pressure in the
developing alveoli resulted in relative differences in the ratio of AT1 and AT2 cells during
late prenatal development. Increased fluid pressure promoted differentiation of AT1
cells, while lower fluid pressure resulted in the differentiation of more AT2 cells (Li et al.,
2018). Thus, there is strong precedent for a role for mechanotransduction, and by
extension Hippo signaling, in AT1 cell identity maintenance (Halder et al., 2012). It is
possible that the higher pressures exerted on the developing epithelium promote YAP
nuclear shuttling through increased cellular strain, reinforcing the development of AT1
cells and overcoming cellular specification events occurring earlier during development.
Moreover, a recent study suggests that mechanical tension is related to AT2-AT1 cell
differentiation (Wu et al., 2020). Ultimately, future work on alveolar mechanotransduction
will be required to determine if changes in forces exerted on cells corresponds to
changes in differentiation or fate in mature cells. Advancements in matrix and
mechanobiology to more closely mimic the native lung environment in vitro should
enhance our ability to investigate the role of the physical niche in regulating cell identity
and behavior (Nossa et al., 2021, Kaluthantrige Don and Huch, 2021, Dye et al., 2020,
De Santis et al., 2021, Tortorella et al., 2021, Kumar et al., 2022).

Loss of YAP/TAZ is sufficient to drive efficient reprogramming of AT1 into AT2 cells in
the absence of injury (Penkala et al., 2021). Previous work has shown that critical
transcriptional regulators such as Nkx2.1 and associated lncRNAs including NANCI
maintain lung epithelial cell identity (Herriges et al., 2017, Little et al., 2019). Moreover,
Chapter 2 shows that epigenetic factors maintain proximal versus distal epithelial cell
fate during development. However, little is known about what preserves the identities of
distinct lung lineages, including AT1 and AT2 cells. The necessity of Yap/Taz in
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restricting AT1 cell identity adds to our knowledge of the key mechanisms maintaining
the AT1 versus AT2 lineage. Future work focused on the downstream signaling
mechanisms regulated by Yap/Taz would improve our understanding of the molecular
barriers between these lineages.

As discussed in Chapters 4 and 6, active maintenance of cell identity is essential for
balancing regenerative responses. Moreover, AT2 and AT1 cells serve critical roles for
lung function aside from their contributions to regeneration. It is possible that these cells
serve additional functions to coordinate the regenerative responses of other cells. For
example, a recent study highlights a role of AT1 cells as signaling hubs, coordinating
early postnatal development (Zepp et al., 2021). Future studies of alternative AT2 and
AT1 responses to injury beyond plasticity would add to our knowledge of the complex
intercellular crosstalk during lung regeneration.

7.4 Modeling intercellular crosstalk in the regenerative niche
As discussed in Chapters 4 and 6, inflammatory signaling after acute lung injury
influences AT2 cell-mediated lung regeneration. The importance of monocyte and
macrophage produced cytokines in the stimulation of AT2 cell proliferation was
demonstrated both in vivo and through co-culturing AT2 cells with macrophages in a
mouse organoid assay (Lechner et al., 2017, Choi et al., 2020). Building on these data, a
recent study employed mouse alveolar organoids to screen for the ability of various
inflammatory cytokines to promote AT2 cell proliferation and identified several proproliferative cytokines, including IL-1β and TNFα (Katsura et al., 2019). However, while
inflammatory signaling may enhance AT2 cell proliferation, inflammatory signaling,
driven by IL-1β in particular, can also impede AT2-AT1 cell differentiation, which may
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contribute to chronic lung disease (Choi et al., 2020). These data demonstrate the
critical importance and temporal role of the inflammatory context during lung injury in
regulating AT2 cell-mediated alveolar regeneration (Worrell and MacLeod, 2021). The
production of pro-regenerative cytokines by immune cells, coupled with mesenchymalderived paracrine signals such as Fgf7 and IL-6, highlights the complex intercellular
crosstalk required for proper alveolar regeneration after acute injury (also see Chapter 4)
(Paris et al., 2020, Zepp et al., 2017). Organoids provide a versatile, reductionist
platform to both screen and validate the roles of various signaling pathways on AT2 cell
behavior, but this assay extends to other lung epithelial cells as well. For example,
organoids have been employed to demonstrate the role of endothelial-epithelial cell
crosstalk in regulating BASC differentiation (Lee et al., 2014). However, just as these
assays can identify the function of specific exogenous factors or cellular interactions that
may be masked in vivo, further assay development, including the combinatorial addition
of different exogenous factors and cell types, is needed to more accurately model the in
vivo injury landscape.

While co-culture of AT2 cells with other cell types can provide important insight into
alveolar paracrine signaling, co-culture can also obscure the primary in vivo response of
AT2 cells to stimulation with exogenous factors. Thus, there is a need to develop a wellcharacterized, chemically defined culturing system to grow AT2 cells in the absence of
support cells. Such a feeder-free culture would also help to promote reproducibility
across experiments and experimental platforms. A more defined culturing system may
also provide insight into why AT2-AT1 cell differentiation is common in mouse alveolar
organoid culture but does not readily occur in human alveolar organoids, although some
aspects of AT2-AT1 cell differentiation do occur (Zacharias et al., 2018). This limitation
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of the human organoid assay will require further optimization of culture conditions and
may reflect fundamental differences between the mouse and human alveolar niche.
Indeed, mouse AT2 cells are restricted to the distal alveolar space, whereas human AT2
cells interweave with poorly characterized distal airway cells in terminal respiratory
airways (ten Have-Opbroek et al., 1991, Barkauskas et al., 2013). Recently, several
groups have developed feeder-free culture conditions for both mouse and human AT2
cells (Table 1.1) (Katsura et al., 2020, Weiner et al., 2019, Shiraishi et al., 2019a,
Shiraishi et al., 2019b, Youk et al., 2020, Ebisudani et al., 2021). In these conditions,
human AT2-AT1 cell differentiation requires addition of serum or 2D culture conditions
(Katsura et al., 2020, Youk et al., 2020). An important next step will be to improve and
optimize such culturing conditions, particularly towards a more defined culture matrix
and away from Matrigel, given its variable composition. Construction of defined, tunable
matrices may hold the key to understanding the signals required for human AT2-AT1 cell
differentiation. As culture conditions are refined, standardization would enable the
precise dissection of causal relationships in organoid models in a reproducible manner.

To maximize the tunability of the system, current alveolar organoid culture medias
contain few added cytokines or growth factors. While optimization of this culture media
could improve the efficiency of the model, the simplicity of the media allows investigators
to test the contributions of other important signaling pathways in alveolar organoid
growth and differentiation. For example, activation of Wnt signaling in mouse and human
organoids promotes AT2 cell growth whereas Wnt inhibition promotes AT1 cell
differentiation (Frank et al., 2016, Zacharias et al., 2018). These results correlate with in
vivo data suggesting Wnt signaling drives AT2 cell identity and promotes AT2 cell
proliferation (Zacharias et al., 2018, Frank et al., 2016, Nabhan et al., 2018, Xi et al.,
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2017). Fgf signaling has also been shown to promote mouse and human alveolar
organoid growth, due to high Fgfr2 expression in AT2 cells (also see Chapter 4) (Zepp et
al., 2017, Zacharias et al., 2018). Interestingly, there is a report of mouse AT1 cells
generating organoids on their own (Jain et al., 2015). This organoid formation is
enhanced by inhibiting Tgf-β signaling. Many recent studies have included Tgf-β
signaling inhibitors in human and mouse alveolar organoid assays to increase their
viability and growth (also see Chapter 4) (Katsura et al., 2019, Katsura et al., 2020).
Further study is needed to understand how inhibition of Tgf-β signaling affects alveolar
organoid growth and differentiation and whether it acts as part of a signaling network
with other pathways, including Fgf and Wnt signaling. Cell type specific inactivation of
Tgfbr signaling in alveolar epithelial cells in vivo, ex vivo, and in combination with other
cell types, would inform our understanding of its role in regulating AT2 cell fate.

7.5 Dissecting cellular heterogeneity in the lung
The use of single cell transcriptomics to investigate cellular heterogeneity has greatly
benefitted the field by incentivizing a systems biology approach to contextualize
experimental findings. Employing single cell RNA sequencing in combination with in vivo
and organoid models, several groups have analyzed epithelial progenitor cells in mouse
and human lungs during the process of regeneration. The identification of a “transitional”
cell state in the alveolar epithelium has allowed the investigation of what signals drive
the dramatic changes epithelial cells undergo in the process of proliferating and
differentiating (Kobayashi et al., 2020, Strunz et al., 2020, Choi et al., 2020). However,
while transcriptomic or epigenetic data sets provide a wealth of opportunity for
hypothesis generation, these data do not replace functional validation of the
mechanisms underlying cell behavior. The identification of genetic markers and signaling
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pathways requires proof of causality to begin to ask more fundamental biological
questions, including what distinguishes a cell lineage from a cell state. Moreover, as
technology rapidly advances to allow for lower cell inputs, deeper sequencing, single cell
resolution, and in situ transcriptomics, there is an increased need for the standardization
and transparency of data quality assessment, processing, and analysis pipelines to
ensure the reproducibility of findings (Longo et al., 2021, Asp et al., 2020). Combination
of this emerging technology with other tools, such as our mapping tool described in
Chapter 3, would greatly enhance our understanding of the diversity of cellular behavior
across heterogeneously damaged tissue and between various acute and chronic
disease states.

Organoids provide a clonal assay to study the behavior of subsets of cells that, while
transcriptionally similar, may be functionally different. A recent report investigating the
diversity of murine airway secretory cells employed a combination of single cell RNA
sequencing and organoid technology to demonstrate the multipotency of a distinct
subset of club cells marked by high expression of H2-K1 (Kathiriya et al., 2020). While
more work is needed to delineate whether and how H2-K1high variant club cells differ
from BASCs in cellular origin and behavior, this study highlights the usefulness of
organoids to explore the plasticity of rare progenitor cells that are difficult to track in vivo.
Such studies could provide critical insight not only into how progenitor cell fate decisions
drive regeneration, but also how cell identity is maintained in complex niches such as the
human respiratory bronchiole. However, organoid assays must be cautiously interpreted
as culture conditions may heavily dictate the potential behaviors of input cell types
regardless of their in vivo behaviors. As demonstrated most clearly by the creation of
induced pluripotent stem cells, with the addition of the right combination of factors, cells
221

can be forced to transdifferentiate (Takahashi et al., 2007, Takahashi and Yamanaka,
2006).

7.6 Organoid models of human disease
Organoid models provide a flexible, accessible system for modeling lung diseases.
Recent advances in organoid technology have enabled the development of functional
assays to assess hallmarks of several lung diseases, including cystic fibrosis, idiopathic
pulmonary fibrosis, and SARS-CoV-2 infection.

Cystic fibrosis is a chronic genetic disease caused by mutations in CFTR, a gene
encoding an anion channel, leading to the progressive accumulation of thick mucus in
multiple organs, particularly in the lungs. Challenges remain in the development of cellbased therapies for Cystic Fibrosis, but advancements in gene editing technology, the
propagation of primary basal cells, and the generation of pluripotent stem cell (PSC)derived basal cells provide disease modeling opportunities and fuel hope for future
therapies (Berical et al., 2019, Geurts et al., 2021). CFTR function can be measured in
vitro directly using Ussing chambers to measure changes in current due to CFTRmediated ion flux across a polarized monolayer (Li et al., 2004, Hawkins et al., 2021). To
measure CFTR function in lung or intestinal organoids, recent work applied a forskolininduced swelling assay to raise intracellular cAMP levels to open CFTR channels,
allowing an influx of anions and media into an organoid, causing it to swell (Dekkers et
al., 2013b, Boj et al., 2017, Sachs et al., 2019, McCauley et al., 2017). While assessing
ion transport by measuring fluid transport presents an indirect assessment of CFTR
function, this assay provides a useful methodology amenable to drug testing and high
throughput screening (Dekkers et al., 2013a). However, airway organoid cultures are
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currently heterogeneous, so while this assay can assess CFTR function, interpretation of
these findings can be confounded by differential basal cell differentiation efficiency in
control and mutant cultures.

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized
by inflammation, fibroblast expansion, and tissue remodeling. While a wealth of studies
describe various mechanisms associated with fibrotic pathogenesis and progression,
recent work in mice highlights how lung epithelial cell dysfunction can drive fibrosis,
including the development of murine models of AT2 cell senescence and surfactant
protein mutations (Yao et al., 2021, Katzen and Beers, 2020, Katzen et al., 2019, Nureki
et al., 2018, Povedano et al., 2015, Whitsett et al., 2015). Organoids provide a useful
model to functionally assess the altered epithelial-mesenchymal signaling in fibrosis to
identify the origins of fibrotic disease (Shiraishi et al., 2019a). Organoid assays allow the
sequential addition of additional cell types such as immune cells to determine whether
and how other cellular crosstalk is involved in different genetic contexts (Ogawa et al.,
2021). However, while recent advances have been made in the characterization of the
heterogeneous populations of mesenchymal cells in mice, significant work remains to
identify whether and how these populations are similar in humans and how to isolate
them (Zepp et al., 2017, Lee et al., 2017). Moreover, the heterogeneous origins of
myofibroblasts during the development of murine fibrosis raise an important question in
IPF research: are the mechanisms driving the initial onset of fibrosis in humans specific
to a single population of mesenchymal cells or do they result from the fibrotic
transformation of multiple mesenchymal lineages (Zepp et al., 2017)? Organoids provide
a platform to test how communication differs between AT2 cells and distinct
mesenchymal lineages in normal versus diseased settings (Ng-Blichfeldt et al., 2019,
223

Zepp et al., 2017). This use of organoid assays has applications beyond fibrosis as a
recent study employs mouse organoids to demonstrate how altered epithelialmesenchymal crosstalk elicits a Lymphangioleiomyomatosis-like phenotype providing
key insight into the disease (Obraztsova et al., 2020).

Primary human cells and tissue are critical resources for investigating lung diseases.
However, the ability to induce or correct mutations in PSCs with gene editing technology
provides an opportunity for research groups without access to primary human cells to
model diseases like IPF. For example, a recent study used PSC-derived AT2 cells to
investigate the molecular biology underlying a surfactant gene mutation known to cause
fibrosis in humans and mice (Alysandratos et al., 2021a). Another study employed PSCderived lung organoids to model Hermansky-Pudlak syndrome-associated interstitial
pneumonia, a disease also characterized by aggressive fibrosis (Strikoudis et al., 2019).
Thus, PSC-derived organoids allow for the detailed molecular dissection of the cell
intrinsic aspects of human disease in a temporal fashion, providing insight into the
signals related to both the origin and progression of fibrotic disease.

The emergence of the COVID-19 pandemic increased interest in ex vivo models of lung
infectious disease (Chen et al., 2021). Many of these studies have employed human
primary or PSC-derived alveolospheres to understand the transcriptional and signaling
responses of AT2 cells to SARS-CoV-2 infection (Hekman et al., 2021, Huang et al.,
2020, Li et al., 2021, Youk et al., 2020, Ebisudani et al., 2021, Katsura et al., 2020).
These organoid models not only allow the dissection of the evoked response of AT2
cells to viral infection in a temporal manner, but they also enable drug testing to identify
agents that will prevent viral entry or reduce viral replication (Huang et al., 2020,
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Ebisudani et al., 2021, Katsura et al., 2020, Mirabelli et al., 2021). However, organoids
are limited in their ability to model infectious diseases. For example, without an active
immune system, organoids may not reflect the in vivo response to infection of cells from
healthy versus chronically diseased patients, which may have different reactions to
SARS-CoV-2 infection due to their different immune microenvironments (Bui et al.,
2021). Additionally, organoids do not reflect the complexity of the innate defenses of the
respiratory tract, including the physical distance needed for the virus to traverse across
the natural mucociliary clearance system to contact AT2 cells in the distal lung (Davis
and Wypych, 2021). Indeed, as infectious lung injury is heterogeneous and AT2 cells
respond to tissue damage in a spatially restricted manner, organoids may oversimplify
the response of the alveolar niche to infectious diseases like COVID-19 (See Chapters 4
and 6). Ultimately, alveolar organoids can provide critical insight into aspects of
infectious disease such as the cell autonomous effects of AT2 cell infection, but
additional assays will be needed, including in vivo models of COVID-19 disease and
long term human patient studies, to fully address the response of the lung to this
devastating respiratory infection (Muñoz-Fontela et al., 2020, Sonnweber et al., 2022,
Fumagalli et al., 2022).

7.7 The road to pluripotent stem cell derived AT1 cells
Human PSCs provide a tractable system for studying human diseases that lack relevant
in vivo models. However, as noted in Chapter 1, while several groups have published
methods to generate PSC-derived AT2 (iAT2) cells, few have described methods to
convincingly generate PSC-derived AT1 (iAT1) cells (Figure 1.5A). Chapter 5 highlights
that AT2 cell regenerative behavior differs across the lifespan in mice (Penkala et al.,
2021). This work shows that AT2 cells do not differentiate into AT1 cells after acute
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injury during the neonatal period, possibly due to either immaturity of the AT2 cells
themselves or to the immaturity of the niche and the resultant cell-cell signaling (Zepp et
al., 2021, Penkala et al., 2021, Riccetti et al., 2022). This finding, along with other recent
data showing that mouse AT2 cells are specified much earlier than previously
appreciated, suggests that protocols guiding the directed differentiation of PSCs toward
lung lineages may inadvertently prepattern or select for iAT2 cells that cannot robustly
generate iAT1 cells (Frank et al., 2019). Indeed, a major drawback of PSC-derived cells
is their potential immaturity compared to their in vivo counterparts (Abo et al., 2022). A
possible solution to this problem would be to directly induce an AT1 cell lineage
trajectory from the Nkx2.1 progenitor stage and to maintain these iAT1 cells in a
proliferative state similar to what is observed in late embryonic lung development.
Moreover, implementing signaling paradigms from developmental and adult regeneration
studies involving AT1 cell fate modulation such as induction of nuclear Yap/Taz
localization, activation of Tgf-β signaling, and inhibition of Wnt and Fgfr2-mediated
signaling could bias early Nkx2.1 progenitors towards an AT1 cell fate (Figure 1.5B)
(Penkala et al., 2021, Wang et al., 2016b, Frank et al., 2016, Li et al., 2018, Nantie et al.,
2018, Sun et al., 2019, LaCanna et al., 2019, Riemondy et al., 2019). Additionally,
controlled alteration of mechanical tension using a tunable matrix may help to
recapitulate the in vivo mechanical signals necessary for proper iAT1 cell specification,
lineage determination, and fate maintenance (Li et al., 2018).

7.8 Concluding Remarks
In this dissertation, I have defined how cell fate decisions impact the generation and
regeneration of the lung and identified targetable pathways for the manipulation of these
processes. Additionally, developing a new tool for mapping the heterogeneously injured
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tissue resulting from acute lung injury, I have classified distinct regenerative niches with
spatially restricted cellular behaviors. Finally, through comparison of neonatal and adult
regeneration, I have challenged the current dogma of unidirectional alveolar epithelial
plasticity. Together, these results redefine our understanding of the importance and
mechanistic regulation of alveolar epithelial cell identity and the role of AT1 cells during
lung regeneration. Future work implementing my experimental approach and analysis
strategies in conjunction with new tools will build on this new understanding of lung
regeneration. I anticipate that these insights will be useful for the development of clinical
interventions to prevent lung damage and to restore functional lung tissue after acute
injury and in the setting of chronic disease.

A good scientist knows that while their interpretations can be right or wrong, data is
simply data, the measured outcome of an experiment. This dissertation contains the
accumulated data from years of experiments that were deemed to be technically
successful based on reproducibility upon repetition and internal controls. Rather than
believe in my own interpretations of these data as fact, I accept the outcomes of these
experiments as evidence to support the conclusions I have drawn. Ultimately, as we
develop new tools, we should continue to reflect on and test the interpretations of past
experiments to drive us closer toward our collective goal as scientists: uncovering the
truth.
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